CPT_id	classType	ui	suppressible	obsolete	rootSource	atomCount	cVMemberCount	attributes	atoms	ancestors	parents	children	descendants	relations	definitions	concepts	defaultPreferredAtom	name
0001U	SourceAtomCluster	0001U	False	False	CPT	5	0					NONE	NONE		NONE	C4521667;C5414375;C4301946		Red blood cell antigen typing, DNA, human erythrocyte antigen gene analysis of 35 antigens from 11 blood groups, utilizing whole blood, common RBC alleles reported
0002M	SourceAtomCluster	0002M	False	False	CPT	4	0					NONE	NONE		NONE	C3869480;C5697505		Liver disease, ten biochemical assays (ALT, A2-macroglobulin, apolipoprotein A-1, total bilirubin, GGT, haptoglobin, AST, glucose, total cholesterol and triglycerides) utilizing serum, prognostic algorithm reported as quantitative scores for fibrosis, steatosis and alcoholic steatohepatitis (ASH)
0002U	SourceAtomCluster	0002U	False	False	CPT	5	0					NONE	NONE		NONE	C5414376;C4521656		Oncology (colorectal), quantitative assessment of three urine metabolites (ascorbic acid, succinic acid and carnitine) by liquid chromatography with tandem mass spectrometry (LC-MS/MS) using multiple reaction monitoring acquisition, algorithm reported as likelihood of adenomatous polyps
0003M	SourceAtomCluster	0003M	False	False	CPT	4	0					NONE	NONE		NONE	C3869479;C5697506		Liver disease, ten biochemical assays (ALT, A2-macroglobulin, apolipoprotein A-1, total bilirubin, GGT, haptoglobin, AST, glucose, total cholesterol and triglycerides) utilizing serum, prognostic algorithm reported as quantitative scores for fibrosis, steatosis and nonalcoholic steatohepatitis (NASH)
0003U	SourceAtomCluster	0003U	False	False	CPT	5	0					NONE	NONE		NONE	C4301944;C4523576		Oncology (ovarian) biochemical assays of five proteins (apolipoprotein A-1, CA 125 II, follicle stimulating hormone, human epididymis protein 4, transferrin), utilizing serum, algorithm reported as a likelihood score
0004M	SourceAtomCluster	0004M	False	False	CPT	4	0					NONE	NONE		NONE	C3869478;C5697507		Scoliosis, DNA analysis of 53 single nucleotide polymorphisms (SNPs), using saliva, prognostic algorithm reported as a risk score
0005U	SourceAtomCluster	0005U	False	False	CPT	5	0					NONE	NONE		NONE	C4521662;C5414377		Oncology (prostate) gene expression profile by real-time RT-PCR of 3 genes (ERG, PCA3, and SPDEF), urine, algorithm reported as risk score
0006M	SourceAtomCluster	0006M	False	False	CPT	4	0					NONE	NONE		NONE	C3869477;C5697508		Oncology (hepatic), mRNA expression levels of 161 genes, utilizing fresh hepatocellular carcinoma tumor tissue, with alpha-fetoprotein level, algorithm reported as a risk classifier
0007M	SourceAtomCluster	0007M	False	False	CPT	4	0					NONE	NONE		NONE	C3869476;C5697509		Oncology (gastrointestinal neuroendocrine tumors), real-time PCR expression analysis of 51 genes, utilizing whole peripheral blood, algorithm reported as a nomogram of tumor disease index
0007U	SourceAtomCluster	0007U	False	False	CPT	5	0					NONE	NONE		NONE	C4521675;C4523580		Drug test(s), presumptive, with definitive confirmation of positive results, any number of drug classes, urine, includes specimen verification including DNA authentication in comparison to buccal DNA, per date of service
0008U	SourceAtomCluster	0008U	False	False	CPT	7	0					NONE	NONE		NONE	C4521495;C5414378;C5414379;C5414380		Helicobacter pylori detection and antibiotic resistance, DNA, 16S and 23S rRNA, gyrA, pbp1, rdxA and rpoB, next generation sequencing, formalin-fixed paraffin-embedded or fresh tissue or fecal sample, predictive, reported as positive or negative for resistance to clarithromycin, fluoroquinolones, metronidazole, amoxicillin, tetracycline, and rifabutin
0009U	SourceAtomCluster	0009U	False	False	CPT	5	0					NONE	NONE		NONE	C4521499;C4521655;C5414381		Oncology (breast cancer), ERBB2 (HER2) copy number by FISH, tumor cells from formalin-fixed paraffin-embedded tissue isolated using image-based dielectrophoresis (DEP) sorting, reported as ERBB2 gene amplified or non-amplified
0010U	SourceAtomCluster	0010U	False	False	CPT	5	0					NONE	NONE		NONE	C0201216;C4521498;C5414382		Infectious disease (bacterial), strain typing by whole genome sequencing, phylogenetic-based report of strain relatedness, per submitted isolate
0011M	SourceAtomCluster	0011M	False	False	CPT	4	0					NONE	NONE		NONE	C5697510;C4732724		Oncology, prostate cancer, mRNA expression assay of 12 genes (10 content and 2 housekeeping), RT-PCR test utilizing blood plasma and urine, algorithms to predict high-grade prostate cancer risk
0011U	SourceAtomCluster	0011U	False	False	CPT	5	0					NONE	NONE		NONE	C4521672;C5414383		Prescription drug monitoring, evaluation of drugs present by LC-MS/MS, using oral fluid, reported as a comparison to an estimated steady-state range, per date of service including all drug compounds and metabolites
0012M	SourceAtomCluster	0012M	False	False	CPT	4	0					NONE	NONE		NONE	C5697511;C4732725		Oncology (urothelial), mRNA, gene expression profiling by real-time quantitative PCR of five genes (MDK, HOXA13, CDC2 [CDK1], IGFBP5, and CXCR2), utilizing urine, algorithm reported as a risk score for having urothelial carcinoma
0013M	SourceAtomCluster	0013M	False	False	CPT	4	0					NONE	NONE		NONE	C4732726;C5697512		Oncology (urothelial), mRNA, gene expression profiling by real-time quantitative PCR of five genes (MDK, HOXA13, CDC2 [CDK1], IGFBP5, and CXCR2), utilizing urine, algorithm reported as a risk score for having recurrent urothelial carcinoma
0015M	SourceAtomCluster	0015M	False	False	CPT	4	0					NONE	NONE		NONE	C5697514;C5416726		Adrenal cortical tumor, biochemical assay of 25 steroid markers, utilizing 24-hour urine specimen and clinical parameters, prognostic algorithm reported as a clinical risk and integrated clinical steroid risk for adrenal cortical carcinoma, adenoma, or other adrenal malignancy
0016M	SourceAtomCluster	0016M	False	False	CPT	4	0					NONE	NONE		NONE	C5416727;C5697515		Oncology (bladder), mRNA, microarray gene expression profiling of 219 genes, utilizing formalin-fixed paraffin-embedded tissue, algorithm reported as molecular subtype (luminal, luminal infiltrated, basal, basal claudin-low, neuroendocrine-like)
0016U	SourceAtomCluster	0016U	False	False	CPT	6	0					NONE	NONE		NONE	C5414389;C4521658;C5414388;C5414387		Oncology (hematolymphoid neoplasia), RNA, BCR/ABL1 major and minor breakpoint fusion transcripts, quantitative PCR amplification, blood or bone marrow, report of fusion not detected or detected with quantitation
0017M	SourceAtomCluster	0017M	False	False	CPT	4	0					NONE	NONE		NONE	C5697516;C5691641		Oncology (diffuse large B-cell lymphoma [DLBCL]), mRNA, gene expression profiling by fluorescent probe hybridization of 20 genes, formalin-fixed paraffin-embedded tissue, algorithm reported as cell of origin
0017U	SourceAtomCluster	0017U	False	False	CPT	6	0					NONE	NONE		NONE	C4521657;C5414390;C5414391;C5414392		Oncology (hematolymphoid neoplasia), JAK2 mutation, DNA, PCR amplification of exons 12-14 and sequence analysis, blood or bone marrow, report of JAK2 mutation not detected or detected
0018M	SourceAtomCluster	0018M	False	False	CPT	4	0					NONE	NONE		NONE	C5691642;C5697517		Transplantation medicine (allograft rejection, renal), measurement of donor and third-party-induced CD154+T-cytotoxic memory cells, utilizing whole peripheral blood, algorithm reported as a rejection risk score
0018U	SourceAtomCluster	0018U	False	False	CPT	5	0					NONE	NONE		NONE	C4542814;C5414393;C4732273		Oncology (thyroid), microRNA profiling by RT-PCR of 10 microRNA sequences, utilizing fine needle aspirate, algorithm reported as a positive or negative result for moderate to high risk of malignancy
0019M	SourceAtomCluster	0019M	False	False	CPT	4	0					NONE	NONE		NONE	C5852380;C5852381		Cardiovascular disease, plasma, analysis of protein biomarkers by aptamer-based microarray and algorithm reported as 4-year likelihood of coronary event in high-risk populations
0019U	SourceAtomCluster	0019U	False	False	CPT	6	0					NONE	NONE		NONE	C4732275;C4732276;C4732277;C4542815		Oncology, RNA, gene expression by whole transcriptome sequencing, formalin-fixed paraffin-embedded tissue or fresh frozen tissue, predictive algorithm reported as potential targets for therapeutic agents
0020M	SourceAtomCluster	0020M	False	False	CPT	4	0					NONE	NONE		NONE	C5945047;C5945048		Oncology (central nervous system), analysis of 30000 DNA methylation loci by methylation array, utilizing DNA extracted from tumor tissue, diagnostic algorithm reported as probability of matching a reference tumor subclass
0021U	SourceAtomCluster	0021U	False	False	CPT	5	0					NONE	NONE		NONE	C4542816;C4732279;C4732280		Oncology (prostate), detection of 8 autoantibodies (ARF 6, NKX3-1, 5'-UTR-BMI1, CEP 164, 3'-UTR-Ropporin, Desmocollin, AURKAIP-1, CSNK2A2), multiplexed immunoassay and flow cytometry serum, algorithm reported as risk score
0022U	SourceAtomCluster	0022U	False	False	CPT	5	0					NONE	NONE		NONE	C4542817;C5851832;C5851833		Targeted genomic sequence analysis panel, non-small cell lung neoplasia, DNA and RNA analysis, 23 genes, interrogation for sequence variants and rearrangements, reported as presence or absence of variants and associated therapy(ies) to consider
0023U	SourceAtomCluster	0023U	False	False	CPT	5	0					NONE	NONE		NONE	C5414395;C4732283;C4542818		Oncology (acute myelogenous leukemia), DNA, genotyping of internal tandem duplication, p.D835, p.I836, using mononuclear cells, reported as detection or non-detection of FLT3 mutation and indication for or against the use of midostaurin
0024U	SourceAtomCluster	0024U	False	False	CPT	5	0					NONE	NONE		NONE	C5414396;C4732285;C4732286		Glycosylated acute phase proteins (GlycA), nuclear magnetic resonance spectroscopy, quantitative
0025U	SourceAtomCluster	0025U	False	False	CPT	5	0					NONE	NONE		NONE	C4732289;C5414397;C4732288		Tenofovir, by liquid chromatography with tandem mass spectrometry (LC-MS/MS), urine, quantitative
0026U	SourceAtomCluster	0026U	False	False	CPT	5	0					NONE	NONE		NONE	C5414398;C4732291;C4732292		Oncology (thyroid), DNA and mRNA of 112 genes, next-generation sequencing, fine needle aspirate of thyroid nodule, algorithmic analysis reported as a categorical result ("Positive, high probability of malignancy" or "Negative, low probability of malignancy")
0027U	SourceAtomCluster	0027U	False	False	CPT	5	0					NONE	NONE		NONE	C4732294;C5414399;C4732295		JAK2 (Janus kinase 2) (eg, myeloproliferative disorder) gene analysis, targeted sequence analysis exons 12-15
0029U	SourceAtomCluster	0029U	False	False	CPT	5	0					NONE	NONE		NONE	C5414400;C4732298;C4732299		Drug metabolism (adverse drug reactions and drug response), targeted sequence analysis (ie, CYP1A2, CYP2C19, CYP2C9, CYP2D6, CYP3A4, CYP3A5, CYP4F2, SLCO1B1, VKORC1 and rs12777823)
0030U	SourceAtomCluster	0030U	False	False	CPT	5	0					NONE	NONE		NONE	C4732302;C5414401;C4732301		Drug metabolism (warfarin drug response), targeted sequence analysis (ie, CYP2C9, CYP4F2, VKORC1, rs12777823)
0031U	SourceAtomCluster	0031U	False	False	CPT	5	0					NONE	NONE		NONE	C4722651;C4732305;C4732304		CYP1A2 (cytochrome P450 family 1, subfamily A, member 2) (eg, drug metabolism) gene analysis, common variants (ie, *1F, *1K, *6, *7)
0032U	SourceAtomCluster	0032U	False	False	CPT	5	0					NONE	NONE		NONE	C4724362;C4732307;C4732306		COMT (catechol-O-methyltransferase) (eg, drug metabolism) gene analysis, c.472G>A (rs4680) variant
0034U	SourceAtomCluster	0034U	False	False	CPT	5	0					NONE	NONE		NONE	C3708795;C4732311;C4732312		TPMT (thiopurine S-methyltransferase), NUDT15 (nudix hydroxylase 15) (eg, thiopurine metabolism) gene analysis, common variants (ie, TPMT *2, *3A, *3B, *3C, *4, *5, *6, *8, *12; NUDT15 *3, *4, *5)
0035U	SourceAtomCluster	0035U	False	False	CPT	5	0					NONE	NONE		NONE	C4732313;C4732315;C4732314		Neurology (prion disease), cerebrospinal fluid, detection of prion protein by quaking-induced conformational conversion, qualitative
0036U	SourceAtomCluster	0036U	False	False	CPT	5	0					NONE	NONE		NONE	C4732316;C4732317;C4732318		Exome (ie, somatic mutations), paired formalin-fixed paraffin-embedded tumor tissue and normal specimen, sequence analyses
0037U	SourceAtomCluster	0037U	False	False	CPT	5	0					NONE	NONE		NONE	C4732321;C4732319;C4732320		Targeted genomic sequence analysis, solid organ neoplasm, DNA analysis of 324 genes, interrogation for sequence variants, gene copy number amplifications, gene rearrangements, microsatellite instability and tumor mutational burden
0038U	SourceAtomCluster	0038U	False	False	CPT	5	0					NONE	NONE		NONE	C5414402;C4732322;C0428586		Vitamin D, 25 hydroxy D2 and D3, by LC-MS/MS, serum microsample, quantitative
0039U	SourceAtomCluster	0039U	False	False	CPT	5	0					NONE	NONE		NONE	C0236300;C4732324;C4732325		Deoxyribonucleic acid (DNA) antibody, double stranded, high avidity
0040U	SourceAtomCluster	0040U	False	False	CPT	5	0					NONE	NONE		NONE	C4732326;C4732327;C5414403		BCR/ABL1 (t(9;22)) (eg, chronic myelogenous leukemia) translocation analysis, major breakpoint, quantitative
0041U	SourceAtomCluster	0041U	False	False	CPT	5	0					NONE	NONE		NONE	C4732330;C4732331;C4732329		Borrelia burgdorferi, antibody detection of 5 recombinant protein groups, by immunoblot, IgM
0042U	SourceAtomCluster	0042U	False	False	CPT	5	0					NONE	NONE		NONE	C4732334;C4732332;C4732333		Borrelia burgdorferi, antibody detection of 12 recombinant protein groups, by immunoblot, IgG
0043U	SourceAtomCluster	0043U	False	False	CPT	5	0					NONE	NONE		NONE	C5414405;C5414404;C4732335		Tick-borne relapsing fever Borrelia group, antibody detection to 4 recombinant protein groups, by immunoblot, IgM
0044U	SourceAtomCluster	0044U	False	False	CPT	5	0					NONE	NONE		NONE	C4732338;C5414406;C4732336		Tick-borne relapsing fever Borrelia group, antibody detection to 4 recombinant protein groups, by immunoblot, IgG
0045U	SourceAtomCluster	0045U	False	False	CPT	5	0					NONE	NONE		NONE	C5414407;C4732341;C4732340		Oncology (breast ductal carcinoma in situ), mRNA, gene expression profiling by real-time RT-PCR of 12 genes (7 content and 5 housekeeping), utilizing formalin-fixed paraffin-embedded tissue, algorithm reported as recurrence score
0046U	SourceAtomCluster	0046U	False	False	CPT	5	0					NONE	NONE		NONE	C5414408;C4732343;C3516223		FLT3 (fms-related tyrosine kinase 3) (eg, acute myeloid leukemia) internal tandem duplication (ITD) variants, quantitative
0047U	SourceAtomCluster	0047U	False	False	CPT	5	0					NONE	NONE		NONE	C5414409;C4732346;C4732345		Oncology (prostate), mRNA, gene expression profiling by real-time RT-PCR of 17 genes (12 content and 5 housekeeping), utilizing formalin-fixed paraffin-embedded tissue, algorithm reported as a risk score
0048U	SourceAtomCluster	0048U	False	False	CPT	5	0					NONE	NONE		NONE	C4732349;C5414410;C4732348		Oncology (solid organ neoplasia), DNA, targeted sequencing of protein-coding exons of 468 cancer-associated genes, including interrogation for somatic mutations and microsatellite instability, matched with normal specimens, utilizing formalin-fixed paraffin-embedded tumor tissue, report of clinically significant mutation(s)
0049U	SourceAtomCluster	0049U	False	False	CPT	5	0					NONE	NONE		NONE	C4732351;C4732352;C4732353		NPM1 (nucleophosmin) (eg, acute myeloid leukemia) gene analysis, quantitative
0050U	SourceAtomCluster	0050U	False	False	CPT	5	0					NONE	NONE		NONE	C4732355;C4732354;C4732356		Targeted genomic sequence analysis panel, acute myelogenous leukemia, DNA analysis, 194 genes, interrogation for sequence variants, copy number variants or rearrangements
0051U	SourceAtomCluster	0051U	False	False	CPT	6	0					NONE	NONE		NONE	C5696560;C5698178;C5698179;C4732357		Prescription drug monitoring, evaluation of drugs present by liquid chromatography tandem mass spectrometry (LC-MS/MS), urine or blood, 31 drug panel, reported as quantitative results, detected or not detected, per date of service
0052U	SourceAtomCluster	0052U	False	False	CPT	5	0					NONE	NONE		NONE	C5414412;C4732360;C4732361		Lipoprotein, blood, high resolution fractionation and quantitation of lipoproteins, including all five major lipoprotein classes and subclasses of HDL, LDL, and VLDL by vertical auto profile ultracentrifugation
0054U	SourceAtomCluster	0054U	False	False	CPT	5	0					NONE	NONE		NONE	C4732367;C4732369;C4732366		Prescription drug monitoring, 14 or more classes of drugs and substances, definitive tandem mass spectrometry with chromatography, capillary blood, quantitative report with therapeutic and toxic ranges, including steady-state range for the prescribed dose when detected, per date of service
0055U	SourceAtomCluster	0055U	False	False	CPT	5	0					NONE	NONE		NONE	C5414414;C4732371;C4732370		Cardiology (heart transplant), cell-free DNA, PCR assay of 96 DNA target sequences (94 single nucleotide polymorphism targets and two control targets), plasma
0058U	SourceAtomCluster	0058U	False	False	CPT	5	0					NONE	NONE		NONE	C4722652;C5414415;C4732380		Oncology (Merkel cell carcinoma), detection of antibodies to the Merkel cell polyoma virus oncoprotein (small T antigen), serum, quantitative
0059U	SourceAtomCluster	0059U	False	False	CPT	5	0					NONE	NONE		NONE	C5414416;C4732381;C4732382		Oncology (Merkel cell carcinoma), detection of antibodies to the Merkel cell polyoma virus capsid protein (VP1), serum, reported as positive or negative
0060U	SourceAtomCluster	0060U	False	False	CPT	5	0					NONE	NONE		NONE	C4732384;C5414417;C4732385		Twin zygosity, genomic-targeted sequence analysis of chromosome 2, using circulating cell-free fetal DNA in maternal blood
0061U	SourceAtomCluster	0061U	False	False	CPT	5	0					NONE	NONE		NONE	C4732387;C4732388;C5414418		Transcutaneous measurement of five biomarkers (tissue oxygenation [StO2], oxyhemoglobin [ctHbO2], deoxyhemoglobin [ctHbR], papillary and reticular dermal hemoglobin concentrations [ctHb1 and ctHb2]), using spatial frequency domain imaging (SFDI) and multi-spectral analysis
0062U	SourceAtomCluster	0062U	False	False	CPT	5	0					NONE	NONE		NONE	C5202015;C4746523;C5202014		Autoimmune (systemic lupus erythematosus), IgG and IgM analysis of 80 biomarkers, utilizing serum, algorithm reported with a risk score
0063U	SourceAtomCluster	0063U	False	False	CPT	5	0					NONE	NONE		NONE	C5414419;C4746524;C5202016		Neurology (autism), 32 amines by LC-MS/MS, using plasma, algorithm reported as metabolic signature associated with autism spectrum disorder
0064U	SourceAtomCluster	0064U	False	False	CPT	5	0					NONE	NONE		NONE	C4746525;C5202018;C5414420		Antibody, Treponema pallidum, total and rapid plasma reagin (RPR), immunoassay, qualitative
0065U	SourceAtomCluster	0065U	False	False	CPT	5	0					NONE	NONE		NONE	C4722653;C5202020;C5414421		Syphilis test, non-treponemal antibody, immunoassay, qualitative (RPR)
0066U																		
0067U	SourceAtomCluster	0067U	False	False	CPT	5	0					NONE	NONE		NONE	C5202024;C4746527;C5202025		Oncology (breast), immunohistochemistry, protein expression profiling of 4 biomarkers (matrix metalloproteinase-1 [MMP-1], carcinoembryonic antigen-related cell adhesion molecule 6 [CEACAM6], hyaluronoglucosaminidase [HYAL1], highly expressed in cancer protein [HEC1]), formalin-fixed paraffin-embedded precancerous breast tissue, algorithm reported as carcinoma risk score
0068U	SourceAtomCluster	0068U	False	False	CPT	5	0					NONE	NONE		NONE	C5202026;C4746528;C5202027		Candida species panel (C. albicans, C. glabrata, C. parapsilosis, C. kruseii, C. tropicalis, and C. auris), amplified probe technique with qualitative report of the presence or absence of each species
0069U	SourceAtomCluster	0069U	False	False	CPT	5	0					NONE	NONE		NONE	C5414423;C4746529;C5202028		Oncology (colorectal), microRNA, RT-PCR expression profiling of miR-31-3p, formalin-fixed paraffin-embedded tissue, algorithm reported as an expression score
0070U	SourceAtomCluster	0070U	False	False	CPT	5	0					NONE	NONE		NONE	C4746530;C5202030;C5202031		CYP2D6 (cytochrome P450, family 2, subfamily D, polypeptide 6) (eg, drug metabolism) gene analysis, common and select rare variants (ie, *2, *3, *4, *4N, *5, *6, *7, *8, *9, *10, *11, *12, *13, *14A, *14B, *15, *17, *29, *35, *36, *41, *57, *61, *63, *68, *83, *xN)
0071U	SourceAtomCluster	0071U	False	False	CPT	5	0					NONE	NONE		NONE	C5201275;C5202033;C5202032		CYP2D6 (cytochrome P450, family 2, subfamily D, polypeptide 6) (eg, drug metabolism) gene analysis, full gene sequence (List separately in addition to code for primary procedure)
0072U	SourceAtomCluster	0072U	False	False	CPT	5	0					NONE	NONE		NONE	C4746531;C5202034;C5414424		CYP2D6 (cytochrome P450, family 2, subfamily D, polypeptide 6) (eg, drug metabolism) gene analysis, targeted sequence analysis (ie, CYP2D6-2D7 hybrid gene) (List separately in addition to code for primary procedure)
0073U	SourceAtomCluster	0073U	False	False	CPT	5	0					NONE	NONE		NONE	C4746532;C5202036;C5414425		CYP2D6 (cytochrome P450, family 2, subfamily D, polypeptide 6) (eg, drug metabolism) gene analysis, targeted sequence analysis (ie, CYP2D7-2D6 hybrid gene) (List separately in addition to code for primary procedure)
0074U	SourceAtomCluster	0074U	False	False	CPT	5	0					NONE	NONE		NONE	C4746533;C5202038;C5414426		CYP2D6 (cytochrome P450, family 2, subfamily D, polypeptide 6) (eg, drug metabolism) gene analysis, targeted sequence analysis (ie, non-duplicated gene when duplication/multiplication is trans) (List separately in addition to code for primary procedure)
0075U	SourceAtomCluster	0075U	False	False	CPT	5	0					NONE	NONE		NONE	C4746534;C5202040;C5414427		CYP2D6 (cytochrome P450, family 2, subfamily D, polypeptide 6) (eg, drug metabolism) gene analysis, targeted sequence analysis (ie, 5' gene duplication/multiplication) (List separately in addition to code for primary procedure)
0076U	SourceAtomCluster	0076U	False	False	CPT	5	0					NONE	NONE		NONE	C4746535;C5202042;C5202041		CYP2D6 (cytochrome P450, family 2, subfamily D, polypeptide 6) (eg, drug metabolism) gene analysis, targeted sequence analysis (ie, 3' gene duplication/multiplication) (List separately in addition to code for primary procedure)
0077U	SourceAtomCluster	0077U	False	False	CPT	6	0					NONE	NONE		NONE	C5202045;C4746536;C5202044;C5202043		Immunoglobulin paraprotein (M-protein), qualitative, immunoprecipitation and mass spectrometry, blood or urine, including isotype
0078U																		
0080U	SourceAtomCluster	0080U	False	False	CPT	5	0					NONE	NONE		NONE	C4746539;C5202050;C5414430		Oncology (lung), mass spectrometric analysis of galectin-3-binding protein and scavenger receptor cysteine-rich type 1 protein M130, with five clinical risk factors (age, smoking status, nodule diameter, nodule-spiculation status and nodule location), utilizing plasma, algorithm reported as a categorical probability of malignancy
0082U	SourceAtomCluster	0082U	False	False	CPT	6	0					NONE	NONE		NONE	C5414432;C5414431;C4746541;C5202053		Drug test(s), definitive, 90 or more drugs or substances, definitive chromatography with mass spectrometry, and presumptive, any number of drug classes, by instrument chemistry analyzer (utilizing immunoassay), urine, report of presence or absence of each drug, drug metabolite or substance with description and severity of significant interactions per date of service
0083U	SourceAtomCluster	0083U	False	False	CPT	6	0					NONE	NONE		NONE	C4746542;C5202056;C5202057;C5202055		Oncology, response to chemotherapy drugs using motility contrast tomography, fresh or frozen tissue, reported as likelihood of sensitivity or resistance to drugs or drug combinations
0084U	SourceAtomCluster	0084U	False	False	CPT	5	0					NONE	NONE		NONE	C5202059;C5202058;C5202060		Red blood cell antigen typing, DNA, genotyping of 10 blood groups with phenotype prediction of 37 red blood cell antigens
0086U	SourceAtomCluster	0086U	False	False	CPT	5	0					NONE	NONE		NONE	C5202065;C5202067;C5202066		Infectious disease (bacterial and fungal), organism identification, blood culture, using rRNA FISH, 6 or more organism targets, reported as positive or negative with phenotypic minimum inhibitory concentration (MIC)-based antimicrobial susceptibility
0087U	SourceAtomCluster	0087U	False	False	CPT	5	0					NONE	NONE		NONE	C5202070;C5202071;C5202072		Cardiology (heart transplant), mRNA gene expression profiling by microarray of 1283 genes, transplant biopsy tissue, allograft rejection and injury algorithm reported as a probability score
0088U	SourceAtomCluster	0088U	False	False	CPT	5	0					NONE	NONE		NONE	C5202073;C5202075;C5202074		Transplantation medicine (kidney allograft rejection), microarray gene expression profiling of 1494 genes, utilizing transplant biopsy tissue, algorithm reported as a probability score for rejection
0089U	SourceAtomCluster	0089U	False	False	CPT	5	0					NONE	NONE		NONE	C5414433;C5202077;C5202076		Oncology (melanoma), gene expression profiling by RTqPCR, PRAME and LINC00518, superficial collection using adhesive patch(es)
0090U	SourceAtomCluster	0090U	False	False	CPT	5	0					NONE	NONE		NONE	C5202080;C5202081		Oncology (cutaneous melanoma), mRNA gene expression profiling by RT-PCR of 23 genes (14 content and 9 housekeeping), utilizing formalin-fixed paraffin-embedded (FFPE) tissue, algorithm reported as a categorical result (ie, benign, intermediate, malignant)
0092U	SourceAtomCluster	0092U	False	False	CPT	5	0					NONE	NONE		NONE	C5202086;C5202088;C5202087		Oncology (lung), three protein biomarkers, immunoassay using magnetic nanosensor technology, plasma, algorithm reported as risk score for likelihood of malignancy
0093U	SourceAtomCluster	0093U	False	False	CPT	5	0					NONE	NONE		NONE	C5202089;C5202090;C5414436		Prescription drug monitoring, evaluation of 65 common drugs by LC-MS/MS, urine, each drug reported detected or not detected
0094U	SourceAtomCluster	0094U	False	False	CPT	7	0					NONE	NONE		NONE	C5202092;C5202095;C5202093;C5202094		Genome (eg, unexplained constitutional or heritable disorder or syndrome), rapid sequence analysis
0095U	SourceAtomCluster	0095U	False	False	CPT	5	0					NONE	NONE		NONE	C5202096;C5202097		Eosinophilic esophagitis (Eotaxin-3 [CCL26 {C-C motif chemokine ligand 26}] and major basic protein [PRG2 {proteoglycan 2, pro eosinophil major basic protein}]), enzyme-linked immunosorbent assays (ELISA), specimen obtained by esophageal string test device, algorithm reported as probability of active or inactive eosinophilic esophagitis
0096U	SourceAtomCluster	0096U	False	False	CPT	5	0					NONE	NONE		NONE	C5202099;C5202100;C5202101		Human papillomavirus (HPV), high-risk types (ie, 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, 68), male urine
0101U	SourceAtomCluster	0101U	False	False	CPT	5	0					NONE	NONE		NONE	C5202114;C5202115;C5414441		Hereditary colon cancer disorders (eg, Lynch syndrome, PTEN hamartoma syndrome, Cowden syndrome, familial adenomatosis polyposis), genomic sequence analysis panel utilizing a combination of NGS, Sanger, MLPA, and array CGH, with mRNA analytics to resolve variants of unknown significance when indicated (15 genes [sequencing and deletion/duplication], EPCAM and GREM1 [deletion/duplication only])
0102U	SourceAtomCluster	0102U	False	False	CPT	5	0					NONE	NONE		NONE	C5202117;C5202118;C5414442		Hereditary breast cancer-related disorders (eg, hereditary breast cancer, hereditary ovarian cancer, hereditary endometrial cancer), genomic sequence analysis panel utilizing a combination of NGS, Sanger, MLPA, and array CGH, with mRNA analytics to resolve variants of unknown significance when indicated (17 genes [sequencing and deletion/duplication])
0103U	SourceAtomCluster	0103U	False	False	CPT	5	0					NONE	NONE		NONE	C5202121;C5202120;C5414443		Hereditary ovarian cancer (eg, hereditary ovarian cancer, hereditary endometrial cancer), genomic sequence analysis panel utilizing a combination of NGS, Sanger, MLPA, and array CGH, with mRNA analytics to resolve variants of unknown significance when indicated (24 genes [sequencing and deletion/duplication], EPCAM [deletion/duplication only])
0105U	SourceAtomCluster	0105U	False	False	CPT	8	0					NONE	NONE		NONE	C5414447;C5414444;C5202123;C5202124;C5414446;C5414445		Nephrology (chronic kidney disease), multiplex electrochemiluminescent immunoassay (ECLIA) of tumor necrosis factor receptor 1A, receptor superfamily 2 (TNFR1, TNFR2), and kidney injury molecule-1 (KIM-1) combined with longitudinal clinical data, including APOL1 genotype if available, and plasma (isolated fresh or frozen), algorithm reported as probability score for rapid kidney function decline (RKFD)
0106U	SourceAtomCluster	0106U	False	False	CPT	5	0					NONE	NONE		NONE	C5202129;C5702108;C5414448		Gastric emptying, serial collection of 7 timed breath specimens, non-radioisotope carbon-13 (13C) spirulina substrate, analysis of each specimen by gas isotope ratio mass spectrometry, reported as rate of 13CO2 excretion
0107U	SourceAtomCluster	0107U	False	False	CPT	5	0					NONE	NONE		NONE	C5414449;C5202132;C5202133		Clostridium difficile toxin(s) antigen detection by immunoassay technique, stool, qualitative, multiple-step method
0108U	SourceAtomCluster	0108U	False	False	CPT	5	0					NONE	NONE		NONE	C5414450;C5202135;C5202136		Gastroenterology (Barrett's esophagus), whole slide-digital imaging, including morphometric analysis, computer-assisted quantitative immunolabeling of 9 protein biomarkers (p16, AMACR, p53, CD68, COX-2, CD45RO, HIF1a, HER-2, K20) and morphology, formalin-fixed paraffin-embedded tissue, algorithm reported as risk of progression to high-grade dysplasia or cancer
0109U	SourceAtomCluster	0109U	False	False	CPT	7	0					NONE	NONE		NONE	C5414453;C5414451;C5202139;C5202138;C5414452		Infectious disease (Aspergillus species), real-time PCR for detection of DNA from 4 species (A. fumigatus, A. terreus, A. niger, and A. flavus), blood, lavage fluid, or tissue, qualitative reporting of presence or absence of each species
0110U	SourceAtomCluster	0110U	False	False	CPT	20	0					NONE	NONE		NONE	C5414458;C5414461;C5414466;C5414454;C5414455;C5414456;C5414467;C5414469;C5202144;C5202143;C5414460;C5414463;C5414464;C5414465;C5414468;C5414457;C5414459;C5414462		Prescription drug monitoring, one or more oral oncology drug(s) and substances, definitive tandem mass spectrometry with chromatography, serum or plasma from capillary blood or venous blood, quantitative report with steady-state range for the prescribed drug(s) when detected
0111U	SourceAtomCluster	0111U	False	False	CPT	5	0					NONE	NONE		NONE	C5202153;C5202154;C5414470		Oncology (colon cancer), targeted KRAS (codons 12, 13, and 61) and NRAS (codons 12, 13, and 61) gene analysis, utilizing formalin-fixed paraffin-embedded tissue
0112U	SourceAtomCluster	0112U	False	False	CPT	5	0					NONE	NONE		NONE	C5202157;C5202156;C5414471		Infectious agent detection and identification, targeted sequence analysis (16S and 18S rRNA genes) with drug-resistance gene
0113U	SourceAtomCluster	0113U	False	False	CPT	5	0					NONE	NONE		NONE	C5202159;C5202160;C5202161		Oncology (prostate), measurement of PCA3 and TMPRSS2-ERG in urine and PSA in serum following prostatic massage, by RNA amplification and fluorescence-based detection, algorithm reported as risk score
0114U	SourceAtomCluster	0114U	False	False	CPT	5	0					NONE	NONE		NONE	C5202162;C5202163;C5202164		Gastroenterology (Barrett's esophagus), VIM and CCNA1 methylation analysis, esophageal cells, algorithm reported as likelihood for Barrett's esophagus
0115U	SourceAtomCluster	0115U	False	False	CPT	5	0					NONE	NONE		NONE	C5202165;C5202166;C5202167		Respiratory infectious agent detection by nucleic acid (DNA and RNA), 18 viral types and subtypes and 2 bacterial targets, amplified probe technique, including multiplex reverse transcription for RNA targets, each analyte reported as detected or not detected
0116U	SourceAtomCluster	0116U	False	False	CPT	5	0					NONE	NONE		NONE	C5202168;C5202169;C5414472		Prescription drug monitoring, enzyme immunoassay of 35 or more drugs confirmed with LC-MS/MS, oral fluid, algorithm results reported as a patient-compliance measurement with risk of drug to drug interactions for prescribed medications
0117U	SourceAtomCluster	0117U	False	False	CPT	5	0					NONE	NONE		NONE	C5202171;C5202172;C5414473		Pain management, analysis of 11 endogenous analytes (methylmalonic acid, xanthurenic acid, homocysteine, pyroglutamic acid, vanilmandelate, 5-hydroxyindoleacetic acid, hydroxymethylglutarate, ethylmalonate, 3-hydroxypropyl mercapturic acid (3-HPMA), quinolinic acid, kynurenic acid), LC-MS/MS, urine, algorithm reported as a pain-index score with likelihood of atypical biochemical function associated with pain
0118U	SourceAtomCluster	0118U	False	False	CPT	5	0					NONE	NONE		NONE	C5202174;C5202175;C5202176		Transplantation medicine, quantification of donor-derived cell-free DNA using whole genome next-generation sequencing, plasma, reported as percentage of donor-derived cell-free DNA in the total cell-free DNA
0119U	SourceAtomCluster	0119U	False	False	CPT	5	0					NONE	NONE		NONE	C5414474;C5202177;C5202178		Cardiology, ceramides by liquid chromatography-tandem mass spectrometry, plasma, quantitative report with risk score for major cardiovascular events
0120U	SourceAtomCluster	0120U	False	False	CPT	5	0					NONE	NONE		NONE	C5202180;C5202182;C5202181		Oncology (B-cell lymphoma classification), mRNA, gene expression profiling by fluorescent probe hybridization of 58 genes (45 content and 13 housekeeping genes), formalin-fixed paraffin-embedded tissue, algorithm reported as likelihood for primary mediastinal B-cell lymphoma (PMBCL) and diffuse large B-cell lymphoma (DLBCL) with cell of origin subtyping in the latter
0121U	SourceAtomCluster	0121U	False	False	CPT	5	0					NONE	NONE		NONE	C5202183;C5202184;C5414475		Sickle cell disease, microfluidic flow adhesion (VCAM-1), whole blood
0122U	SourceAtomCluster	0122U	False	False	CPT	5	0					NONE	NONE		NONE	C5202188;C5202186;C5202187		Sickle cell disease, microfluidic flow adhesion (P-Selectin), whole blood
0123U	SourceAtomCluster	0123U	False	False	CPT	5	0					NONE	NONE		NONE	C5202189;C5202190;C5414476		Mechanical fragility, RBC, shear stress and spectral analysis profiling
0129U	SourceAtomCluster	0129U	False	False	CPT	5	0					NONE	NONE		NONE	C5202207;C5202208;C5414477		Hereditary breast cancer-related disorders (eg, hereditary breast cancer, hereditary ovarian cancer, hereditary endometrial cancer), genomic sequence analysis and deletion/duplication analysis panel (ATM, BRCA1, BRCA2, CDH1, CHEK2, PALB2, PTEN, and TP53)
0130U	SourceAtomCluster	0130U	False	False	CPT	5	0					NONE	NONE		NONE	C5414478;C5202210;C5202211		Hereditary colon cancer disorders (eg, Lynch syndrome, PTEN hamartoma syndrome, Cowden syndrome, familial adenomatosis polyposis), targeted mRNA sequence analysis panel (APC, CDH1, CHEK2, MLH1, MSH2, MSH6, MUTYH, PMS2, PTEN, and TP53) (List separately in addition to code for primary procedure)
0133U	SourceAtomCluster	0133U	False	False	CPT	5	0					NONE	NONE		NONE	C5202220;C5202219;C5414480		Hereditary prostate cancer-related disorders, targeted mRNA sequence analysis panel (11 genes) (List separately in addition to code for primary procedure)
0134U	SourceAtomCluster	0134U	False	False	CPT	5	0					NONE	NONE		NONE	C5202222;C5202223;C5414481		Hereditary pan cancer (eg, hereditary breast and ovarian cancer, hereditary endometrial cancer, hereditary colorectal cancer), targeted mRNA sequence analysis panel (18 genes) (List separately in addition to code for primary procedure)
0136U	SourceAtomCluster	0136U	False	False	CPT	5	0					NONE	NONE		NONE	C5202229;C5202228;C5202230		ATM (ataxia telangiectasia mutated) (eg, ataxia telangiectasia) mRNA sequence analysis (List separately in addition to code for primary procedure)
0137U	SourceAtomCluster	0137U	False	False	CPT	5	0					NONE	NONE		NONE	C5202231;C5202232;C5414483		PALB2 (partner and localizer of BRCA2) (eg, breast and pancreatic cancer) mRNA sequence analysis (List separately in addition to code for primary procedure)
0138U	SourceAtomCluster	0138U	False	False	CPT	5	0					NONE	NONE		NONE	C5202234;C5202235;C5414484		BRCA1 (BRCA1, DNA repair associated), BRCA2 (BRCA2, DNA repair associated) (eg, hereditary breast and ovarian cancer) mRNA sequence analysis (List separately in addition to code for primary procedure)
0140U	SourceAtomCluster	0140U	False	False	CPT	5	0					NONE	NONE		NONE	C5229224;C5414487;C5414488		Infectious disease (fungi), fungal pathogen identification, DNA (15 fungal targets), blood culture, amplified probe technique, each target reported as detected or not detected
0141U	SourceAtomCluster	0141U	False	False	CPT	5	0					NONE	NONE		NONE	C5414489;C5229225;C5414490		Infectious disease (bacteria and fungi), gram-positive organism identification and drug resistance element detection, DNA (20 gram-positive bacterial targets, 4 resistance genes, 1 pan gram-negative bacterial target, 1 pan Candida target), blood culture, amplified probe technique, each target reported as detected or not detected
0142U	SourceAtomCluster	0142U	False	False	CPT	5	0					NONE	NONE		NONE	C5414491;C5414492;C5229226		Infectious disease (bacteria and fungi), gram-negative bacterial identification and drug resistance element detection, DNA (21 gram-negative bacterial targets, 6 resistance genes, 1 pan gram-positive bacterial target, 1 pan Candida target), amplified probe technique, each target reported as detected or not detected
0152U	SourceAtomCluster	0152U	False	False	CPT	5	0					NONE	NONE		NONE	C5229235;C5698180;C5696561		Infectious disease (bacteria, fungi, parasites, and DNA viruses), microbial cell-free DNA, plasma, untargeted next-generation sequencing, report for significant positive pathogens
0153U	SourceAtomCluster	0153U	False	False	CPT	5	0					NONE	NONE		NONE	C5414514;C5229236;C5414513		Oncology (breast), mRNA, gene expression profiling by next-generation sequencing of 101 genes, utilizing formalin-fixed paraffin-embedded tissue, algorithm reported as a triple negative breast cancer clinical subtype(s) with information on immune cell involvement
0154U	SourceAtomCluster	0154U	False	False	CPT	5	0					NONE	NONE		NONE	C5414517;C5414515;C5414516		Oncology (urothelial cancer), RNA, analysis by real-time RT-PCR of the FGFR3 (fibroblast growth factor receptor 3) gene analysis (ie, p.R248C [c.742C>T], p.S249C [c.746C>G], p.G370C [c.1108G>T], p.Y373C [c.1118A>G], FGFR3-TACC3v1, and FGFR3-TACC3v3), utilizing formalin-fixed paraffin-embedded urothelial cancer tumor tissue, reported as FGFR gene alteration status
0155U	SourceAtomCluster	0155U	False	False	CPT	5	0					NONE	NONE		NONE	C5414518;C5414519;C5414520		Oncology (breast cancer), DNA, PIK3CA (phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha) (eg, breast cancer) gene analysis (ie, p.C420R, p.E542K, p.E545A, p.E545D [g.1635G>T only], p.E545G, p.E545K, p.Q546E, p.Q546R, p.H1047L, p.H1047R, p.H1047Y), utilizing formalin-fixed paraffin-embedded breast tumor tissue, reported as PIK3CA gene mutation status
0156U	SourceAtomCluster	0156U	False	False	CPT	5	0					NONE	NONE		NONE	C5229239;C5414521;C5414522		Copy number (eg, intellectual disability, dysmorphology), sequence analysis
0157U	SourceAtomCluster	0157U	False	False	CPT	5	0					NONE	NONE		NONE	C5414524;C5225015;C5414523		APC (APC regulator of WNT signaling pathway) (eg, familial adenomatosis polyposis [FAP]) mRNA sequence analysis (List separately in addition to code for primary procedure)
0158U	SourceAtomCluster	0158U	False	False	CPT	5	0					NONE	NONE		NONE	C5414525;C5225017;C5414526		MLH1 (mutL homolog 1) (eg, hereditary non-polyposis colorectal cancer, Lynch syndrome) mRNA sequence analysis (List separately in addition to code for primary procedure)
0159U	SourceAtomCluster	0159U	False	False	CPT	5	0					NONE	NONE		NONE	C5414527;C5414528;C5225018		MSH2 (mutS homolog 2) (eg, hereditary colon cancer, Lynch syndrome) mRNA sequence analysis (List separately in addition to code for primary procedure)
0160U	SourceAtomCluster	0160U	False	False	CPT	5	0					NONE	NONE		NONE	C5225019;C5414529;C5414530		MSH6 (mutS homolog 6) (eg, hereditary colon cancer, Lynch syndrome) mRNA sequence analysis (List separately in addition to code for primary procedure)
0161U	SourceAtomCluster	0161U	False	False	CPT	5	0					NONE	NONE		NONE	C5229244;C5414532;C5414531		PMS2 (PMS1 homolog 2, mismatch repair system component) (eg, hereditary non-polyposis colorectal cancer, Lynch syndrome) mRNA sequence analysis (List separately in addition to code for primary procedure)
0162U	SourceAtomCluster	0162U	False	False	CPT	5	0					NONE	NONE		NONE	C5414533;C5229245;C5414534		Hereditary colon cancer (Lynch syndrome), targeted mRNA sequence analysis panel (MLH1, MSH2, MSH6, PMS2) (List separately in addition to code for primary procedure)
0163U	SourceAtomCluster	0163U	False	False	CPT	5	0					NONE	NONE		NONE	C5414537;C5414535;C5414536		Oncology (colorectal) screening, biochemical enzyme-linked immunosorbent assay (ELISA) of 3 plasma or serum proteins (teratocarcinoma derived growth factor-1 [TDGF-1, Cripto-1], carcinoembryonic antigen [CEA], extracellular matrix protein [ECM]), with demographic data (age, gender, CRC-screening compliance) using a proprietary algorithm and reported as likelihood of CRC or advanced adenomas
0164U	SourceAtomCluster	0164U	False	False	CPT	5	0					NONE	NONE		NONE	C5414538;C5414539;C5414540		Gastroenterology (irritable bowel syndrome [IBS]), immunoassay for anti-CdtB and anti-vinculin antibodies, utilizing plasma, algorithm for elevated or not elevated qualitative results
0165U	SourceAtomCluster	0165U	False	False	CPT	5	0					NONE	NONE		NONE	C5414541;C5414542;C5414543		Peanut allergen-specific quantitative assessment of multiple epitopes using enzyme-linked immunosorbent assay (ELISA), blood, individual epitope results and probability of peanut allergy
0166U	SourceAtomCluster	0166U	False	False	CPT	5	0					NONE	NONE		NONE	C5414544;C5414545;C5414546		Liver disease, 10 biochemical assays (Î±2-macroglobulin, haptoglobin, apolipoprotein A1, bilirubin, GGT, ALT, AST, triglycerides, cholesterol, fasting glucose) and biometric and demographic data, utilizing serum, algorithm reported as scores for fibrosis, necroinflammatory activity, and steatosis with a summary interpretation
0169U	SourceAtomCluster	0169U	False	False	CPT	5	0					NONE	NONE		NONE	C5414553;C5414555;C5414554		NUDT15 (nudix hydrolase 15) and TPMT (thiopurine S-methyltransferase) (eg, drug metabolism) gene analysis, common variants
0170U	SourceAtomCluster	0170U	False	False	CPT	5	0					NONE	NONE		NONE	C5414556;C5414558;C5414557		Neurology (autism spectrum disorder [ASD]), RNA, next-generation sequencing, saliva, algorithmic analysis, and results reported as predictive probability of ASD diagnosis
0171U	SourceAtomCluster	0171U	False	False	CPT	5	0					NONE	NONE		NONE	C5414559;C5414560;C5414561		Targeted genomic sequence analysis panel, acute myeloid leukemia, myelodysplastic syndrome, and myeloproliferative neoplasms, DNA analysis, 23 genes, interrogation for sequence variants, rearrangements and minimal residual disease, reported as presence/absence
0172U	SourceAtomCluster	0172U	False	False	CPT	5	0					NONE	NONE		NONE	C5414562;C5414563;C5414564		Oncology (solid tumor as indicated by the label), somatic mutation analysis of BRCA1 (BRCA1, DNA repair associated), BRCA2 (BRCA2, DNA repair associated) and analysis of homologous recombination deficiency pathways, DNA, formalin-fixed paraffin-embedded tissue, algorithm quantifying tumor genomic instability score
0173U	SourceAtomCluster	0173U	False	False	CPT	5	0					NONE	NONE		NONE	C5414566;C5414567;C5414565		Psychiatry (ie, depression, anxiety), genomic analysis panel, includes variant analysis of 14 genes
0174T	SourceAtomCluster	0174T	False	False	CPT	4	0					NONE	NONE		NONE	C1742232;C3517548		Computer-aided detection (CAD) (computer algorithm analysis of digital image data for lesion detection) with further physician review for interpretation and report, with or without digitization of film radiographic images, chest radiograph(s), performed concurrent with primary interpretation (List separately in addition to code for primary procedure)
0174U	SourceAtomCluster	0174U	False	False	CPT	5	0					NONE	NONE		NONE	C5414568;C5414569;C5414570		Oncology (solid tumor), mass spectrometric 30 protein targets, formalin-fixed paraffin-embedded tissue, prognostic and predictive algorithm reported as likely, unlikely, or uncertain benefit of 39 chemotherapy and targeted therapeutic oncology agents
0175T	SourceAtomCluster	0175T	False	False	CPT	4	0					NONE	NONE		NONE	C1741964;C3517549		Computer-aided detection (CAD) (computer algorithm analysis of digital image data for lesion detection) with further physician review for interpretation and report, with or without digitization of film radiographic images, chest radiograph(s), performed remote from primary interpretation
0175U	SourceAtomCluster	0175U	False	False	CPT	5	0					NONE	NONE		NONE	C5414571;C5414572;C5414573		Psychiatry (eg, depression, anxiety), genomic analysis panel, variant analysis of 15 genes
0176U	SourceAtomCluster	0176U	False	False	CPT	6	0					NONE	NONE		NONE	C5414574;C5202063;C5202064;C5202061		Cytolethal distending toxin B (CdtB) and vinculin IgG antibodies by immunoassay (ie, ELISA)
0177U	SourceAtomCluster	0177U	False	False	CPT	5	0					NONE	NONE		NONE	C5414577;C5414575;C5414576		Oncology (breast cancer), DNA, PIK3CA (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha) gene analysis of 11 gene variants utilizing plasma, reported as PIK3CA gene mutation status
0178U	SourceAtomCluster	0178U	False	False	CPT	5	0					NONE	NONE		NONE	C5414580;C5414578;C5414579		Peanut allergen-specific quantitative assessment of multiple epitopes using enzyme-linked immunosorbent assay (ELISA), blood, report of minimum eliciting exposure for a clinical reaction
0179U	SourceAtomCluster	0179U	False	False	CPT	5	0					NONE	NONE		NONE	C5414582;C5414581;C5414583		Oncology (non-small cell lung cancer), cell-free DNA, targeted sequence analysis of 23 genes (single nucleotide variations, insertions and deletions, fusions without prior knowledge of partner/breakpoint, copy number variations), with report of significant mutation(s)
0180U	SourceAtomCluster	0180U	False	False	CPT	5	0					NONE	NONE		NONE	C5414586;C5414584;C5414585		Red cell antigen (ABO blood group) genotyping (ABO), gene analysis Sanger/chain termination/conventional sequencing, ABO (ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase) gene, including subtyping, 7 exons
0181U	SourceAtomCluster	0181U	False	False	CPT	5	0					NONE	NONE		NONE	C5414587;C5414588;C5414589		Red cell antigen (Colton blood group) genotyping (CO), gene analysis, AQP1 (aquaporin 1 [Colton blood group]) exon 1
0182U	SourceAtomCluster	0182U	False	False	CPT	5	0					NONE	NONE		NONE	C5414590;C5414591;C5414592		Red cell antigen (Cromer blood group) genotyping (CROM), gene analysis, CD55 (CD55 molecule [Cromer blood group]) exons 1-10
0183U	SourceAtomCluster	0183U	False	False	CPT	5	0					NONE	NONE		NONE	C5414593;C5414594;C5414595		Red cell antigen (Diego blood group) genotyping (DI), gene analysis, SLC4A1 (solute carrier family 4 member 1 [Diego blood group]) exon 19
0184U	SourceAtomCluster	0184U	False	False	CPT	5	0					NONE	NONE		NONE	C5414596;C5414598;C5414597		Red cell antigen (Dombrock blood group) genotyping (DO), gene analysis, ART4 (ADP-ribosyltransferase 4 [Dombrock blood group]) exon 2
0185U	SourceAtomCluster	0185U	False	False	CPT	5	0					NONE	NONE		NONE	C5414599;C5414600;C5414601		Red cell antigen (H blood group) genotyping (FUT1), gene analysis, FUT1 (fucosyltransferase 1 [H blood group]) exon 4
0186U	SourceAtomCluster	0186U	False	False	CPT	5	0					NONE	NONE		NONE	C5414602;C5414603;C5414604		Red cell antigen (H blood group) genotyping (FUT2), gene analysis, FUT2 (fucosyltransferase 2) exon 2
0187U	SourceAtomCluster	0187U	False	False	CPT	5	0					NONE	NONE		NONE	C5414605;C5414606;C5414607		Red cell antigen (Duffy blood group) genotyping (FY), gene analysis, ACKR1 (atypical chemokine receptor 1 [Duffy blood group]) exons 1-2
0188U	SourceAtomCluster	0188U	False	False	CPT	5	0					NONE	NONE		NONE	C5414610;C5414609;C5414608		Red cell antigen (Gerbich blood group) genotyping (GE), gene analysis, GYPC (glycophorin C [Gerbich blood group]) exons 1-4
0189U	SourceAtomCluster	0189U	False	False	CPT	5	0					NONE	NONE		NONE	C5414612;C5414613;C5414611		Red cell antigen (MNS blood group) genotyping (GYPA), gene analysis, GYPA (glycophorin A [MNS blood group]) introns 1, 5, exon 2
0190U	SourceAtomCluster	0190U	False	False	CPT	5	0					NONE	NONE		NONE	C5414614;C5414616;C5414615		Red cell antigen (MNS blood group) genotyping (GYPB), gene analysis, GYPB (glycophorin B [MNS blood group]) introns 1, 5, pseudoexon 3
0191U	SourceAtomCluster	0191U	False	False	CPT	5	0					NONE	NONE		NONE	C5414618;C5414619;C5414617		Red cell antigen (Indian blood group) genotyping (IN), gene analysis, CD44 (CD44 molecule [Indian blood group]) exons 2, 3, 6
0192U	SourceAtomCluster	0192U	False	False	CPT	5	0					NONE	NONE		NONE	C5414620;C5414622;C5414621		Red cell antigen (Kidd blood group) genotyping (JK), gene analysis, SLC14A1 (solute carrier family 14 member 1 [Kidd blood group]) gene promoter, exon 9
0193U	SourceAtomCluster	0193U	False	False	CPT	5	0					NONE	NONE		NONE	C5414625;C5414623;C5414624		Red cell antigen (JR blood group) genotyping (JR), gene analysis, ABCG2 (ATP binding cassette subfamily G member 2 [Junior blood group]) exons 2-26
0194U	SourceAtomCluster	0194U	False	False	CPT	5	0					NONE	NONE		NONE	C5414627;C5414626;C5414628		Red cell antigen (Kell blood group) genotyping (KEL), gene analysis, KEL (Kell metallo-endopeptidase [Kell blood group]) exon 8
0195U	SourceAtomCluster	0195U	False	False	CPT	6	0					NONE	NONE		NONE	C5414632;C5414629;C5414630;C5414631		KLF1 (Kruppel-like factor 1), targeted sequencing (ie, exon 13)
0196U	SourceAtomCluster	0196U	False	False	CPT	5	0					NONE	NONE		NONE	C5414633;C5414635;C5414634		Red cell antigen (Lutheran blood group) genotyping (LU), gene analysis, BCAM (basal cell adhesion molecule [Lutheran blood group]) exon 3
0197U	SourceAtomCluster	0197U	False	False	CPT	5	0					NONE	NONE		NONE	C5414637;C5414636;C5414638		Red cell antigen (Landsteiner-Wiener blood group) genotyping (LW), gene analysis, ICAM4 (intercellular adhesion molecule 4 [Landsteiner-Wiener blood group]) exon 1
0198U	SourceAtomCluster	0198U	False	False	CPT	5	0					NONE	NONE		NONE	C5414639;C5414641;C5414640		Red cell antigen (RH blood group) genotyping (RHD and RHCE), gene analysis Sanger/chain termination/conventional sequencing, RHD (Rh blood group D antigen) exons 1-10 and RHCE (Rh blood group CcEe antigens) exon 5
0199U	SourceAtomCluster	0199U	False	False	CPT	5	0					NONE	NONE		NONE	C5414642;C5414643;C5414644		Red cell antigen (Scianna blood group) genotyping (SC), gene analysis, ERMAP (erythroblast membrane associated protein [Scianna blood group]) exons 4, 12
0200U	SourceAtomCluster	0200U	False	False	CPT	5	0					NONE	NONE		NONE	C5414645;C5414646;C5414647		Red cell antigen (Kx blood group) genotyping (XK), gene analysis, XK (X-linked Kx blood group) exons 1-3
0201U	SourceAtomCluster	0201U	False	False	CPT	5	0					NONE	NONE		NONE	C5414650;C5414649;C5414648		Red cell antigen (Yt blood group) genotyping (YT), gene analysis, ACHE (acetylcholinesterase [Cartwright blood group]) exon 2
0202U	SourceAtomCluster	0202U	False	False	CPT	5	0					NONE	NONE		NONE	C5414652;C5400851;C5414651		Infectious disease (bacterial or viral respiratory tract infection), pathogen-specific nucleic acid (DNA or RNA), 22 targets including severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), qualitative RT-PCR, nasopharyngeal swab, each pathogen reported as detected or not detected
0203U	SourceAtomCluster	0203U	False	False	CPT	5	0					NONE	NONE		NONE	C5414655;C5414653;C5414654		Autoimmune (inflammatory bowel disease), mRNA, gene expression profiling by quantitative RT-PCR, 17 genes (15 target and 2 reference genes), whole blood, reported as a continuous risk score and classification of inflammatory bowel disease aggressiveness
0205U	SourceAtomCluster	0205U	False	False	CPT	5	0					NONE	NONE		NONE	C5414660;C5414661;C5414659		Ophthalmology (age-related macular degeneration), analysis of 3 gene variants (2 CFH gene, 1 ARMS2 gene), using PCR and MALDI-TOF, buccal swab, reported as positive or negative for neovascular age-related macular-degeneration risk associated with zinc supplements
0206U	SourceAtomCluster	0206U	False	False	CPT	5	0					NONE	NONE		NONE	C5414662;C5414663;C5414664		Neurology (Alzheimer disease); cell aggregation using morphometric imaging and protein kinase C-epsilon (PKCe) concentration in response to amylospheroid treatment by ELISA, cultured skin fibroblasts, each reported as positive or negative for Alzheimer disease
0207U	SourceAtomCluster	0207U	False	False	CPT	5	0					NONE	NONE		NONE	C5414665;C5414666;C5414667		Neurology (Alzheimer disease); quantitative imaging of phosphorylated ERK1 and ERK2 in response to bradykinin treatment by in situ immunofluorescence, using cultured skin fibroblasts, reported as a probability index for Alzheimer disease (List separately in addition to code for primary procedure)
0209U	SourceAtomCluster	0209U	False	False	CPT	5	0					NONE	NONE		NONE	C5414671;C5414672;C5414673		Cytogenomic constitutional (genome-wide) analysis, interrogation of genomic regions for copy number, structural changes and areas of homozygosity for chromosomal abnormalities
0210U	SourceAtomCluster	0210U	False	False	CPT	5	0					NONE	NONE		NONE	C5414674;C5414676;C5414675		Syphilis test, non-treponemal antibody, immunoassay, quantitative (RPR)
0211U	SourceAtomCluster	0211U	False	False	CPT	5	0					NONE	NONE		NONE	C5414677;C5414678;C5414679		Oncology (pan-tumor), DNA and RNA by next-generation sequencing, utilizing formalin-fixed paraffin-embedded tissue, interpretative report for single nucleotide variants, copy number alterations, tumor mutational burden, and microsatellite instability, with therapy association
0212U	SourceAtomCluster	0212U	False	False	CPT	6	0					NONE	NONE		NONE	C5414680;C5414683;C5414681;C5414682		Rare diseases (constitutional/heritable disorders), whole genome and mitochondrial DNA sequence analysis, including small sequence changes, deletions, duplications, short tandem repeat gene expansions, and variants in non-uniquely mappable regions, blood or saliva, identification and categorization of genetic variants, proband
0213U	SourceAtomCluster	0213U	False	False	CPT	8	0					NONE	NONE		NONE	C5414689;C5414685;C5414686;C5414684;C5414688;C5414687		Rare diseases (constitutional/heritable disorders), whole genome and mitochondrial DNA sequence analysis, including small sequence changes, deletions, duplications, short tandem repeat gene expansions, and variants in non-uniquely mappable regions, blood or saliva, identification and categorization of genetic variants, each comparator genome (eg, parent, sibling)
0214U	SourceAtomCluster	0214U	False	False	CPT	6	0					NONE	NONE		NONE	C5414690;C5414692;C5414691;C5414693		Rare diseases (constitutional/heritable disorders), whole exome and mitochondrial DNA sequence analysis, including small sequence changes, deletions, duplications, short tandem repeat gene expansions, and variants in non-uniquely mappable regions, blood or saliva, identification and categorization of genetic variants, proband
0215U	SourceAtomCluster	0215U	False	False	CPT	8	0					NONE	NONE		NONE	C5414699;C5414696;C5414694;C5414697;C5414698;C5414695		Rare diseases (constitutional/heritable disorders), whole exome and mitochondrial DNA sequence analysis, including small sequence changes, deletions, duplications, short tandem repeat gene expansions, and variants in non-uniquely mappable regions, blood or saliva, identification and categorization of genetic variants, each comparator exome (eg, parent, sibling)
0216U	SourceAtomCluster	0216U	False	False	CPT	6	0					NONE	NONE		NONE	C5414700;C5414702;C5414703;C5414701		Neurology (inherited ataxias), genomic DNA sequence analysis of 12 common genes including small sequence changes, deletions, duplications, short tandem repeat gene expansions, and variants in non-uniquely mappable regions, blood or saliva, identification and categorization of genetic variants
0217U	SourceAtomCluster	0217U	False	False	CPT	6	0					NONE	NONE		NONE	C5414704;C5414705;C5414707;C5414706		Neurology (inherited ataxias), genomic DNA sequence analysis of 51 genes including small sequence changes, deletions, duplications, short tandem repeat gene expansions, and variants in non-uniquely mappable regions, blood or saliva, identification and categorization of genetic variants
0218U	SourceAtomCluster	0218U	False	False	CPT	6	0					NONE	NONE		NONE	C5414708;C5414711;C5414710;C5414709		Neurology (muscular dystrophy), DMD gene sequence analysis, including small sequence changes, deletions, duplications, and variants in non-uniquely mappable regions, blood or saliva, identification and characterization of genetic variants
0219U	SourceAtomCluster	0219U	False	False	CPT	5	0					NONE	NONE		NONE	C5414712;C5414714;C5414713		Infectious agent (human immunodeficiency virus), targeted viral next-generation sequence analysis (ie, protease [PR], reverse transcriptase [RT], integrase [INT]), algorithm reported as prediction of antiviral drug susceptibility
0220U	SourceAtomCluster	0220U	False	False	CPT	5	0					NONE	NONE		NONE	C5414715;C5414717;C5414716		Oncology (breast cancer), image analysis with artificial intelligence assessment of 12 histologic and immunohistochemical features, reported as a recurrence score
0221U	SourceAtomCluster	0221U	False	False	CPT	5	0					NONE	NONE		NONE	C5414718;C5414719;C5414720		Red cell antigen (ABO blood group) genotyping (ABO), gene analysis, next-generation sequencing, ABO (ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase) gene
0222U	SourceAtomCluster	0222U	False	False	CPT	5	0					NONE	NONE		NONE	C5414722;C5414721;C5414723		Red cell antigen (RH blood group) genotyping (RHD and RHCE), gene analysis, next-generation sequencing, RH proximal promoter, exons 1-10, portions of introns 2-3
0223U	SourceAtomCluster	0223U	False	False	CPT	5	0					NONE	NONE		NONE	C5414651;C5400850;C5414724		Infectious disease (bacterial or viral respiratory tract infection), pathogen-specific nucleic acid (DNA or RNA), 22 targets including severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), qualitative RT-PCR, nasopharyngeal swab, each pathogen reported as detected or not detected
0224U	SourceAtomCluster	0224U	False	False	CPT	7	0					NONE	NONE		NONE	C5414727;C5413657;C5414725;C5414726		Antibody, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]), includes titer(s), when performed
0225U	SourceAtomCluster	0225U	False	False	CPT	5	0					NONE	NONE		NONE	C5414728;C5414729;C5414730		Infectious disease (bacterial or viral respiratory tract infection) pathogen-specific DNA and RNA, 21 targets, including severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), amplified probe technique, including multiplex reverse transcription for RNA targets, each analyte reported as detected or not detected
0226U	SourceAtomCluster	0226U	False	False	CPT	6	0					NONE	NONE		NONE	C5414731;C5414733;C5414734;C5414732		Surrogate viral neutralization test (sVNT), severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]), ELISA, plasma, serum
0227U	SourceAtomCluster	0227U	False	False	CPT	5	0					NONE	NONE		NONE	C5439855;C5698181;C5696562		Drug assay, presumptive, 30 or more drugs or metabolites, urine, liquid chromatography with tandem mass spectrometry (LC-MS/MS) using multiple reaction monitoring (MRM), with drug or metabolite description, includes sample validation
0228U	SourceAtomCluster	0228U	False	False	CPT	5	0					NONE	NONE		NONE	C5439856;C5698182;C5696563		Oncology (prostate), multianalyte molecular profile by photometric detection of macromolecules adsorbed on nanosponge array slides with machine learning, utilizing first morning voided urine, algorithm reported as likelihood of prostate cancer
0229U	SourceAtomCluster	0229U	False	False	CPT	5	0					NONE	NONE		NONE	C5439857		BCAT1 (Branched chain amino acid transaminase 1) and IKZF1 (IKAROS family zinc finger 1) (eg, colorectal cancer) promoter methylation analysis
0230U	SourceAtomCluster	0230U	False	False	CPT	5	0					NONE	NONE		NONE	C5439858;C5696565;C5698184		AR (androgen receptor) (eg, spinal and bulbar muscular atrophy, Kennedy disease, X chromosome inactivation), full sequence analysis, including small sequence changes in exonic and intronic regions, deletions, duplications, short tandem repeat (STR) expansions, mobile element insertions, and variants in non-uniquely mappable regions
0231U	SourceAtomCluster	0231U	False	False	CPT	5	0					NONE	NONE		NONE	C5439859;C5696566;C5698185		CACNA1A (calcium voltage-gated channel subunit alpha 1A) (eg, spinocerebellar ataxia), full gene analysis, including small sequence changes in exonic and intronic regions, deletions, duplications, short tandem repeat (STR) gene expansions, mobile element insertions, and variants in non-uniquely mappable regions
0232U	SourceAtomCluster	0232U	False	False	CPT	5	0					NONE	NONE		NONE	C5439860;C5696567;C5698186		CSTB (cystatin B) (eg, progressive myoclonic epilepsy type 1A, Unverricht-Lundborg disease), full gene analysis, including small sequence changes in exonic and intronic regions, deletions, duplications, short tandem repeat (STR) expansions, mobile element insertions, and variants in non-uniquely mappable regions
0233U	SourceAtomCluster	0233U	False	False	CPT	5	0					NONE	NONE		NONE	C5575053;C5696568;C5698187		FXN (frataxin) (eg, Friedreich ataxia), gene analysis, including small sequence changes in exonic and intronic regions, deletions, duplications, short tandem repeat (STR) expansions, mobile element insertions, and variants in non-uniquely mappable regions
0234U	SourceAtomCluster	0234U	False	False	CPT	5	0					NONE	NONE		NONE	C5696569;C5439861;C5698188		MECP2 (methyl CpG binding protein 2) (eg, Rett syndrome), full gene analysis, including small sequence changes in exonic and intronic regions, deletions, duplications, mobile element insertions, and variants in non-uniquely mappable regions
0235U	SourceAtomCluster	0235U	False	False	CPT	5	0					NONE	NONE		NONE	C5439862;C5698189;C5696570		PTEN (phosphatase and tensin homolog) (eg, Cowden syndrome, PTEN hamartoma tumor syndrome), full gene analysis, including small sequence changes in exonic and intronic regions, deletions, duplications, mobile element insertions, and variants in non-uniquely mappable regions
0236U	SourceAtomCluster	0236U	False	False	CPT	5	0					NONE	NONE		NONE	C5696571;C5439863;C5698190		SMN1 (survival of motor neuron 1, telomeric) and SMN2 (survival of motor neuron 2, centromeric) (eg, spinal muscular atrophy) full gene analysis, including small sequence changes in exonic and intronic regions, duplications, deletions, and mobile element insertions
0237U	SourceAtomCluster	0237U	False	False	CPT	5	0					NONE	NONE		NONE	C5696572;C5439864;C5698191		Cardiac ion channelopathies (eg, Brugada syndrome, long QT syndrome, short QT syndrome, catecholaminergic polymorphic ventricular tachycardia), genomic sequence analysis panel including ANK2, CASQ2, CAV3, KCNE1, KCNE2, KCNH2, KCNJ2, KCNQ1, RYR2, and SCN5A, including small sequence changes in exonic and intronic regions, deletions, duplications, mobile element insertions, and variants in non-uniquely mappable regions
0238U	SourceAtomCluster	0238U	False	False	CPT	5	0					NONE	NONE		NONE	C5696573;C5439865;C5698192		Oncology (Lynch syndrome), genomic DNA sequence analysis of MLH1, MSH2, MSH6, PMS2, and EPCAM, including small sequence changes in exonic and intronic regions, deletions, duplications, mobile element insertions, and variants in non-uniquely mappable regions
0239U	SourceAtomCluster	0239U	False	False	CPT	5	0					NONE	NONE		NONE	C5439866;C5696574;C5698193		Targeted genomic sequence analysis panel, solid organ neoplasm, cell-free DNA, analysis of 311 or more genes, interrogation for sequence variants, including substitutions, insertions, deletions, select rearrangements, and copy number variations
0242U	SourceAtomCluster	0242U	False	False	CPT	5	0					NONE	NONE		NONE	C5696577;C5691504;C5698196		Targeted genomic sequence analysis panel, solid organ neoplasm, cell-free circulating DNA analysis of 55-74 genes, interrogation for sequence variants, gene copy number amplifications, and gene rearrangements
0243U	SourceAtomCluster	0243U	False	False	CPT	5	0					NONE	NONE		NONE	C5691505;C5696578;C5698197		Obstetrics (preeclampsia), biochemical assay of placental-growth factor, time-resolved fluorescence immunoassay, maternal serum, predictive algorithm reported as a risk score for preeclampsia
0244U	SourceAtomCluster	0244U	False	False	CPT	5	0					NONE	NONE		NONE	C5696579;C5691506;C5698198		Oncology (solid organ), DNA, comprehensive genomic profiling, 257 genes, interrogation for single-nucleotide variants, insertions/deletions, copy number alterations, gene rearrangements, tumor-mutational burden and microsatellite instability, utilizing formalin-fixed paraffin-embedded tumor tissue
0245U	SourceAtomCluster	0245U	False	False	CPT	5	0					NONE	NONE		NONE	C5691507;C5696580;C5698199		Oncology (thyroid), mutation analysis of 10 genes and 37 RNA fusions and expression of 4 mRNA markers using next-generation sequencing, fine needle aspirate, report includes associated risk of malignancy expressed as a percentage
0246U	SourceAtomCluster	0246U	False	False	CPT	5	0					NONE	NONE		NONE	C5698200;C5691508;C5696581		Red blood cell antigen typing, DNA, genotyping of at least 16 blood groups with phenotype prediction of at least 51 red blood cell antigens
0247U	SourceAtomCluster	0247U	False	False	CPT	5	0					NONE	NONE		NONE	C5696582;C5698201;C5691509		Obstetrics (preterm birth), insulin-like growth factor-binding protein 4 (IBP4), sex hormone-binding globulin (SHBG), quantitative measurement by LC-MS/MS, utilizing maternal serum, combined with clinical data, reported as predictive-risk stratification for spontaneous preterm birth
0248U	SourceAtomCluster	0248U	False	False	CPT	6	0					NONE	NONE		NONE	C5691510;C5944586;C5696583;C5944587		Oncology, spheroid cell culture in 3D microenvironment, 12-drug panel, brain- or brain metastasis-response prediction for each drug
0249U	SourceAtomCluster	0249U	False	False	CPT	5	0					NONE	NONE		NONE	C5696584;C5691511;C5698203		Oncology (breast), semiquantitative analysis of 32 phosphoproteins and protein analytes, includes laser capture microdissection, with algorithmic analysis and interpretative report
0250U	SourceAtomCluster	0250U	False	False	CPT	5	0					NONE	NONE		NONE	C5691512;C5696585;C5698204		Oncology (solid organ neoplasm), targeted genomic sequence DNA analysis of 505 genes, interrogation for somatic alterations (SNVs [single nucleotide variant], small insertions and deletions, one amplification, and four translocations), microsatellite instability and tumor-mutation burden
0251U	SourceAtomCluster	0251U	False	False	CPT	6	0					NONE	NONE		NONE	C5541207;C5696586;C5698205;C5698206		Hepcidin-25, enzyme-linked immunosorbent assay (ELISA), serum or plasma
0252U	SourceAtomCluster	0252U	False	False	CPT	5	0					NONE	NONE		NONE	C5698207;C5691513;C5696587		Fetal aneuploidy short tandem-repeat comparative analysis, fetal DNA from products of conception, reported as normal (euploidy), monosomy, trisomy, or partial deletion/duplication, mosaicism, and segmental aneuploidy
0253U	SourceAtomCluster	0253U	False	False	CPT	5	0					NONE	NONE		NONE	C5696588;C5698208;C5691514		Reproductive medicine (endometrial receptivity analysis), RNA gene expression profile, 238 genes by next-generation sequencing, endometrial tissue, predictive algorithm reported as endometrial window of implantation (eg, pre-receptive, receptive, post-receptive)
0254U	SourceAtomCluster	0254U	False	False	CPT	5	0					NONE	NONE		NONE	C5691515;C5698209;C5696589		Reproductive medicine (preimplantation genetic assessment), analysis of 24 chromosomes using embryonic DNA genomic sequence analysis for aneuploidy, and a mitochondrial DNA score in euploid embryos, results reported as normal (euploidy), monosomy, trisomy, or partial deletion/duplication, mosaicism, and segmental aneuploidy, per embryo tested
0255U	SourceAtomCluster	0255U	False	False	CPT	6	0					NONE	NONE		NONE	C5698211;C5691516;C5696590;C5698210		Andrology (infertility), sperm-capacitation assessment of ganglioside GM1 distribution patterns, fluorescence microscopy, fresh or frozen specimen, reported as percentage of capacitated sperm and probability of generating a pregnancy score
0256U	SourceAtomCluster	0256U	False	False	CPT	5	0					NONE	NONE		NONE	C5696591;C5698212;C5691517		Trimethylamine/trimethylamine N-oxide (TMA/TMAO) profile, tandem mass spectrometry (MS/MS), urine, with algorithmic analysis and interpretive report
0257U	SourceAtomCluster	0257U	False	False	CPT	5	0					NONE	NONE		NONE	C5696592;C5691518;C5698213		Very long chain acyl-coenzyme A (CoA) dehydrogenase (VLCAD), leukocyte enzyme activity, whole blood
0258U	SourceAtomCluster	0258U	False	False	CPT	5	0					NONE	NONE		NONE	C5698214;C5691519;C5696593		Autoimmune (psoriasis), mRNA, next-generation sequencing, gene expression profiling of 50-100 genes, skin-surface collection using adhesive patch, algorithm reported as likelihood of response to psoriasis biologics
0259U	SourceAtomCluster	0259U	False	False	CPT	5	0					NONE	NONE		NONE	C5698215;C5691520;C5696594		Nephrology (chronic kidney disease), nuclear magnetic resonance spectroscopy measurement of myo-inositol, valine, and creatinine, algorithmically combined with cystatin C (by immunoassay) and demographic data to determine estimated glomerular filtration rate (GFR), serum, quantitative
0260U	SourceAtomCluster	0260U	False	False	CPT	5	0					NONE	NONE		NONE	C5970180;C5696595;C5698216		Rare diseases (constitutional/heritable disorders), identification of copy number variations, inversions, insertions, translocations, and other structural variants by optical genome mapping
0261U	SourceAtomCluster	0261U	False	False	CPT	5	0					NONE	NONE		NONE	C5698217;C5691521;C5696596		Oncology (colorectal cancer), image analysis with artificial intelligence assessment of 4 histologic and immunohistochemical features (CD3 and CD8 within tumor-stroma border and tumor core), tissue, reported as immune response and recurrence-risk score
0262U	SourceAtomCluster	0262U	False	False	CPT	5	0					NONE	NONE		NONE	C5698218;C5691522;C5696597		Oncology (solid tumor), gene expression profiling by real-time RT-PCR of 7 gene pathways (ER, AR, PI3K, MAPK, HH, TGFB, Notch), formalin-fixed paraffin-embedded (FFPE), algorithm reported as gene pathway activity score
0263U	SourceAtomCluster	0263U	False	False	CPT	5	0					NONE	NONE		NONE	C5691523;C5696598;C5698219		Neurology (autism spectrum disorder [ASD]), quantitative measurements of 16 central carbon metabolites (ie, Î±-ketoglutarate, alanine, lactate, phenylalanine, pyruvate, succinate, carnitine, citrate, fumarate, hypoxanthine, inosine, malate, S-sulfocysteine, taurine, urate, and xanthine), liquid chromatography tandem mass spectrometry (LC-MS/MS), plasma, algorithmic analysis with result reported as negative or positive (with metabolic subtypes of ASD)
0264U	SourceAtomCluster	0264U	False	False	CPT	5	0					NONE	NONE		NONE	C5696595;C5698220;C5671325		Rare diseases (constitutional/heritable disorders), identification of copy number variations, inversions, insertions, translocations, and other structural variants by optical genome mapping
0265U	SourceAtomCluster	0265U	False	False	CPT	9	0					NONE	NONE		NONE	C5698222;C5698225;C5691524;C5696599;C5698221;C5698223;C5698224		Rare constitutional and other heritable disorders, whole genome and mitochondrial DNA sequence analysis, blood, frozen and formalin-fixed paraffin-embedded (FFPE) tissue, saliva, buccal swabs or cell lines, identification of single nucleotide and copy number variants
0266U	SourceAtomCluster	0266U	False	False	CPT	7	0					NONE	NONE		NONE	C5691525;C5696600;C5698227;C5698228;C5698226		Unexplained constitutional or other heritable disorders or syndromes, tissue-specific gene expression by whole-transcriptome and next-generation sequencing, blood, formalin-fixed paraffin-embedded (FFPE) tissue or fresh frozen tissue, reported as presence or absence of splicing or expression changes
0267U	SourceAtomCluster	0267U	False	False	CPT	5	0					NONE	NONE		NONE	C5691526;C5696601;C5698229		Rare constitutional and other heritable disorders, identification of copy number variations, inversions, insertions, translocations, and other structural variants by optical genome mapping and whole genome sequencing
0268U	SourceAtomCluster	0268U	False	False	CPT	7	0					NONE	NONE		NONE	C5691527;C5696602;C5698230;C5698231;C5698232		Hematology (atypical hemolytic uremic syndrome [aHUS]), genomic sequence analysis of 15 genes, blood, buccal swab, or amniotic fluid
0269U	SourceAtomCluster	0269U	False	False	CPT	7	0					NONE	NONE		NONE	C5851834;C5851837;C5851836;C5851835;C5691528		Hematology (autosomal dominant congenital thrombocytopenia), genomic sequence analysis of 22 genes, blood, buccal swab, or amniotic fluid
0270U	SourceAtomCluster	0270U	False	False	CPT	7	0					NONE	NONE		NONE	C5698238;C5691529;C5696604;C5698237;C5698236		Hematology (congenital coagulation disorders), genomic sequence analysis of 20 genes, blood, buccal swab, or amniotic fluid
0271U	SourceAtomCluster	0271U	False	False	CPT	7	0					NONE	NONE		NONE	C5851838;C5851839;C5851841;C5851840;C5691530		Hematology (congenital neutropenia), genomic sequence analysis of 24 genes, blood, buccal swab, or amniotic fluid
0272U	SourceAtomCluster	0272U	False	False	CPT	20	0					NONE	NONE		NONE	C5851843;C5851844;C5851852;C5851856;C5851842;C5851849;C5851851;C5851853;C5851847;C5851854;C5851857;C5851845;C5851846;C5851848;C5851850;C5851855;C5691531		Hematology (genetic bleeding disorders), genomic sequence analysis of 60 genes and duplication/deletion of PLAU, blood, buccal swab, or amniotic fluid, comprehensive
0273U	SourceAtomCluster	0273U	False	False	CPT	7	0					NONE	NONE		NONE	C5691532;C5698247;C5698245;C5698246		Hematology (genetic hyperfibrinolysis, delayed bleeding), analysis of 9 genes (F13A1, F13B, FGA, FGB, FGG, SERPINA1, SERPINE1, SERPINF2 by next-generation sequencing, and PLAU by array comparative genomic hybridization), blood, buccal swab, or amniotic fluid
0274U	SourceAtomCluster	0274U	False	False	CPT	20	0					NONE	NONE		NONE	C5851867;C5851872;C5851874;C5851860;C5851861;C5851873;C5851858;C5851859;C5851863;C5851864;C5851868;C5851870;C5851862;C5851865;C5851866;C5851869;C5851871;C5691533		Hematology (genetic platelet disorders), genomic sequence analysis of 62 genes and duplication/deletion of PLAU, blood, buccal swab, or amniotic fluid
0275U	SourceAtomCluster	0275U	False	False	CPT	5	0					NONE	NONE		NONE	C5696609;C5691534;C5698251		Hematology (heparin-induced thrombocytopenia), platelet antibody reactivity by flow cytometry, serum
0276U	SourceAtomCluster	0276U	False	False	CPT	7	0					NONE	NONE		NONE	C5702110;C5691535;C5702111;C5702112;C5702109		Hematology (inherited thrombocytopenia), genomic sequence analysis of 42 genes, blood, buccal swab, or amniotic fluid
0277U	SourceAtomCluster	0277U	False	False	CPT	31	0					NONE	NONE		NONE	C5851877;C5851879;C5851880;C5851883;C5851885;C5851886;C5851887;C5851890;C5851893;C5851898;C5851899;C5851900;C5851878;C5851889;C5851896;C5851884;C5851891;C5851894;C5851875;C5851881;C5851882;C5851888;C5851895;C5851876;C5851892		Hematology (genetic platelet function disorder), genomic sequence analysis of 40 genes and duplication/deletion of PLAU, blood, buccal swab, or amniotic fluid
0278U	SourceAtomCluster	0278U	False	False	CPT	8	0					NONE	NONE		NONE	C5691537;C5851901;C5851903;C5851904;C5851902		Hematology (genetic thrombosis), genomic sequence analysis of 14 genes, blood, buccal swab, or amniotic fluid
0279U	SourceAtomCluster	0279U	False	False	CPT	5	0					NONE	NONE		NONE	C5691538;C5696613;C5698261		Hematology (von Willebrand disease [VWD]), von Willebrand factor (VWF) and collagen III binding by enzyme-linked immunosorbent assays (ELISA), plasma, report of collagen III binding
0280U	SourceAtomCluster	0280U	False	False	CPT	5	0					NONE	NONE		NONE	C5691539;C5696614;C5698262		Hematology (von Willebrand disease [VWD]), von Willebrand factor (VWF) and collagen IV binding by enzyme-linked immunosorbent assays (ELISA), plasma, report of collagen IV binding
0281U	SourceAtomCluster	0281U	False	False	CPT	5	0					NONE	NONE		NONE	C5691540;C5698263;C5696615		Hematology (von Willebrand disease [VWD]), von Willebrand propeptide, enzyme-linked immunosorbent assays (ELISA), plasma, diagnostic report of von Willebrand factor (VWF) propeptide antigen level
0282U	SourceAtomCluster	0282U	False	False	CPT	5	0					NONE	NONE		NONE	C5691541;C5696616;C5698264		Red blood cell antigen typing, DNA, genotyping of 12 blood group system genes to predict 44 red blood cell antigen phenotypes
0283U	SourceAtomCluster	0283U	False	False	CPT	5	0					NONE	NONE		NONE	C5696617;C5698265;C5691542		von Willebrand factor (VWF), type 2B, platelet-binding evaluation, radioimmunoassay, plasma
0284U	SourceAtomCluster	0284U	False	False	CPT	5	0					NONE	NONE		NONE	C5691543;C5696618;C5698266		von Willebrand factor (VWF), type 2N, factor VIII and VWF binding evaluation, enzyme-linked immunosorbent assays (ELISA), plasma
0285U	SourceAtomCluster	0285U	False	False	CPT	5	0					NONE	NONE		NONE	C5702113;C5702114		Oncology, response to radiation, cell-free DNA, quantitative branched chain DNA amplification, plasma, reported as a radiation toxicity score
0286U	SourceAtomCluster	0286U	False	False	CPT	5	0					NONE	NONE		NONE	C5702115		CEP72 (centrosomal protein, 72-KDa), NUDT15 (nudix hydrolase 15) and TPMT (thiopurine S-methyltransferase) (eg, drug metabolism) gene analysis, common variants
0287U	SourceAtomCluster	0287U	False	False	CPT	6	0					NONE	NONE		NONE	C5702116;C5702117;C5702118;C5702119		Oncology (thyroid), DNA and mRNA, next-generation sequencing analysis of 112 genes, fine needle aspirate or formalin-fixed paraffin-embedded (FFPE) tissue, algorithmic prediction of cancer recurrence, reported as a categorical risk result (low, intermediate, high)
0288U	SourceAtomCluster	0288U	False	False	CPT	5	0					NONE	NONE		NONE	C5702120;C5702121		Oncology (lung), mRNA, quantitative PCR analysis of 11 genes (BAG1, BRCA1, CDC6, CDK2AP1, ERBB3, FUT3, IL11, LCK, RND3, SH3BGR, WNT3A) and 3 reference genes (ESD, TBP, YAP1), formalin-fixed paraffin-embedded (FFPE) tumor tissue, algorithmic interpretation reported as a recurrence risk score
0289U	SourceAtomCluster	0289U	False	False	CPT	5	0					NONE	NONE		NONE	C5702122		Neurology (Alzheimer disease), mRNA, gene expression profiling by RNA sequencing of 24 genes, whole blood, algorithm reported as predictive risk score
0290U	SourceAtomCluster	0290U	False	False	CPT	5	0					NONE	NONE		NONE	C5702123		Pain management, mRNA, gene expression profiling by RNA sequencing of 36 genes, whole blood, algorithm reported as predictive risk score
0291U	SourceAtomCluster	0291U	False	False	CPT	5	0					NONE	NONE		NONE	C5702124		Psychiatry (mood disorders), mRNA, gene expression profiling by RNA sequencing of 144 genes, whole blood, algorithm reported as predictive risk score
0292U	SourceAtomCluster	0292U	False	False	CPT	5	0					NONE	NONE		NONE	C5702125		Psychiatry (stress disorders), mRNA, gene expression profiling by RNA sequencing of 72 genes, whole blood, algorithm reported as predictive risk score
0293U	SourceAtomCluster	0293U	False	False	CPT	5	0					NONE	NONE		NONE	C5702126		Psychiatry (suicidal ideation), mRNA, gene expression profiling by RNA sequencing of 54 genes, whole blood, algorithm reported as predictive risk score
0294U	SourceAtomCluster	0294U	False	False	CPT	5	0					NONE	NONE		NONE	C5702127;C5702128		Longevity and mortality risk, mRNA, gene expression profiling by RNA sequencing of 18 genes, whole blood, algorithm reported as predictive risk score
0295U	SourceAtomCluster	0295U	False	False	CPT	5	0					NONE	NONE		NONE	C5702130;C5702129		Oncology (breast ductal carcinoma in situ), protein expression profiling by immunohistochemistry of 7 proteins (COX2, FOXA1, HER2, Ki-67, p16, PR, SIAH2), with 4 clinicopathologic factors (size, age, margin status, palpability), utilizing formalin-fixed paraffin-embedded (FFPE) tissue, algorithm reported as a recurrence risk score
0296U	SourceAtomCluster	0296U	False	False	CPT	5	0					NONE	NONE		NONE	C5702131;C5702132		Oncology (oral and/or oropharyngeal cancer), gene expression profiling by RNA sequencing of at least 20 molecular features (eg, human and/or microbial mRNA), saliva, algorithm reported as positive or negative for signature associated with malignancy
0297U	SourceAtomCluster	0297U	False	False	CPT	8	0					NONE	NONE		NONE	C5702135;C5702137;C5702138;C5702133;C5702134;C5702136		Oncology (pan tumor), whole genome sequencing of paired malignant and normal DNA specimens, fresh or formalin-fixed paraffin-embedded (FFPE) tissue, blood or bone marrow, comparative sequence analyses and variant identification
0298U	SourceAtomCluster	0298U	False	False	CPT	8	0					NONE	NONE		NONE	C5702139;C5702141;C5702140;C5702144;C5702142;C5702143		Oncology (pan tumor), whole transcriptome sequencing of paired malignant and normal RNA specimens, fresh or formalin-fixed paraffin-embedded (FFPE) tissue, blood or bone marrow, comparative sequence analyses and expression level and chimeric transcript identification
0299U	SourceAtomCluster	0299U	False	False	CPT	7	0					NONE	NONE		NONE	C5702146;C5702147;C5702148;C5702149;C5702145		Oncology (pan tumor), whole genome optical genome mapping of paired malignant and normal DNA specimens, fresh frozen tissue, blood, or bone marrow, comparative structural variant identification
0300U	SourceAtomCluster	0300U	False	False	CPT	7	0					NONE	NONE		NONE	C5702152;C5702153;C5702150;C5702151		Oncology (pan tumor), whole genome sequencing and optical genome mapping of paired malignant and normal DNA specimens, fresh tissue, blood, or bone marrow, comparative sequence analyses and variant identification
0301U	SourceAtomCluster	0301U	False	False	CPT	5	0					NONE	NONE		NONE	C5702154;C5702155		Infectious agent detection by nucleic acid (DNA or RNA), Bartonella henselae and Bartonella quintana, droplet digital PCR (ddPCR)
0302U	SourceAtomCluster	0302U	False	False	CPT	5	0					NONE	NONE		NONE	C5702156;C5702157		Infectious agent detection by nucleic acid (DNA or RNA), Bartonella henselae and Bartonella quintana, droplet digital PCR (ddPCR); following liquid enrichment
0303U	SourceAtomCluster	0303U	False	False	CPT	6	0					NONE	NONE		NONE	C5702159;C5702161;C5702160		Hematology, red blood cell (RBC) adhesion to endothelial/subendothelial adhesion molecules, functional assessment, whole blood, with algorithmic analysis and result reported as an RBC adhesion index; hypoxic
0304U	SourceAtomCluster	0304U	False	False	CPT	6	0					NONE	NONE		NONE	C5702162;C5702164;C5702163		Hematology, red blood cell (RBC) adhesion to endothelial/subendothelial adhesion molecules, functional assessment, whole blood, with algorithmic analysis and result reported as an RBC adhesion index; normoxic
0305U	SourceAtomCluster	0305U	False	False	CPT	5	0					NONE	NONE		NONE	C5702165		Hematology, red blood cell (RBC) functionality and deformity as a function of shear stress, whole blood, reported as a maximum elongation index
0306U	SourceAtomCluster	0306U	False	False	CPT	5	0					NONE	NONE		NONE	C5702166		Oncology (minimal residual disease [MRD]), next-generation targeted sequencing analysis, cell-free DNA, initial (baseline) assessment to determine a patient-specific panel for future comparisons to evaluate for MRD
0307U	SourceAtomCluster	0307U	False	False	CPT	5	0					NONE	NONE		NONE	C5702167		Oncology (minimal residual disease [MRD]), next-generation targeted sequencing analysis of a patient-specific panel, cell-free DNA, subsequent assessment with comparison to previously analyzed patient specimens to evaluate for MRD
0308U	SourceAtomCluster	0308U	False	False	CPT	5	0					NONE	NONE		NONE	C5702168;C5851905		Cardiology (coronary artery disease [CAD]), analysis of 3 proteins (high sensitivity [hs] troponin, adiponectin, and kidney injury molecule-1 [KIM-1]) with 3 clinical parameters (age, sex, history of cardiac intervention), plasma, algorithm reported as a risk score for obstructive CAD
0309U	SourceAtomCluster	0309U	False	False	CPT	5	0					NONE	NONE		NONE	C5702169		Cardiology (cardiovascular disease), analysis of 4 proteins (NT-proBNP, osteopontin, tissue inhibitor of metalloproteinase-1 [TIMP-1], and kidney injury molecule-1 [KIM-1]), plasma, algorithm reported as a risk score for major adverse cardiac event
0310U	SourceAtomCluster	0310U	False	False	CPT	5	0					NONE	NONE		NONE	C5702170;C5702171		Pediatrics (vasculitis, Kawasaki disease [KD]), analysis of 3 biomarkers (NT-proBNP, C-reactive protein, and T-uptake), plasma, algorithm reported as a risk score for KD
0311U	SourceAtomCluster	0311U	False	False	CPT	5	0					NONE	NONE		NONE	C5702172		Infectious disease (bacterial), quantitative antimicrobial susceptibility reported as phenotypic minimum inhibitory concentration (MIC)-based antimicrobial susceptibility for each organism identified
0312U	SourceAtomCluster	0312U	False	False	CPT	6	0					NONE	NONE		NONE	C5702173;C5702175;C5702174		Autoimmune diseases (eg, systemic lupus erythematosus [SLE]), analysis of 8 IgG autoantibodies and 2 cell-bound complement activation products using enzyme-linked immunosorbent immunoassay (ELISA), flow cytometry and indirect immunofluorescence, serum, or plasma and whole blood, individual components reported along with an algorithmic SLE-likelihood assessment
0313U	SourceAtomCluster	0313U	False	False	CPT	5	0					NONE	NONE		NONE	C5702176		Oncology (pancreas), DNA and mRNA next-generation sequencing analysis of 74 genes and analysis of CEA (CEACAM5) gene expression, pancreatic cyst fluid, algorithm reported as a categorical result (ie, negative, low probability of neoplasia or positive, high probability of neoplasia)
0314U	SourceAtomCluster	0314U	False	False	CPT	5	0					NONE	NONE		NONE	C5702178;C5702177		Oncology (cutaneous melanoma), mRNA gene expression profiling by RT-PCR of 35 genes (32 content and 3 housekeeping), utilizing formalin-fixed paraffin-embedded (FFPE) tissue, algorithm reported as a categorical result (ie, benign, intermediate, malignant)
0315U	SourceAtomCluster	0315U	False	False	CPT	5	0					NONE	NONE		NONE	C5702179		Oncology (cutaneous squamous cell carcinoma), mRNA gene expression profiling by RT-PCR of 40 genes (34 content and 6 housekeeping), utilizing formalin-fixed paraffin-embedded (FFPE) tissue, algorithm reported as a categorical risk result (ie, Class 1, Class 2A, Class 2B)
0316U	SourceAtomCluster	0316U	False	False	CPT	5	0					NONE	NONE		NONE	C5702180		Borrelia burgdorferi (Lyme disease), OspA protein evaluation, urine
0317U	SourceAtomCluster	0317U	False	False	CPT	5	0					NONE	NONE		NONE	C5702181		Oncology (lung cancer), four-probe FISH (3q29, 3p22.1, 10q22.3, 10cen) assay, whole blood, predictive algorithm-generated evaluation reported as decreased or increased risk for lung cancer
0318U	SourceAtomCluster	0318U	False	False	CPT	5	0					NONE	NONE		NONE	C5702183;C5702182		Pediatrics (congenital epigenetic disorders), whole genome methylation analysis by microarray for 50 or more genes, blood
0319U	SourceAtomCluster	0319U	False	False	CPT	5	0					NONE	NONE		NONE	C5702184		Nephrology (renal transplant), RNA expression by select transcriptome sequencing, using pretransplant peripheral blood, algorithm reported as a risk score for early acute rejection
0320U	SourceAtomCluster	0320U	False	False	CPT	5	0					NONE	NONE		NONE	C5702185		Nephrology (renal transplant), RNA expression by select transcriptome sequencing, using posttransplant peripheral blood, algorithm reported as a risk score for acute cellular rejection
0321U	SourceAtomCluster	0321U	False	False	CPT	6	0					NONE	NONE		NONE	C5702186;C5702187		Infectious agent detection by nucleic acid (DNA or RNA), genitourinary pathogens, identification of 20 bacterial and fungal organisms and identification of 16 associated antibiotic-resistance genes, multiplex amplified probe technique
0322U	SourceAtomCluster	0322U	False	False	CPT	5	0					NONE	NONE		NONE	C5702188		Neurology (autism spectrum disorder [ASD]), quantitative measurements of 14 acyl carnitines and microbiome-derived metabolites, liquid chromatography with tandem mass spectrometry (LC-MS/MS), plasma, results reported as negative or positive for risk of metabolic subtypes associated with ASD
0323U	SourceAtomCluster	0323U	False	False	CPT	8	0					NONE	NONE		NONE	C5702193;C5702190;C5702189;C5702191;C5702192		Infectious agent detection by nucleic acid (DNA and RNA), central nervous system pathogen, metagenomic next-generation sequencing, cerebrospinal fluid (CSF), identification of pathogenic bacteria, viruses, parasites, or fungi
0326U	SourceAtomCluster	0326U	False	False	CPT	5	0					NONE	NONE		NONE	C5702196;C5702197		Targeted genomic sequence analysis panel, solid organ neoplasm, cell-free circulating DNA analysis of 83 or more genes, interrogation for sequence variants, gene copy number amplifications, gene rearrangements, microsatellite instability and tumor mutational burden
0327U	SourceAtomCluster	0327U	False	False	CPT	6	0					NONE	NONE		NONE	C5702198;C5702200;C5702199		Fetal aneuploidy (trisomy 13, 18, and 21), DNA sequence analysis of selected regions using maternal plasma, algorithm reported as a risk score for each trisomy, includes sex reporting, if performed
0328U	SourceAtomCluster	0328U	False	False	CPT	5	0					NONE	NONE		NONE	C5702202;C5702201		Drug assay, definitive, 120 or more drugs and metabolites, urine, quantitative liquid chromatography with tandem mass spectrometry (LC-MS/MS), includes specimen validity and algorithmic analysis describing drug or metabolite and presence or absence of risks for a significant patient-adverse event, per date of service
0329U	SourceAtomCluster	0329U	False	False	CPT	6	0					NONE	NONE		NONE	C5702204;C5702205;C5702203;C5702206		Oncology (neoplasia), exome and transcriptome sequence analysis for sequence variants, gene copy number amplifications and deletions, gene rearrangements, microsatellite instability and tumor mutational burden utilizing DNA and RNA from tumor with DNA from normal blood or saliva for subtraction, report of clinically significant mutation(s) with therapy associations
0330T	SourceAtomCluster	0330T	False	False	CPT	4	0					NONE	NONE		NONE	C3704187;C3702532		Tear film imaging, unilateral or bilateral, with interpretation and report
0330U	SourceAtomCluster	0330U	False	False	CPT	5	0					NONE	NONE		NONE	C5702207;C5702208		Infectious agent detection by nucleic acid (DNA or RNA), vaginal pathogen panel, identification of 27 organisms, amplified probe technique, vaginal swab
0331T	SourceAtomCluster	0331T	False	False	CPT	4	0					NONE	NONE		NONE	C3704188;C3702533		Myocardial sympathetic innervation imaging, planar qualitative and quantitative assessment
0331U	SourceAtomCluster	0331U	False	False	CPT	6	0					NONE	NONE		NONE	C5702209;C5702212;C5702211;C5702210		Oncology (hematolymphoid neoplasia), optical genome mapping for copy number alterations and gene rearrangements utilizing DNA from blood or bone marrow, report of clinically significant alterations
0332T	SourceAtomCluster	0332T	False	False	CPT	4	0					NONE	NONE		NONE	C3704189;C3702534		Myocardial sympathetic innervation imaging, planar qualitative and quantitative assessment; with tomographic SPECT
0332U	SourceAtomCluster	0332U	False	False	CPT	5	0					NONE	NONE		NONE	C5702213;C5702214		Oncology (pan-tumor), genetic profiling of 8 DNA-regulatory (epigenetic) markers by quantitative polymerase chain reaction (qPCR), whole blood, reported as a high or low probability of responding to immune checkpoint-inhibitor therapy
0333U	SourceAtomCluster	0333U	False	False	CPT	5	0					NONE	NONE		NONE	C5702215;C5702216		Oncology (liver), surveillance for hepatocellular carcinoma (HCC) in high-risk patients, analysis of methylation patterns on circulating cell-free DNA (cfDNA) plus measurement of serum of AFP/AFP-L3 and oncoprotein des-gamma-carboxy-prothrombin (DCP), algorithm reported as normal or abnormal result
0334U	SourceAtomCluster	0334U	False	False	CPT	5	0					NONE	NONE		NONE	C5702217;C5702218		Oncology (solid organ), targeted genomic sequence analysis, formalin-fixed paraffin-embedded (FFPE) tumor tissue, DNA analysis, 84 or more genes, interrogation for sequence variants, gene copy number amplifications, gene rearrangements, microsatellite instability and tumor mutational burden
0335U	SourceAtomCluster	0335U	False	False	CPT	5	0					NONE	NONE		NONE	C5702219		Rare diseases (constitutional/heritable disorders), whole genome sequence analysis, including small sequence changes, copy number variants, deletions, duplications, mobile element insertions, uniparental disomy (UPD), inversions, aneuploidy, mitochondrial genome sequence analysis with heteroplasmy and large deletions, short tandem repeat (STR) gene expansions, fetal sample, identification and categorization of genetic variants
0336U	SourceAtomCluster	0336U	False	False	CPT	8	0					NONE	NONE		NONE	C5702223;C5702224;C5702220;C5702222;C5702225;C5702221		Rare diseases (constitutional/heritable disorders), whole genome sequence analysis, including small sequence changes, copy number variants, deletions, duplications, mobile element insertions, uniparental disomy (UPD), inversions, aneuploidy, mitochondrial genome sequence analysis with heteroplasmy and large deletions, short tandem repeat (STR) gene expansions, blood or saliva, identification and categorization of genetic variants, each comparator genome (eg, parent)
0337U	SourceAtomCluster	0337U	False	False	CPT	5	0					NONE	NONE		NONE	C5702226;C5702227		Oncology (plasma cell disorders and myeloma), circulating plasma cell immunologic selection, identification, morphological characterization, and enumeration of plasma cells based on differential CD138, CD38, CD19, and CD45 protein biomarker expression, peripheral blood
0338U	SourceAtomCluster	0338U	False	False	CPT	5	0					NONE	NONE		NONE	C5702228;C5702229		Oncology (solid tumor), circulating tumor cell selection, identification, morphological characterization, detection and enumeration based on differential EpCAM, cytokeratins 8, 18, and 19, and CD45 protein biomarkers, and quantification of HER2 protein biomarker-expressing cells, peripheral blood
0339U	SourceAtomCluster	0339U	False	False	CPT	5	0					NONE	NONE		NONE	C5702230;C5702231		Oncology (prostate), mRNA expression profiling of HOXC6 and DLX1, reverse transcription polymerase chain reaction (RT-PCR), first-void urine following digital rectal examination, algorithm reported as probability of high-grade cancer
0340U	SourceAtomCluster	0340U	False	False	CPT	6	0					NONE	NONE		NONE	C5702232;C5702233;C5702234		Oncology (pan-cancer), analysis of minimal residual disease (MRD) from plasma, with assays personalized to each patient based on prior next-generation sequencing of the patient's tumor and germline DNA, reported as absence or presence of MRD, with disease-burden correlation, if appropriate
0341U	SourceAtomCluster	0341U	False	False	CPT	5	0					NONE	NONE		NONE	C5702235;C5702236		Fetal aneuploidy DNA sequencing comparative analysis, fetal DNA from products of conception, reported as normal (euploidy), monosomy, trisomy, or partial deletion/duplication, mosaicism, and segmental aneuploid
0342U	SourceAtomCluster	0342U	False	False	CPT	5	0					NONE	NONE		NONE	C5702238;C5702237		Oncology (pancreatic cancer), multiplex immunoassay of C5, C4, cystatin C, factor B, osteoprotegerin (OPG), gelsolin, IGFBP3, CA125 and multiplex electrochemiluminescent immunoassay (ECLIA) for CA19-9, serum, diagnostic algorithm reported qualitatively as positive, negative, or borderline
0343U	SourceAtomCluster	0343U	False	False	CPT	5	0					NONE	NONE		NONE	C5702239;C5702240		Oncology (prostate), exosome-based analysis of 442 small noncoding RNAs (sncRNAs) by quantitative reverse transcription polymerase chain reaction (RT-qPCR), urine, reported as molecular evidence of no-, low-, intermediate- or high-risk of prostate cancer
0344U	SourceAtomCluster	0344U	False	False	CPT	5	0					NONE	NONE		NONE	C5702242;C5702241		Hepatology (nonalcoholic fatty liver disease [NAFLD]), semiquantitative evaluation of 28 lipid markers by liquid chromatography with tandem mass spectrometry (LC-MS/MS), serum, reported as at-risk for nonalcoholic steatohepatitis (NASH) or not NASH
0345U	SourceAtomCluster	0345U	False	False	CPT	5	0					NONE	NONE		NONE	C5702243;C5702245;C5702244		Psychiatry (eg, depression, anxiety, attention deficit hyperactivity disorder [ADHD]), genomic analysis panel, variant analysis of 15 genes, including deletion/duplication analysis of CYP2D6
0347U	SourceAtomCluster	0347U	False	False	CPT	6	0					NONE	NONE		NONE	C5702247;C5702250;C5702248;C5702249		Drug metabolism or processing (multiple conditions), whole blood or buccal specimen, DNA analysis, 16 gene report, with variant analysis and reported phenotypes
0348U	SourceAtomCluster	0348U	False	False	CPT	6	0					NONE	NONE		NONE	C5702251;C5702253;C5702254;C5702252		Drug metabolism or processing (multiple conditions), whole blood or buccal specimen, DNA analysis, 25 gene report, with variant analysis and reported phenotypes
0349U	SourceAtomCluster	0349U	False	False	CPT	6	0					NONE	NONE		NONE	C5702255;C5702257;C5702256;C5702258		Drug metabolism or processing (multiple conditions), whole blood or buccal specimen, DNA analysis, 27 gene report, with variant analysis, including reported phenotypes and impacted gene-drug interactions
0350U	SourceAtomCluster	0350U	False	False	CPT	6	0					NONE	NONE		NONE	C5702259;C5702261;C5702260;C5702262		Drug metabolism or processing (multiple conditions), whole blood or buccal specimen, DNA analysis, 27 gene report, with variant analysis and reported phenotypes
0351U	SourceAtomCluster	0351U	False	False	CPT	5	0					NONE	NONE		NONE	C5702264;C5702265;C5702263		Infectious disease (bacterial or viral), biochemical assays, tumor necrosis factor-related apoptosis-inducing ligand (TRAIL), interferon gamma-induced protein-10 (IP-10), and C-reactive protein, serum, or venous whole blood, algorithm reported as likelihood of bacterial infection
0355U	SourceAtomCluster	0355U	False	False	CPT	6	0					NONE	NONE		NONE	C5702960		APOL1 (apolipoprotein L1) (eg, chronic kidney disease), risk variants (G1, G2)
0356U	SourceAtomCluster	0356U	False	False	CPT	5	0					NONE	NONE		NONE	C5944589;C5771752;C5944588		Oncology (oropharyngeal or anal), evaluation of 17 DNA biomarkers using droplet digital PCR (ddPCR), cell-free DNA, algorithm reported as a prognostic risk score for cancer recurrence
0358U	SourceAtomCluster	0358U	False	False	CPT	5	0					NONE	NONE		NONE	C5771754;C5851907		Neurology (mild cognitive impairment), analysis of Î²-amyloid 1-42 and 1-40, chemiluminescence enzyme immunoassay, cerebral spinal fluid, reported as positive, likely positive, or negative
0359U	SourceAtomCluster	0359U	False	False	CPT	5	0					NONE	NONE		NONE	C5771755;C5851908		Oncology (prostate cancer), analysis of all prostate-specific antigen (PSA) structural isoforms by phase separation and immunoassay, plasma, algorithm reports risk of cancer
0360U	SourceAtomCluster	0360U	False	False	CPT	5	0					NONE	NONE		NONE	C5771756;C5851909		Oncology (lung), enzyme-linked immunosorbent assay (ELISA) of 7 autoantibodies (p53, NY-ESO-1, CAGE, GBU4-5, SOX2, MAGE A4, and HuD), plasma, algorithm reported as a categorical result for risk of malignancy
0362U	SourceAtomCluster	0362U	False	False	CPT	7	0					NONE	NONE		NONE	C5771758;C5851911;C5851912;C5851910		Oncology (papillary thyroid cancer), gene-expression profiling via targeted hybrid capture-enrichment RNA sequencing of 82 content genes and 10 housekeeping genes, fine needle aspirate or formalin-fixed paraffin-embedded (FFPE) tissue, algorithm reported as one of three molecular subtypes
0363U	SourceAtomCluster	0363U	False	False	CPT	5	0					NONE	NONE		NONE	C5771759;C5851913		Oncology (urothelial), mRNA, gene-expression profiling by real-time quantitative PCR of 5 genes (MDK, HOXA13, CDC2 [CDK1], IGFBP5, and CXCR2), utilizing urine, algorithm incorporates age, sex, smoking history, and macrohematuria frequency, reported as a risk score for having urothelial carcinoma
0364U	SourceAtomCluster	0364U	False	False	CPT	5	0					NONE	NONE		NONE	C5851914;C5851915;C5851916		Oncology (hematolymphoid neoplasm), genomic sequence analysis using multiplex (PCR) and next-generation sequencing with algorithm, quantification of dominant clonal sequence(s), reported as presence or absence of minimal residual disease (MRD) with quantitation of disease burden, when appropriate
0365U	SourceAtomCluster	0365U	False	False	CPT	5	0					NONE	NONE		NONE	C5851918;C5851917		Oncology (bladder), analysis of 10 protein biomarkers (A1AT, ANG, APOE, CA9, IL8, MMP9, MMP10, PAI1, SDC1, and VEGFA) by immunoassays, urine, algorithm reported as a probability of bladder cancer
0366U	SourceAtomCluster	0366U	False	False	CPT	5	0					NONE	NONE		NONE	C5851919;C5851920		Oncology (bladder), analysis of 10 protein biomarkers (A1AT, ANG, APOE, CA9, IL8, MMP9, MMP10, PAI1, SDC1, and VEGFA) by immunoassays, urine, algorithm reported as a probability of recurrent bladder cancer
0367U	SourceAtomCluster	0367U	False	False	CPT	7	0					NONE	NONE		NONE	C5851922;C5851924;C5851925;C5851921;C5851923		Oncology (bladder), analysis of 10 protein biomarkers (A1AT, ANG, APOE, CA9, IL8, MMP9, MMP10, PAI1, SDC1, and VEGFA) by immunoassays, urine, diagnostic algorithm reported as a risk score for probability of rapid recurrence of recurrent or persistent cancer following transurethral resection
0368U	SourceAtomCluster	0368U	False	False	CPT	7	0					NONE	NONE		NONE	C5851926;C5851927;C5851929;C5851928		Oncology (colorectal cancer), evaluation for mutations of APC, BRAF, CTNNB1, KRAS, NRAS, PIK3CA, SMAD4, and TP53, and methylation markers (MYO1G, KCNQ5, C9ORF50, FLI1, CLIP4, ZNF132, and TWIST1), multiplex quantitative polymerase chain reaction (qPCR), circulating cell-free DNA (cfDNA), plasma, report of risk score for advanced adenoma or colorectal cancer
0371U	SourceAtomCluster	0371U	False	False	CPT	7	0					NONE	NONE		NONE	C5851943;C5851944;C5851940;C5851941;C5851942		Infectious agent detection by nucleic acid (DNA or RNA), genitourinary pathogen, semiquantitative identification, DNA from 16 bacterial organisms and 1 fungal organism, multiplex amplified probe technique via quantitative polymerase chain reaction (qPCR), urine
0372U	SourceAtomCluster	0372U	False	False	CPT	5	0					NONE	NONE		NONE	C5851945;C5851946		Infectious disease (genitourinary pathogens), antibiotic-resistance gene detection, multiplex amplified probe technique, urine, reported as an antimicrobial stewardship risk score
0375U	SourceAtomCluster	0375U	False	False	CPT	5	0					NONE	NONE		NONE	C5851961;C5851962		Oncology (ovarian), biochemical assays of 7 proteins (follicle stimulating hormone, human epididymis protein 4, apolipoprotein A-1, transferrin, beta-2 macroglobulin, prealbumin [ie, transthyretin], and cancer antigen 125), algorithm reported as ovarian cancer risk score
0376U	SourceAtomCluster	0376U	False	False	CPT	5	0					NONE	NONE		NONE	C5851963;C5851965;C5851964		Oncology (prostate cancer), image analysis of at least 128 histologic features and clinical factors, prognostic algorithm determining the risk of distant metastases, and prostate cancer-specific mortality, includes predictive algorithm to androgen deprivation-therapy response, if appropriate
0377U	SourceAtomCluster	0377U	False	False	CPT	5	0					NONE	NONE		NONE	C5851966;C5851967		Cardiovascular disease, quantification of advanced serum or plasma lipoprotein profile, by nuclear magnetic resonance (NMR) spectrometry with report of a lipoprotein profile (including 23 variables)
0378U	SourceAtomCluster	0378U	False	False	CPT	8	0					NONE	NONE		NONE	C5851968;C5851969;C5851972;C5851970;C5851971		RFC1 (replication factor C subunit 1), repeat expansion variant analysis by traditional and repeat-primed PCR, blood, saliva, or buccal swab
0379U	SourceAtomCluster	0379U	False	False	CPT	5	0					NONE	NONE		NONE	C5851973;C5851974		Targeted genomic sequence analysis panel, solid organ neoplasm, DNA (523 genes) and RNA (55 genes) by next-generation sequencing, interrogation for sequence variants, gene copy number amplifications, gene rearrangements, microsatellite instability, and tumor mutational burden
0381U	SourceAtomCluster	0381U	False	False	CPT	5	0					NONE	NONE		NONE	C5851979;C5851980		Maple syrup urine disease monitoring by patient-collected blood card sample, quantitative measurement of allo-isoleucine, leucine, isoleucine, and valine, liquid chromatography with tandem mass spectrometry (LC-MS/MS)
0382U	SourceAtomCluster	0382U	False	False	CPT	5	0					NONE	NONE		NONE	C5851981;C5851982		Hyperphenylalaninemia monitoring by patient-collected blood card sample, quantitative measurement of phenylalanine and tyrosine, liquid chromatography with tandem mass spectrometry (LC-MS/MS)
0383U	SourceAtomCluster	0383U	False	False	CPT	5	0					NONE	NONE		NONE	C5851983;C5851984		Tyrosinemia type I monitoring by patient-collected blood card sample, quantitative measurement of tyrosine, phenylalanine, methionine, succinylacetone, nitisinone, liquid chromatography with tandem mass spectrometry (LC-MS/MS)
0384U	SourceAtomCluster	0384U	False	False	CPT	5	0					NONE	NONE		NONE	C5851985;C5851986		Nephrology (chronic kidney disease), carboxymethyllysine, methylglyoxal hydroimidazolone, and carboxyethyl lysine by liquid chromatography with tandem mass spectrometry (LC-MS/MS) and HbA1c and estimated glomerular filtration rate (GFR), with risk score reported for predictive progression to high-stage kidney disease
0385U	SourceAtomCluster	0385U	False	False	CPT	5	0					NONE	NONE		NONE	C5851987;C5851988		Nephrology (chronic kidney disease), apolipoprotein A4 (ApoA4), CD5 antigen-like (CD5L), and insulin-like growth factor binding protein 3 (IGFBP3) by enzyme-linked immunoassay (ELISA), plasma, algorithm combining results with HDL, estimated glomerular filtration rate (GFR) and clinical data reported as a risk score for developing diabetic kidney disease
0387U	SourceAtomCluster	0387U	False	False	CPT	5	0					NONE	NONE		NONE	C5851989;C5851990		Oncology (melanoma), autophagy and beclin 1 regulator 1 (AMBRA1) and loricrin (AMLo) by immunohistochemistry, formalin-fixed paraffin-embedded (FFPE) tissue, report for risk of progression
0388U	SourceAtomCluster	0388U	False	False	CPT	5	0					NONE	NONE		NONE	C5851991;C5851992		Oncology (non-small cell lung cancer), next-generation sequencing with identification of single nucleotide variants, copy number variants, insertions and deletions, and structural variants in 37 cancer-related genes, plasma, with report for alteration detection
0389U	SourceAtomCluster	0389U	False	False	CPT	5	0					NONE	NONE		NONE	C5851993;C5851994		Pediatric febrile illness (Kawasaki disease [KD]), interferon alpha-inducible protein 27 (IFI27) and mast cell-expressed membrane protein 1 (MCEMP1), RNA, using quantitative reverse transcription polymerase chain reaction (RT-qPCR), blood, reported as a risk score for KD
0390U	SourceAtomCluster	0390U	False	False	CPT	5	0					NONE	NONE		NONE	C5851996;C5851995		Obstetrics (preeclampsia), kinase insert domain receptor (KDR), Endoglin (ENG), and retinol-binding protein 4 (RBP4), by immunoassay, serum, algorithm reported as a risk score
0391U	SourceAtomCluster	0391U	False	False	CPT	5	0					NONE	NONE		NONE	C5851997;C5851998		Oncology (solid tumor), DNA and RNA by next-generation sequencing, utilizing formalin-fixed paraffin-embedded (FFPE) tissue, 437 genes, interpretive report for single nucleotide variants, splice-site variants, insertions/deletions, copy number alterations, gene fusions, tumor mutational burden, and microsatellite instability, with algorithm quantifying immunotherapy response score
0392U	SourceAtomCluster	0392U	False	False	CPT	16	0					NONE	NONE		NONE	C5852007;C5852008;C5851999;C5852002;C5852006;C5852005;C5852009;C5852000;C5852001;C5852004;C5852010;C5852011;C5852003		Drug metabolism (depression, anxiety, attention deficit hyperactivity disorder [ADHD]), gene-drug interactions, variant analysis of 16 genes, including deletion/duplication analysis of CYP2D6, reported as impact of gene-drug interaction for each drug
0393U	SourceAtomCluster	0393U	False	False	CPT	6	0					NONE	NONE		NONE	C5852012;C5852013;C5852014;C5852015		Neurology (eg, Parkinson disease, dementia with Lewy bodies), cerebrospinal fluid (CSF), detection of misfolded Î±-synuclein protein by seed amplification assay, qualitative
0394U	SourceAtomCluster	0394U	False	False	CPT	13	0					NONE	NONE		NONE	C5852017;C5852020;C5852022;C5852021;C5852016;C5852024;C5852026;C5852018;C5852019;C5852025;C5852023		Perfluoroalkyl substances (PFAS) (eg, perfluorooctanoic acid, perfluorooctane sulfonic acid), 16 PFAS compounds by liquid chromatography with tandem mass spectrometry (LC-MS/MS), plasma or serum, quantitative
0395T	SourceAtomCluster	0395T	False	False	CPT	4	0					NONE	NONE		NONE	C5416616;C4051827		High dose rate electronic brachytherapy, interstitial or intracavitary treatment, per fraction, includes basic dosimetry, when performed
0395U	SourceAtomCluster	0395U	False	False	CPT	5	0					NONE	NONE		NONE	C5852028;C5852027		Oncology (lung), multi-omics (microbial DNA by shotgun next-generation sequencing and carcinoembryonic antigen and osteopontin by immunoassay), plasma, algorithm reported as malignancy risk for lung nodules in early-stage disease
0398U	SourceAtomCluster	0398U	False	False	CPT	5	0					NONE	NONE		NONE	C5852030;C5852031		Gastroenterology (Barrett's esophagus), P16, RUNX3, HPP1, and FBN1 DNA methylation analysis using PCR, formalin-fixed paraffin-embedded (FFPE) tissue, algorithm reported as risk score for progression to high-grade dysplasia or cancer
0399U	SourceAtomCluster	0399U	False	False	CPT	5	0					NONE	NONE		NONE	C5852032;C5852033;C5852034		Neurology (cerebral folate deficiency), serum, detection of anti-human folate receptor IgG-binding antibody and blocking autoantibodies by enzyme-linked immunoassay (ELISA), qualitative, and blocking autoantibodies, using a functional blocking assay for IgG or IgM, quantitative, reported as positive or not detected
0400U	SourceAtomCluster	0400U	False	False	CPT	5	0					NONE	NONE		NONE	C5852035;C5852036		Obstetrics (expanded carrier screening), 145 genes by next-generation sequencing, fragment analysis and multiplex ligation-dependent probe amplification, DNA, reported as carrier positive or negative
0401U	SourceAtomCluster	0401U	False	False	CPT	8	0					NONE	NONE		NONE	C5852038;C5852037;C5852041;C5852039;C5852040		Cardiology (coronary heart disease [CHD]), 9 genes (12 variants), targeted variant genotyping, blood, saliva, or buccal swab, algorithm reported as a genetic risk score for a coronary event
0402U	SourceAtomCluster	0402U	False	False	CPT	8	0					NONE	NONE		NONE	C5852042;C5852046;C5852044;C5852045;C5852043		Infectious agent (sexually transmitted infection), Chlamydia trachomatis, Neisseria gonorrhoeae, Trichomonas vaginalis, Mycoplasma genitalium, multiplex amplified probe technique, vaginal, endocervical, or male urine, each pathogen reported as detected or not detected
0403U	SourceAtomCluster	0403U	False	False	CPT	5	0					NONE	NONE		NONE	C5852048;C5852047;C5944590		Oncology (prostate), mRNA, gene expression profiling of 18 genes, first-catch urine, algorithm reported as percentage of likelihood of detecting clinically significant prostate cancer
0404U	SourceAtomCluster	0404U	False	False	CPT	5	0					NONE	NONE		NONE	C5852051;C5852052		Oncology (breast), semiquantitative measurement of thymidine kinase activity by immunoassay, serum, results reported as risk of disease progression
0405U	SourceAtomCluster	0405U	False	False	CPT	5	0					NONE	NONE		NONE	C5852054;C5852053		Oncology (pancreatic), 59 methylation haplotype block markers, next-generation sequencing, plasma, reported as cancer signal detected or not detected
0406U	SourceAtomCluster	0406U	False	False	CPT	5	0					NONE	NONE		NONE	C5852055;C5852056		Oncology (lung), flow cytometry, sputum, 5 markers (meso-tetra [4-carboxyphenyl] porphyrin [TCPP], CD206, CD66b, CD3, CD19), algorithm reported as likelihood of lung cancer
0407U	SourceAtomCluster	0407U	False	False	CPT	5	0					NONE	NONE		NONE	C5852057;C5852058		Nephrology (diabetic chronic kidney disease [CKD]), multiplex electrochemiluminescent immunoassay (ECLIA) of soluble tumor necrosis factor receptor 1 (sTNFR1), soluble tumor necrosis receptor 2 (sTNFR2), and kidney injury molecule 1 (KIM-1) combined with clinical data, plasma, algorithm reported as risk for progressive decline in kidney function
0408U	SourceAtomCluster	0408U	False	False	CPT	5	0					NONE	NONE		NONE	C5852059		Infectious agent antigen detection by bulk acoustic wave biosensor immunoassay, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19])
0409U	SourceAtomCluster	0409U	False	False	CPT	5	0					NONE	NONE		NONE	C5852061;C5852060		Oncology (solid tumor), DNA (80 genes) and RNA (36 genes), by next-generation sequencing from plasma, including single nucleotide variants, insertions/deletions, copy number alterations, microsatellite instability, and fusions, report showing identified mutations with clinical actionability
0410U	SourceAtomCluster	0410U	False	False	CPT	7	0					NONE	NONE		NONE	C5852062;C5852063;C5852064;C5852065;C5852066		Oncology (pancreatic), DNA, whole genome sequencing with 5-hydroxymethylcytosine enrichment, whole blood or plasma, algorithm reported as cancer detected or not detected
0411U	SourceAtomCluster	0411U	False	False	CPT	8	0					NONE	NONE		NONE	C5852070;C5848697;C5852067;C5852069;C5852071;C5852068		Psychiatry (eg, depression, anxiety, attention deficit hyperactivity disorder [ADHD]), genomic analysis panel, variant analysis of 15 genes, including deletion/duplication analysis of CYP2D6
0412U	SourceAtomCluster	0412U	False	False	CPT	5	0					NONE	NONE		NONE	C5852072;C5852073		Beta amyloid, AÎ²42/40 ratio, immunoprecipitation with quantitation by liquid chromatography with tandem mass spectrometry (LC-MS/MS) and qualitative ApoE isoform-specific proteotyping, plasma combined with age, algorithm reported as presence or absence of brain amyloid pathology
0413U	SourceAtomCluster	0413U	False	False	CPT	5	0					NONE	NONE		NONE	C5852074;C5852075		Oncology (hematolymphoid neoplasm), optical genome mapping for copy number alterations, aneuploidy, and balanced/complex structural rearrangements, DNA from blood or bone marrow, report of clinically significant alterations
0414U	SourceAtomCluster	0414U	False	False	CPT	5	0					NONE	NONE		NONE	C5852078;C5852076;C5852077		Oncology (lung), augmentative algorithmic analysis of digitized whole slide imaging for 8 genes (ALK, BRAF, EGFR, ERBB2, MET, NTRK1-3, RET, ROS1), and KRAS G12C and PD-L1, if performed, formalin-fixed paraffin-embedded (FFPE) tissue, reported as positive or negative for each biomarker
0415U	SourceAtomCluster	0415U	False	False	CPT	5	0					NONE	NONE		NONE	C5852079;C5852080		Cardiovascular disease (acute coronary syndrome [ACS]), IL-16, FAS, FASLigand, HGF, CTACK, EOTAXIN, and MCP-3 by immunoassay combined with age, sex, family history, and personal history of diabetes, blood, algorithm reported as a 5-year (deleted risk) score for ACS
0417U	SourceAtomCluster	0417U	False	False	CPT	7	0					NONE	NONE		NONE	C5852083;C5852087;C5852085;C5852086;C5852084		Rare diseases (constitutional/heritable disorders), whole mitochondrial genome sequence with heteroplasmy detection and deletion analysis, nuclear-encoded mitochondrial gene analysis of 335 nuclear genes, including sequence changes, deletions, insertions, and copy number variants analysis, blood or saliva, identification and categorization of mitochondrial disorder-associated genetic variants
0418U	SourceAtomCluster	0418U	False	False	CPT	5	0					NONE	NONE		NONE	C5852088;C5852089;C5852090		Oncology (breast), augmentative algorithmic analysis of digitized whole slide imaging of 8 histologic and immunohistochemical features, reported as a recurrence score
0419U	SourceAtomCluster	0419U	False	False	CPT	13	0					NONE	NONE		NONE	C5852091;C5852093;C5852098;C5852100;C5852101;C5852092;C5852097;C5852095;C5852096;C5852094;C5852099		Neuropsychiatry (eg, depression, anxiety), genomic sequence analysis panel, variant analysis of 13 genes, saliva or buccal swab, report of each gene phenotype
0420U	SourceAtomCluster	0420U	False	False	CPT	5	0					NONE	NONE		NONE	C5884297;C5944591		Oncology (urothelial), mRNA expression profiling by real-time quantitative PCR of MDK, HOXA13, CDC2, IGFBP5, and CXCR2 in combination with droplet digital PCR (ddPCR) analysis of 6 single-nucleotide polymorphisms (SNPs) of genes TERT and FGFR3, urine, algorithm reported as a risk score for urothelial carcinoma
0421U	SourceAtomCluster	0421U	False	False	CPT	5	0					NONE	NONE		NONE	C5884298;C5944592		Oncology (colorectal) screening, quantitative real-time target and signal amplification of 8 RNA markers (GAPDH, SMAD4, ACY1, AREG, CDH1, KRAS, TNFRSF10B, EGLN2) and fecal hemoglobin, algorithm reported as a positive or negative for colorectal cancer risk
0422T	SourceAtomCluster	0422T	False	False	CPT	4	0					NONE	NONE		NONE	C4067646		Tactile breast imaging by computer-aided tactile sensors, unilateral or bilateral
0422U	SourceAtomCluster	0422U	False	False	CPT	5	0					NONE	NONE		NONE	C5884299;C5944593;C5944594		Oncology (pan-solid tumor), analysis of DNA biomarker response to anti-cancer therapy using cell-free circulating DNA, biomarker comparison to a previous baseline pre-treatment cell-free circulating DNA analysis using next-generation sequencing, algorithm reported as a quantitative change from baseline, including specific alterations, if appropriate
0423U	SourceAtomCluster	0423U	False	False	CPT	5	0					NONE	NONE		NONE	C5884300;C5944595;C5944596		Psychiatry (eg, depression, anxiety), genomic analysis panel, including variant analysis of 26 genes, buccal swab, report including metabolizer status and risk of drug toxicity by condition
0424U	SourceAtomCluster	0424U	False	False	CPT	5	0					NONE	NONE		NONE	C5884301;C5944597		Oncology (prostate), exosome-based analysis of 53 small noncoding RNAs (sncRNAs) by quantitative reverse transcription polymerase chain reaction (RT-qPCR), urine, reported as no molecular evidence, low-, moderate-, or elevated-risk of prostate cancer
0425U	SourceAtomCluster	0425U	False	False	CPT	5	0					NONE	NONE		NONE	C5884302;C5944598		Genome (eg, unexplained constitutional or heritable disorder or syndrome), rapid sequence analysis, each comparator genome (eg, parents, siblings)
0426U	SourceAtomCluster	0426U	False	False	CPT	5	0					NONE	NONE		NONE	C5878571;C5944599		Genome (eg, unexplained constitutional or heritable disorder or syndrome), ultra-rapid sequence analysis
0427U	SourceAtomCluster	0427U	False	False	CPT	5	0					NONE	NONE		NONE	C5876644		Monocyte distribution width, whole blood (List separately in addition to code for primary procedure)
0429U	SourceAtomCluster	0429U	False	False	CPT	5	0					NONE	NONE		NONE	C5884306;C5944601		Human papillomavirus (HPV), oropharyngeal swab, 14 high-risk types (ie, 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, and 68)
0430U	SourceAtomCluster	0430U	False	False	CPT	5	0					NONE	NONE		NONE	C5884307;C5944602		Gastroenterology, malabsorption evaluation of alpha-1-antitrypsin, calprotectin, pancreatic elastase and reducing substances, feces, quantitative
0431U	SourceAtomCluster	0431U	False	False	CPT	6	0					NONE	NONE		NONE	C5884308;C5944603;C5944604;C5944605		Glycine receptor alpha1 IgG, serum or cerebrospinal fluid (CSF), live cell-binding assay (LCBA), qualitative
0432U	SourceAtomCluster	0432U	False	False	CPT	6	0					NONE	NONE		NONE	C5884309;C5944608;C5944606;C5944607		Kelch-like protein 11 (KLHL11) antibody, serum or cerebrospinal fluid (CSF), cell-binding assay, qualitative
0433U	SourceAtomCluster	0433U	False	False	CPT	5	0					NONE	NONE		NONE	C5884310;C5944609		Oncology (prostate), 5 DNA regulatory markers by quantitative PCR, whole blood, algorithm, including prostate-specific antigen, reported as likelihood of cancer
0434U	SourceAtomCluster	0434U	False	False	CPT	5	0					NONE	NONE		NONE	C5884311;C5944610		Drug metabolism (adverse drug reactions and drug response), genomic analysis panel, variant analysis of 25 genes with reported phenotypes
0435U	SourceAtomCluster	0435U	False	False	CPT	5	0					NONE	NONE		NONE	C5884312;C5944611		Oncology, chemotherapeutic drug cytotoxicity assay of cancer stem cells (CSCs), from cultured CSCs and primary tumor cells, categorical drug response reported based on cytotoxicity percentage observed, minimum of 14 drugs or drug combinations
0436U	SourceAtomCluster	0436U	False	False	CPT	5	0					NONE	NONE		NONE	C5884313;C5944612		Oncology (lung), plasma analysis of 388 proteins, using aptamer-based proteomics technology, predictive algorithm reported as clinical benefit from immune checkpoint inhibitor therapy
0437U	SourceAtomCluster	0437U	False	False	CPT	5	0					NONE	NONE		NONE	C5884314		Psychiatry (anxiety disorders), mRNA, gene expression profiling by RNA sequencing of 15 biomarkers, whole blood, algorithm reported as predictive risk score
0438U	SourceAtomCluster	0438U	False	False	CPT	5	0					NONE	NONE		NONE	C5884315;C5944613		Drug metabolism (adverse drug reactions and drug response), buccal specimen, gene-drug interactions, variant analysis of 33 genes, including deletion/duplication analysis of CYP2D6, including reported phenotypes and impacted gene-drug interactions
0439U	SourceAtomCluster	0439U	False	False	CPT	5	0					NONE	NONE		NONE	C5944614;C5944615		Cardiology (coronary heart disease [CHD]), DNA, analysis of 5 single-nucleotide polymorphisms (SNPs) (rs11716050 [LOC105376934], rs6560711 [WDR37], rs3735222 [SCIN/LOC107986769], rs6820447 [intergenic], and rs9638144 [ESYT2]) and 3 DNA methylation markers (cg00300879 [transcription start site {TSS200} of CNKSR1], cg09552548 [intergenic], and cg14789911 [body of SPATC1L]), qPCR and digital PCR, whole blood, algorithm reported as a 4-tiered risk score for a 3-year risk of symptomatic CHD
0440U	SourceAtomCluster	0440U	False	False	CPT	5	0					NONE	NONE		NONE	C5944616;C5944617		Cardiology (coronary heart disease [CHD]), DNA, analysis of 10 single-nucleotide polymorphisms (SNPs) (rs710987 [LINC010019], rs1333048 [CDKN2B-AS1], rs12129789 [KCND3], rs942317 [KTN1-AS1], rs1441433 [PPP3CA], rs2869675 [PREX1], rs4639796 [ZBTB41], rs4376434 [LINC00972], rs12714414 [TMEM18], and rs7585056 [TMEM18]) and 6 DNA methylation markers (cg03725309 [SARS1], cg12586707 [CXCL1], cg04988978 [MPO], cg17901584 [DHCR24-DT], cg21161138 [AHRR], and cg12655112 [EHD4]), qPCR and digital PCR, whole blood, algorithm reported as detected or not detected for CHD
0441U	SourceAtomCluster	0441U	False	False	CPT	7	0					NONE	NONE		NONE	C5944618;C5944619;C5944621;C5944620		Infectious disease (bacterial, fungal, or viral infection), semiquantitative biomechanical assessment (via deformability cytometry), whole blood, with algorithmic analysis and result reported as an index
0442U	SourceAtomCluster	0442U	False	False	CPT	5	0					NONE	NONE		NONE	C5944622;C5944623		Infectious disease (respiratory infection), Myxovirus resistance protein A (MxA) and C-reactive protein (CRP), fingerstick whole blood specimen, each biomarker reported as present or absent
0443U	SourceAtomCluster	0443U	False	False	CPT	6	0					NONE	NONE		NONE	C5944625;C5944624;C5944626		Neurofilament light chain (NfL), ultra-sensitive immunoassay, serum or cerebrospinal fluid
0444U	SourceAtomCluster	0444U	False	False	CPT	5	0					NONE	NONE		NONE	C5944627		Oncology (solid organ neoplasia), targeted genomic sequence analysis panel of 361 genes, interrogation for gene fusions, translocations, or other rearrangements, using DNA from formalin-fixed paraffin-embedded (FFPE) tumor tissue, report of clinically significant variant(s)
0445U	SourceAtomCluster	0445U	False	False	CPT	5	0					NONE	NONE		NONE	C5944628		Î²-amyloid (Abeta42) and phospho tau (181P) (pTau181), electrochemiluminescent immunoassay (ECLIA), cerebral spinal fluid, ratio reported as positive or negative for amyloid pathology
0446U	SourceAtomCluster	0446U	False	False	CPT	5	0					NONE	NONE		NONE	C5944629		Autoimmune diseases (systemic lupus erythematosus [SLE]), analysis of 10 cytokine soluble mediator biomarkers by immunoassay, plasma, individual components reported with an algorithmic risk score for current disease activity
0447U	SourceAtomCluster	0447U	False	False	CPT	5	0					NONE	NONE		NONE	C5944630		Autoimmune diseases (systemic lupus erythematosus [SLE]), analysis of 11 cytokine soluble mediator biomarkers by immunoassay, plasma, individual components reported with an algorithmic prognostic risk score for developing a clinical flare
0449U	SourceAtomCluster	0449U	False	False	CPT	5	0					NONE	NONE		NONE	C5944635;C5944634;C5944633		Carrier screening for severe inherited conditions (eg, cystic fibrosis, spinal muscular atrophy, beta hemoglobinopathies [including sickle cell disease], alpha thalassemia), regardless of race or self-identified ancestry, genomic sequence analysis panel, must include analysis of 5 genes (CFTR, SMN1, HBB, HBA1, HBA2)
0452U	SourceAtomCluster	0452U	False	False	CPT	5	0					NONE	NONE		NONE	C5944641;C5944640		Oncology (bladder), methylated PENK DNA detection by linear target enrichment-quantitative methylation-specific real-time PCR (LTE-qMSP), urine, reported as likelihood of bladder cancer
0453U	SourceAtomCluster	0453U	False	False	CPT	5	0					NONE	NONE		NONE	C5944642;C5944643		Oncology (colorectal cancer), cell-free DNA (cfDNA), methylation-based quantitative PCR assay (SEPTIN9, IKZF1, BCAT1, Septin9-2, VAV3, BCAN), plasma, reported as presence or absence of circulating tumor DNA (ctDNA)
0454U	SourceAtomCluster	0454U	False	False	CPT	5	0					NONE	NONE		NONE	C5944645;C5944644;C5944646		Rare diseases (constitutional/heritable disorders), identification of copy number variations, inversions, insertions, translocations, and other structural variants by optical genome mapping
0455U	SourceAtomCluster	0455U	False	False	CPT	11	0					NONE	NONE		NONE	C5944654;C5944648;C5944655;C5944649;C5944650;C5944653;C5944647;C5944651;C5944652		Infectious agents (sexually transmitted infection), Chlamydia trachomatis, Neisseria gonorrhoeae, and Trichomonas vaginalis, multiplex amplified probe technique, vaginal, endocervical, gynecological specimens, oropharyngeal swabs, rectal swabs, female or male urine, each pathogen reported as detected or not detected
0457U	SourceAtomCluster	0457U	False	False	CPT	6	0					NONE	NONE		NONE	C5944658;C5944659;C5944661;C5944660		Perfluoroalkyl substances (PFAS) (eg, perfluorooctanoic acid, perfluorooctane sulfonic acid), 9 PFAS compounds by LC-MS/MS, plasma or serum, quantitative
0458U	SourceAtomCluster	0458U	False	False	CPT	5	0					NONE	NONE		NONE	C5944663;C5944662		Oncology (breast cancer), S100A8 and S100A9, by enzyme-linked immunosorbent assay (ELISA), tear fluid with age, algorithm reported as a risk score
0459U	SourceAtomCluster	0459U	False	False	CPT	5	0					NONE	NONE		NONE	C5944664;C5944665		Î²-amyloid (Abeta42) and total tau (tTau), electrochemiluminescent immunoassay (ECLIA), cerebral spinal fluid, ratio reported as positive or negative for amyloid pathology
0460U	SourceAtomCluster	0460U	False	False	CPT	6	0					NONE	NONE		NONE	C5944666;C5944669;C5944667;C5944668		Oncology, whole blood or buccal, DNA single-nucleotide polymorphism (SNP) genotyping by real-time PCR of 24 genes, with variant analysis and reported phenotypes
0461U	SourceAtomCluster	0461U	False	False	CPT	6	0					NONE	NONE		NONE	C5944670;C5944671;C5944673;C5944672		Oncology, pharmacogenomic analysis of single-nucleotide polymorphism (SNP) genotyping by real-time PCR of 24 genes, whole blood or buccal swab, with variant analysis, including impacted gene-drug interactions and reported phenotypes
0462U	SourceAtomCluster	0462U	False	False	CPT	5	0					NONE	NONE		NONE	C5944674;C5944675		Melatonin levels test, sleep study, 7 or 9 sample melatonin profile (cortisol optional), enzyme-linked immunosorbent assay (ELISA), saliva, screening/preliminary
0463U	SourceAtomCluster	0463U	False	False	CPT	6	0					NONE	NONE		NONE	C5944676;C5944678;C5944677;C5944679		Oncology (cervix), mRNA gene expression profiling of 14 biomarkers (E6 and E7 of the highest-risk human papillomavirus [HPV] types 16, 18, 31, 33, 45, 52, 58), by real-time nucleic acid sequence-based amplification (NASBA), exo- or endocervical epithelial cells, algorithm reported as positive or negative for increased risk of cervical dysplasia or cancer for each biomarker
0464U	SourceAtomCluster	0464U	False	False	CPT	5	0					NONE	NONE		NONE	C5944680;C5944681		Oncology (colorectal) screening, quantitative real-time target and signal amplification, methylated DNA markers, including LASS4, LRRC4 and PPP2R5C, a reference marker ZDHHC1, and a protein marker (fecal hemoglobin), utilizing stool, algorithm reported as a positive or negative result
0465U	SourceAtomCluster	0465U	False	False	CPT	5	0					NONE	NONE		NONE	C5944682;C5944683		Oncology (urothelial carcinoma), DNA, quantitative methylation-specific PCR of 2 genes (ONECUT2, VIM), algorithmic analysis reported as positive or negative
0466U	SourceAtomCluster	0466U	False	False	CPT	5	0					NONE	NONE		NONE	C5944685;C5944684;C5944686		Cardiology (coronary artery disease [CAD]), DNA, genome-wide association studies (564856 single-nucleotide polymorphisms [SNPs], targeted variant genotyping), patient lifestyle and clinical data, buccal swab, algorithm reported as polygenic risk to acquired heart disease
0467U	SourceAtomCluster	0467U	False	False	CPT	5	0					NONE	NONE		NONE	C5944687;C5944688		Oncology (bladder), DNA, next-generation sequencing (NGS) of 60 genes and whole genome aneuploidy, urine, algorithms reported as minimal residual disease (MRD) status positive or negative and quantitative disease burden
0468U	SourceAtomCluster	0468U	False	False	CPT	6	0					NONE	NONE		NONE	C5944689;C5944690;C5944691;C5944692		Hepatology (nonalcoholic steatohepatitis [NASH]), miR-34a-5p, alpha 2-macroglobulin, YKL40, HbA1c, serum and whole blood, algorithm reported as a single score for NASH activity and fibrosis
0469U	SourceAtomCluster	0469U	False	False	CPT	7	0					NONE	NONE		NONE	C5944693;C5944694;C5944696;C5944695;C5944697		Rare diseases (constitutional/heritable disorders), whole genome sequence analysis for chromosomal abnormalities, copy number variants, duplications/deletions, inversions, unbalanced translocations, regions of homozygosity (ROH), inheritance pattern that indicate uniparental disomy (UPD), and aneuploidy, fetal sample (amniotic fluid, chorionic villus sample, or products of conception), identification and categorization of genetic variants, diagnostic report of fetal results based on phenotype with maternal sample and paternal sample, if performed, as comparators and/or maternal cell contamination
0470U	SourceAtomCluster	0470U	False	False	CPT	5	0					NONE	NONE		NONE	C5944698;C5944699		Oncology (oropharyngeal), detection of minimal residual disease by next-generation sequencing (NGS) based quantitative evaluation of 8 DNA targets, cell-free HPV 16 and 18 DNA from plasma
0471U	SourceAtomCluster	0471U	False	False	CPT	5	0					NONE	NONE		NONE	C5944700;C5944701		Oncology (colorectal cancer), qualitative real-time PCR of 35 variants of KRAS and NRAS genes (exons 2, 3, 4), formalin-fixed paraffin-embedded (FFPE), predictive, identification of detected mutations
0472U	SourceAtomCluster	0472U	False	False	CPT	5	0					NONE	NONE		NONE	C5944702;C5944703		Carbonic anhydrase VI (CA VI), parotid specific/secretory protein (PSP) and salivary protein (SP1) IgG, IgM, and IgA antibodies, enzyme-linked immunosorbent assay (ELISA), semiqualitative, blood, reported as predictive evidence of early SjÃ¶gren's syndrome
0473U	SourceAtomCluster	0473U	False	False	CPT	5	0					NONE	NONE		NONE	C5944704;C5944705		Oncology (solid tumor), next-generation sequencing (NGS) of DNA from formalin-fixed paraffin-embedded (FFPE) tissue with comparative sequence analysis from a matched normal specimen (blood or saliva), 648 genes, interrogation for sequence variants, insertion and deletion alterations, copy number variants, rearrangements, microsatellite instability, and tumor-mutation burden
0474U	SourceAtomCluster	0474U	False	False	CPT	5	0					NONE	NONE		NONE	C5944706;C5944707;C5944708		Hereditary pan-cancer (eg, hereditary sarcomas, hereditary endocrine tumors, hereditary neuroendocrine tumors, hereditary cutaneous melanoma), genomic sequence analysis panel of 88 genes with 20 duplications/deletions using next-generation sequencing (NGS), Sanger sequencing, blood or saliva, reported as positive or negative for germline variants, each gene
0475U	SourceAtomCluster	0475U	False	False	CPT	5	0					NONE	NONE		NONE	C5944710;C5944709;C5944711		Hereditary prostate cancer-related disorders, genomic sequence analysis panel using next-generation sequencing (NGS), Sanger sequencing, multiplex ligation-dependent probe amplification (MLPA), and array comparative genomic hybridization (CGH), evaluation of 23 genes and duplications/deletions when indicated, pathologic mutations reported with a genetic risk score for prostate cancer
0476U	SourceAtomCluster	0476U	False	False	CPT	6	0					NONE	NONE		NONE	C5944712;C5944713;C5944714;C5944715		Drug metabolism, psychiatry (eg, major depressive disorder, general anxiety disorder, attention deficit hyperactivity disorder [ADHD], schizophrenia), whole blood, buccal swab, and pharmacogenomic genotyping of 14 genes and CYP2D6 copy number variant analysis and reported phenotypes
0477U	SourceAtomCluster	0477U	False	False	CPT	6	0					NONE	NONE		NONE	C5944717;C5944716;C5944718;C5944719		Drug metabolism, psychiatry (eg, major depressive disorder, general anxiety disorder, attention deficit hyperactivity disorder [ADHD], schizophrenia), whole blood, buccal swab, and pharmacogenomic genotyping of 14 genes and CYP2D6 copy number variant analysis, including impacted gene-drug interactions and reported phenotypes
0478U	SourceAtomCluster	0478U	False	False	CPT	6	0					NONE	NONE		NONE	C5944723;C5944720;C5944722;C5944721		Oncology (non-small cell lung cancer), DNA and RNA, digital PCR analysis of 9 genes (EGFR, KRAS, BRAF, ALK, ROS1, RET, NTRK 1/2/3, ERBB2, and MET) in formalin-fixed paraffin-embedded (FFPE) tissue, interrogation for single-nucleotide variants, insertions/deletions, gene rearrangements, and reported as actionable detected variants for therapy selection
0479U	SourceAtomCluster	0479U	False	False	CPT	5	0					NONE	NONE		NONE	C5944724;C5944725		Tau, phosphorylated, pTau217
0480U	SourceAtomCluster	0480U	False	False	CPT	6	0					NONE	NONE		NONE	C5944727;C5944726;C5944728;C5944729		Infectious disease (bacteria, viruses, fungi, and parasites), cerebrospinal fluid (CSF), metagenomic next-generation sequencing (DNA and RNA), bioinformatic analysis, with positive pathogen identification
0481U	SourceAtomCluster	0481U	False	False	CPT	5	0					NONE	NONE		NONE	C5944730;C5944731		IDH1 (isocitrate dehydrogenase 1 [NADP+]), IDH2 (isocitrate dehydrogenase 2 [NADP+]), and TERT (telomerase reverse transcriptase) promoter (eg, central nervous system [CNS] tumors), next-generation sequencing (single-nucleotide variants [SNV], deletions, and insertions)
0482U	SourceAtomCluster	0482U	False	False	CPT	5	0					NONE	NONE		NONE	C5944732;C5944733		Obstetrics (preeclampsia), biochemical assay of soluble fms-like tyrosine kinase 1 (sFlt-1) and placental growth factor (PlGF), serum, ratio reported for sFlt-1/PlGF, with risk of progression for preeclampsia with severe features within 2 weeks
0483U	SourceAtomCluster	0483U	False	False	CPT	7	0					NONE	NONE		NONE	C5944737;C5944734;C5944735;C5944736;C5944738		Infectious disease (Neisseria gonorrhoeae), sensitivity, ciprofloxacin resistance (gyrA S91F point mutation), oral, rectal, or vaginal swab, algorithm reported as probability of fluoroquinolone resistance
0484U	SourceAtomCluster	0484U	False	False	CPT	7	0					NONE	NONE		NONE	C5944740;C5944743;C5944741;C5944739;C5944742		Infectious disease (Mycoplasma genitalium), macrolide sensitivity (23S rRNA point mutation), oral, rectal, or vaginal swab, algorithm reported as probability of macrolide resistance
0485U	SourceAtomCluster	0485U	False	False	CPT	6	0					NONE	NONE		NONE	C5944747;C5944745;C5944746;C5944744		Oncology (solid tumor), cell-free DNA and RNA by next-generation sequencing, interpretative report for germline mutations, clonal hematopoiesis of indeterminate potential, and tumor-derived single-nucleotide variants, small insertions/deletions, copy number alterations, fusions, microsatellite instability, and tumor mutational burden
0486U	SourceAtomCluster	0486U	False	False	CPT	5	0					NONE	NONE		NONE	C5944748;C5944749;C5944750		Oncology (pan-solid tumor), next-generation sequencing analysis of tumor methylation markers present in cell-free circulating tumor DNA, algorithm reported as quantitative measurement of methylation as a correlate of tumor fraction
0487U	SourceAtomCluster	0487U	False	False	CPT	5	0					NONE	NONE		NONE	C5944751;C5944752		Oncology (solid tumor), cell-free circulating DNA, targeted genomic sequence analysis panel of 84 genes, interrogation for sequence variants, aneuploidy-corrected gene copy number amplifications and losses, gene rearrangements, and microsatellite instability
0488U	SourceAtomCluster	0488U	False	False	CPT	5	0					NONE	NONE		NONE	C5944754;C5944753;C5944755		Obstetrics (fetal antigen noninvasive prenatal test), cell-free DNA sequence analysis for detection of fetal presence or absence of 1 or more of the Rh, C, c, D, E, Duffy (Fya), or Kell (K) antigen in alloimmunized pregnancies, reported as selected antigen(s) detected or not detected
0489U	SourceAtomCluster	0489U	False	False	CPT	5	0					NONE	NONE		NONE	C5944756;C5944757;C5944758		Obstetrics (single-gene noninvasive prenatal test), cell-free DNA sequence analysis of 1 or more targets (eg, CFTR, SMN1, HBB, HBA1, HBA2) to identify paternally inherited pathogenic variants, and relative mutation-dosage analysis based on molecular counts to determine fetal inheritance of maternal mutation, algorithm reported as a fetal risk score for the condition (eg, cystic fibrosis, spinal muscular atrophy, beta hemoglobinopathies [including sickle cell disease], alpha thalassemia)
0490U	SourceAtomCluster	0490U	False	False	CPT	5	0					NONE	NONE		NONE	C5944759;C5944760		Oncology (cutaneous or uveal melanoma), circulating tumor cell selection, morphological characterization and enumeration based on differential CD146, high molecular-weight melanoma-associated antigen, CD34 and CD45 protein biomarkers, peripheral blood
0491U	SourceAtomCluster	0491U	False	False	CPT	5	0					NONE	NONE		NONE	C5944762;C5944761		Oncology (solid tumor), circulating tumor cell selection, morphological characterization and enumeration based on differential epithelial cell adhesion molecule (EpCAM), cytokeratins 8, 18, and 19, CD45 protein biomarkers, and quantification of estrogen receptor (ER) protein biomarker-expressing cells, peripheral blood
0492U	SourceAtomCluster	0492U	False	False	CPT	5	0					NONE	NONE		NONE	C5944763;C5944764		Oncology (solid tumor), circulating tumor cell selection, morphological characterization and enumeration based on differential epithelial cell adhesion molecule (EpCAM), cytokeratins 8, 18, and 19, CD45 protein biomarkers, and quantification of PD-L1 protein biomarker-expressing cells, peripheral blood
0493U	SourceAtomCluster	0493U	False	False	CPT	5	0					NONE	NONE		NONE	C5944765;C5944766		Transplantation medicine, quantification of donor-derived cell-free DNA (cfDNA) using next-generation sequencing, plasma, reported as percentage of donor-derived cell-free DNA
0494U	SourceAtomCluster	0494U	False	False	CPT	5	0					NONE	NONE		NONE	C5944767;C5944768;C5944769		Red blood cell antigen (fetal RhD gene analysis), next-generation sequencing of circulating cell-free DNA (cfDNA) of blood in pregnant individuals known to be RhD negative, reported as positive or negative
0495U	SourceAtomCluster	0495U	False	False	CPT	5	0					NONE	NONE		NONE	C5944770;C5944771		Oncology (prostate), analysis of circulating plasma proteins (tPSA, fPSA, KLK2, PSP94, and GDF15), germline polygenic risk score (60 variants), clinical information (age, family history of prostate cancer, prior negative prostate biopsy), algorithm reported as risk of likelihood of detecting clinically significant prostate cancer
0496U	SourceAtomCluster	0496U	False	False	CPT	5	0					NONE	NONE		NONE	C5944773;C5944772		Oncology (colorectal), cell-free DNA, 8 genes for mutations, 7 genes for methylation by real-time RT-PCR, and 4 proteins by enzyme-linked immunosorbent assay, blood, reported positive or negative for colorectal cancer or advanced adenoma risk
0497U	SourceAtomCluster	0497U	False	False	CPT	5	0					NONE	NONE		NONE	C5944775;C5944774		Oncology (prostate), mRNA gene-expression profiling by real-time RT-PCR of 6 genes (FOXM1, MCM3, MTUS1, TTC21B, ALAS1, and PPP2CA), utilizing formalin-fixed paraffin-embedded (FFPE) tissue, algorithm reported as a risk score for prostate cancer
0498U	SourceAtomCluster	0498U	False	False	CPT	6	0					NONE	NONE		NONE	C5944776;C5944777;C5944779;C5944778		Oncology (colorectal), next-generation sequencing for mutation detection in 43 genes and methylation pattern in 45 genes, blood, and formalin-fixed paraffin-embedded (FFPE) tissue, report of variants and methylation pattern with interpretation
0499U	SourceAtomCluster	0499U	False	False	CPT	6	0					NONE	NONE		NONE	C5944781;C5944780;C5944782;C5944783		Oncology (colorectal and lung), DNA from formalin-fixed paraffin-embedded (FFPE) tissue, next-generation sequencing of 8 genes (NRAS, EGFR, CTNNB1, PIK3CA, APC, BRAF, KRAS, and TP53), mutation detection
0500U	SourceAtomCluster	0500U	False	False	CPT	5	0					NONE	NONE		NONE	C5944784;C5944785		Autoinflammatory disease (VEXAS syndrome), DNA, UBA1 gene mutations, targeted variant analysis (M41T, M41V, M41L, c.118-2A>C, c.118-1G>C, c.118-9_118-2del, S56F, S621C)
0501U	SourceAtomCluster	0501U	False	False	CPT	5	0					NONE	NONE		NONE	C5944786;C5944787		Oncology (colorectal), blood, quantitative measurement of cell-free DNA (cfDNA)
0502U	SourceAtomCluster	0502U	False	False	CPT	5	0					NONE	NONE		NONE	C5944788;C5944789		Human papillomavirus (HPV), E6/E7 markers for high-risk types (16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, and 68), cervical cells, branched-chain capture hybridization, reported as negative or positive for high risk for HPV
0503U	SourceAtomCluster	0503U	False	False	CPT	5	0					NONE	NONE		NONE	C5944791;C5944790		Neurology (Alzheimer disease), beta amyloid (AÎ²40, AÎ²42, AÎ²42/40 ratio) and tau-protein (ptau217, np-tau217, ptau217/np-tau217 ratio), blood, immunoprecipitation with quantitation by liquid chromatography with tandem mass spectrometry (LC-MS/MS), algorithm score reported as likelihood of positive or negative for amyloid plaques
0504U	SourceAtomCluster	0504U	False	False	CPT	5	0					NONE	NONE		NONE	C5944792;C5944793		Infectious disease (urinary tract infection), identification of 17 pathologic organisms, urine, real-time PCR, reported as positive or negative for each organism
0505U	SourceAtomCluster	0505U	False	False	CPT	5	0					NONE	NONE		NONE	C5944794;C5944795		Infectious disease (vaginal infection), identification of 32 pathogenic organisms, swab, real-time PCR, reported as positive or negative for each organism
0506U	SourceAtomCluster	0506U	False	False	CPT	5	0					NONE	NONE		NONE	C5944796;C5944797		Gastroenterology (Barrett's esophagus), esophageal cells, DNA methylation analysis by next-generation sequencing of at least 89 differentially methylated genomic regions, algorithm reported as likelihood for Barrett's esophagus
0507U	SourceAtomCluster	0507U	False	False	CPT	6	0					NONE	NONE		NONE	C5944801;C5944798;C5944799;C5944800		Oncology (ovarian), DNA, whole-genome sequencing with 5-hydroxymethylcytosine (5hmC) enrichment, using whole blood or plasma, algorithm reported as cancer detected or not detected
0510U	SourceAtomCluster	0510U	False	False	CPT	5	0					NONE	NONE		NONE	C5944808;C5944809		Oncology (pancreatic cancer), augmentative algorithmic analysis of 16 genes from previously sequenced RNA whole-transcriptome data, reported as probability of predicted molecular subtype
0511U	SourceAtomCluster	0511U	False	False	CPT	5	0					NONE	NONE		NONE	C5944810		Oncology (solid tumor), tumor cell culture in 3D microenvironment, 36 or more drug panel, reported as tumor-response prediction for each drug
0512U	SourceAtomCluster	0512U	False	False	CPT	5	0					NONE	NONE		NONE	C5944811;C5944812		Oncology (prostate), augmentative algorithmic analysis of digitized whole-slide imaging of histologic features for microsatellite instability (MSI) status, formalin-fixed paraffin-embedded (FFPE) tissue, reported as increased or decreased probability of MSI-high (MSI-H)
0513U	SourceAtomCluster	0513U	False	False	CPT	5	0					NONE	NONE		NONE	C5944814;C5944813		Oncology (prostate), augmentative algorithmic analysis of digitized whole-slide imaging of histologic features for microsatellite instability (MSI) and homologous recombination deficiency (HRD) status, formalin-fixed paraffin-embedded (FFPE) tissue, reported as increased or decreased probability of each biomarker
0514U	SourceAtomCluster	0514U	False	False	CPT	5	0					NONE	NONE		NONE	C5944815;C5944816		Gastroenterology (irritable bowel disease [IBD]), immunoassay for quantitative determination of adalimumab (ADL) levels in venous serum in patients undergoing adalimumab therapy, results reported as a numerical value as micrograms per milliliter (Âµg/mL)
0515U	SourceAtomCluster	0515U	False	False	CPT	5	0					NONE	NONE		NONE	C5944817;C5944818		Gastroenterology (irritable bowel disease [IBD]), immunoassay for quantitative determination of infliximab (IFX) levels in venous serum in patients undergoing infliximab therapy, results reported as a numerical value as micrograms per milliliter (Âµg/mL)
0516U	SourceAtomCluster	0516U	False	False	CPT	5	0					NONE	NONE		NONE	C5944820;C5944819		Drug metabolism, whole blood, pharmacogenomic genotyping of 40 genes and CYP2D6 copy number variant analysis, reported as metabolizer status
0517U	SourceAtomCluster	0517U	False	False	CPT	5	0					NONE	NONE		NONE	C5944822;C5944823;C5944821		Therapeutic drug monitoring, 80 or more psychoactive drugs or substances, LC-MS/MS, plasma, qualitative and quantitative therapeutic minimally and maximally effective dose of prescribed and non-prescribed medications
0518U	SourceAtomCluster	0518U	False	False	CPT	5	0					NONE	NONE		NONE	C5944824;C5944825		Therapeutic drug monitoring, 90 or more pain and mental health drugs or substances, LC-MS/MS, plasma, qualitative and quantitative therapeutic minimally effective range of prescribed and non-prescribed medications
0519U	SourceAtomCluster	0519U	False	False	CPT	5	0					NONE	NONE		NONE	C5944826;C5944827;C5944828		Therapeutic drug monitoring, medications specific to pain, depression, and anxiety, LC-MS/MS, plasma, 110 or more drugs or substances, qualitative and quantitative therapeutic minimally effective range of prescribed, non-prescribed, and illicit medications in circulation
0520U	SourceAtomCluster	0520U	False	False	CPT	5	0					NONE	NONE		NONE	C5944829;C5944830;C5944831		Therapeutic drug monitoring, 200 or more drugs or substances, LC-MS/MS, plasma, qualitative and quantitative therapeutic minimally effective range of prescribed and non-prescribed medications
0521U																		
0522U																		
0523U																		
0524U																		
0525U																		
0526U																		
0527U																		
0528U																		
0529U																		
0530U																		
0531U																		
0532U																		
0533U																		
0534U																		
0535U																		
0536U																		
0537U																		
0538U																		
0539U																		
0540U																		
0541U																		
0542U																		
0543U																		
0545U																		
0546U																		
0547U																		
0548U																		
0549U																		
0552U																		
0553U																		
0554U																		
0555U																		
0556U																		
0557U																		
0558T	SourceAtomCluster	0558T	False	False	CPT	4	0					NONE	NONE		NONE	C5202482;C5202483		Computed tomography scan taken for the purpose of biomechanical computed tomography analysis
0558U																		
0559U																		
0560U																		
0561U																		
0562U																		
0563U																		
0564U																		
0565U																		
0566U																		
0567U																		
0568U																		
0569U																		
0570U																		
0571U																		
0572U																		
0573U																		
0574U																		
0575U																		
0576U																		
0577U																		
0578U																		
0579U																		
0580U																		
0581U																		
0582U																		
0583U																		
0584U																		
0585U																		
0586U																		
0587U																		
0588U																		
0589U																		
0590U																		
0591U																		
0592U																		
0593U																		
0594U																		
0595U																		
0596U																		
0597U																		
0598T	SourceAtomCluster	0598T	False	False	CPT	4	0					NONE	NONE		NONE	C5416636;C5416637		Noncontact real-time fluorescence wound imaging, for bacterial presence, location, and load, per session; first anatomic site (eg, lower extremity)
0598U																		
0599T	SourceAtomCluster	0599T	False	False	CPT	4	0					NONE	NONE		NONE	C5416638;C5416639		Noncontact real-time fluorescence wound imaging, for bacterial presence, location, and load, per session; each additional anatomic site (eg, upper extremity) (List separately in addition to code for primary procedure)
0599U																		
0600U																		
0601U																		
0602U																		
0603U																		
0604U																		
0605U																		
0606U																		
0607U																		
0608U																		
0609U																		
0610U																		
0611U																		
0612U																		
0613U																		
0633T	SourceAtomCluster	0633T	False	False	CPT	4	0					NONE	NONE		NONE	C5416710;C5416711		Computed tomography, breast, including 3D rendering, when performed, unilateral; without contrast material
0634T	SourceAtomCluster	0634T	False	False	CPT	4	0					NONE	NONE		NONE	C5416712;C5416713		Computed tomography, breast, including 3D rendering, when performed, unilateral; with contrast material(s)
0635T	SourceAtomCluster	0635T	False	False	CPT	4	0					NONE	NONE		NONE	C5416714;C5416715		Computed tomography, breast, including 3D rendering, when performed, unilateral; without contrast, followed by contrast material(s)
0636T	SourceAtomCluster	0636T	False	False	CPT	4	0					NONE	NONE		NONE	C5416717;C5416718		Computed tomography, breast, including 3D rendering, when performed, bilateral; without contrast material(s)
0637T	SourceAtomCluster	0637T	False	False	CPT	4	0					NONE	NONE		NONE	C5416720;C5416719		Computed tomography, breast, including 3D rendering, when performed, bilateral; with contrast material(s)
0638T	SourceAtomCluster	0638T	False	False	CPT	4	0					NONE	NONE		NONE	C5416721;C5416722		Computed tomography, breast, including 3D rendering, when performed, bilateral; without contrast, followed by contrast material(s)
0640T	SourceAtomCluster	0640T	False	False	CPT	4	0					NONE	NONE		NONE	C5852194;C5691575		Noncontact near-infrared spectroscopy (eg, for measurement of deoxyhemoglobin, oxyhemoglobin, and ratio of tissue oxygenation), other than for screening for peripheral arterial disease, image acquisition, interpretation, and report; first anatomic site
0648T	SourceAtomCluster	0648T	False	False	CPT	4	0					NONE	NONE		NONE	C5691583;C5697442		Quantitative magnetic resonance for analysis of tissue composition (eg, fat, iron, water content), including multiparametric data acquisition, data preparation and transmission, interpretation and report, obtained without diagnostic MRI examination of the same anatomy (eg, organ, gland, tissue, target structure) during the same session; single organ
0649T	SourceAtomCluster	0649T	False	False	CPT	4	0					NONE	NONE		NONE	C5691585;C5697444		Quantitative magnetic resonance for analysis of tissue composition (eg, fat, iron, water content), including multiparametric data acquisition, data preparation and transmission, interpretation and report, obtained with diagnostic MRI examination of the same anatomy (eg, organ, gland, tissue, target structure); single organ (List separately in addition to code for primary procedure)
0721T	SourceAtomCluster	0721T	False	False	CPT	4	0					NONE	NONE		NONE	C5702414;C5702413		Quantitative computed tomography (CT) tissue characterization, including interpretation and report, obtained without concurrent CT examination of any structure contained in previously acquired diagnostic imaging
0722T	SourceAtomCluster	0722T	False	False	CPT	4	0					NONE	NONE		NONE	C5702415		Quantitative computed tomography (CT) tissue characterization, including interpretation and report, obtained with concurrent CT examination of any structure contained in the concurrently acquired diagnostic imaging dataset (List separately in addition to code for primary procedure)
0723T	SourceAtomCluster	0723T	False	False	CPT	4	0					NONE	NONE		NONE	C5702416;C5702417		Quantitative magnetic resonance cholangiopancreatography (QMRCP), including data preparation and transmission, interpretation and report, obtained without diagnostic magnetic resonance imaging (MRI) examination of the same anatomy (eg, organ, gland, tissue, target structure) during the same session
0724T	SourceAtomCluster	0724T	False	False	CPT	4	0					NONE	NONE		NONE	C5702418;C5702419		Quantitative magnetic resonance cholangiopancreatography (QMRCP), including data preparation and transmission, interpretation and report, obtained with diagnostic magnetic resonance imaging (MRI) examination of the same anatomy (eg, organ, gland, tissue, target structure) (List separately in addition to code for primary procedure)
0807T	SourceAtomCluster	0807T	False	False	CPT	4	0					NONE	NONE		NONE	C5852329;C5852330		Pulmonary tissue ventilation analysis using software-based processing of data from separately captured cinefluorograph images; in combination with previously acquired computed tomography (CT) images, including data preparation and transmission, quantification of pulmonary tissue ventilation, data review, interpretation and report
0808T	SourceAtomCluster	0808T	False	False	CPT	4	0					NONE	NONE		NONE	C5852331;C5852332		Pulmonary tissue ventilation analysis using software-based processing of data from separately captured cinefluorograph images; in combination with computed tomography (CT) images taken for the purpose of pulmonary tissue ventilation analysis, including data preparation and transmission, quantification of pulmonary tissue ventilation, data review, interpretation and report
0815T	SourceAtomCluster	0815T	False	False	CPT	4	0					NONE	NONE		NONE	C5852344;C5852345		Ultrasound-based radiofrequency echographic multi-spectrometry (REMS), bone-density study and fracture-risk assessment, 1 or more sites, hips, pelvis, or spine
0857T	SourceAtomCluster	0857T	False	False	CPT	4	0					NONE	NONE		NONE	C5852370;C5852371		Opto-acoustic imaging, breast, unilateral, including axilla when performed, real-time with image documentation, augmentative analysis and report (List separately in addition to code for primary procedure)
0859T	SourceAtomCluster	0859T	False	False	CPT	4	0					NONE	NONE		NONE	C5852195;C5852196		Noncontact near-infrared spectroscopy (eg, for measurement of deoxyhemoglobin, oxyhemoglobin, and ratio of tissue oxygenation), other than for screening for peripheral arterial disease, image acquisition, interpretation, and report; each additional anatomic site (List separately in addition to code for primary procedure)
0860T	SourceAtomCluster	0860T	False	False	CPT	4	0					NONE	NONE		NONE	C5852198;C5852197		Noncontact near-infrared spectroscopy (eg, for measurement of deoxyhemoglobin, oxyhemoglobin, and ratio of tissue oxygenation), for screening for peripheral arterial disease, including provocative maneuvers, image acquisition, interpretation, and report, one or both lower extremities
0865T	SourceAtomCluster	0865T	False	False	CPT	4	0					NONE	NONE		NONE	C5852376;C5852377		Quantitative magnetic resonance image (MRI) analysis of the brain with comparison to prior magnetic resonance (MR) study(ies), including lesion identification, characterization, and quantification, with brain volume(s) quantification and/or severity score, when performed, data preparation and transmission, interpretation and report, obtained without diagnostic MRI examination of the brain during the same session
0866T	SourceAtomCluster	0866T	False	False	CPT	4	0					NONE	NONE		NONE	C5852378;C5852379		Quantitative magnetic resonance image (MRI) analysis of the brain with comparison to prior magnetic resonance (MR) study(ies), including lesion detection, characterization, and quantification, with brain volume(s) quantification and/or severity score, when performed, data preparation and transmission, interpretation and report, obtained with diagnostic MRI examination of the brain (List separately in addition to code for primary procedure)
0877T	SourceAtomCluster	0877T	False	False	CPT	4	0					NONE	NONE		NONE	C5944935		Augmentative analysis of chest computed tomography (CT) imaging data to provide categorical diagnostic subtype classification of interstitial lung disease; obtained without concurrent CT examination of any structure contained in previously acquired diagnostic imaging
0878T	SourceAtomCluster	0878T	False	False	CPT	4	0					NONE	NONE		NONE	C5944936		Augmentative analysis of chest computed tomography (CT) imaging data to provide categorical diagnostic subtype classification of interstitial lung disease; obtained with concurrent CT examination of the same structure
0879T	SourceAtomCluster	0879T	False	False	CPT	4	0					NONE	NONE		NONE	C5944937		Augmentative analysis of chest computed tomography (CT) imaging data to provide categorical diagnostic subtype classification of interstitial lung disease; radiological data preparation and transmission
0880T	SourceAtomCluster	0880T	False	False	CPT	4	0					NONE	NONE		NONE	C5944938		Augmentative analysis of chest computed tomography (CT) imaging data to provide categorical diagnostic subtype classification of interstitial lung disease; physician or other qualified health care professional interpretation and report
0889T	SourceAtomCluster	0889T	False	False	CPT	4	0					NONE	NONE		NONE	C5944948		Personalized target development for accelerated, repetitive high-dose functional connectivity MRI-guided theta-burst stimulation derived from a structural and resting-state functional MRI, including data preparation and transmission, generation of the target, motor threshold-starting location, neuronavigation files and target report, review and interpretation
0898T	SourceAtomCluster	0898T	False	False	CPT	4	0					NONE	NONE		NONE	C5944961		Noninvasive prostate cancer estimation map, derived from augmentative analysis of image-guided fusion biopsy and pathology, including visualization of margin volume and location, with margin determination and physician interpretation and report
0899T	SourceAtomCluster	0899T	False	False	CPT	4	0					NONE	NONE		NONE	C5944962		Noninvasive determination of absolute quantitation of myocardial blood flow (AQMBF), derived from augmentative algorithmic analysis of the dataset acquired via contrast cardiac magnetic resonance (CMR), pharmacologic stress, with interpretation and report by a physician or other qualified health care professional (List separately in addition to code for primary procedure)
0900T	SourceAtomCluster	0900T	False	False	CPT	4	0					NONE	NONE		NONE	C5944963		Noninvasive estimate of absolute quantitation of myocardial blood flow (AQMBF), derived from assistive algorithmic analysis of the dataset acquired via contrast cardiac magnetic resonance (CMR), pharmacologic stress, with interpretation and report by a physician or other qualified health care professional (List separately in addition to code for primary procedure)
0932T	SourceAtomCluster	0932T	False	False	CPT	4	0					NONE	NONE		NONE	C5945018;C5945019		Noninvasive detection of heart failure derived from augmentative analysis of an echocardiogram that demonstrated preserved ejection fraction, with interpretation and report by a physician or other qualified health care professional
0944T	SourceAtomCluster	0944T	False	False	CPT	4	0					NONE	NONE		NONE	C5945040		3D contour simulation of target liver lesion(s) and margin(s) for image-guided percutaneous microwave ablation
0946T	SourceAtomCluster	0946T	False	False	CPT	4	0					NONE	NONE		NONE	C5945043;C5945044		Orthopedic implant movement analysis using paired computed tomography (CT) examination of the target structure, including data acquisition, data preparation and transmission, interpretation and report (including CT scan of the joint or extremity performed with paired views)
0947T	SourceAtomCluster	0947T	False	False	CPT	4	0					NONE	NONE		NONE	C5945045;C5945046		Magnetic resonance image guided low intensity focused ultrasound (MRgFUS), stereotactic blood-brain barrier disruption using microbubble resonators to increase the concentration of blood-based biomarkers of target, intracranial, including stereotactic navigation and frame placement, when performed
0961T																		
0972T																		
0977T																		
0984T																		
0985T																		
0986T																		
0987T																		
0992T																		
0993T																		
1010T																		
1020T																		
19296	SourceAtomCluster	19296	False	False	CPT	6	0					NONE	NONE		NONE	C3705628;C1504120;C3705629;C5692260		Placement of radiotherapy afterloading expandable catheter (single or multichannel) into the breast for interstitial radioelement application following partial mastectomy, includes imaging guidance; on date separate from partial mastectomy
19297	SourceAtomCluster	19297	False	False	CPT	6	0					NONE	NONE		NONE	C3705630;C1504121;C5692261;C3705631		Placement of radiotherapy afterloading expandable catheter (single or multichannel) into the breast for interstitial radioelement application following partial mastectomy, includes imaging guidance; concurrent with partial mastectomy (List separately in addition to code for primary procedure)
19298	SourceAtomCluster	19298	False	False	CPT	7	0					NONE	NONE		NONE	C1504122;C3705633;C3705632;C5692262;C3518233		Placement of radiotherapy after loading brachytherapy catheters (multiple tube and button type) into the breast for interstitial radioelement application following (at the time of or subsequent to) partial mastectomy, includes imaging guidance
20555	SourceAtomCluster	20555	False	False	CPT	10	0					NONE	NONE		NONE	C1964173;C3518253;C3518252;C3518254;C5692289;C3518251;C3518249;C3518250		Placement of needles or catheters into muscle and/or soft tissue for subsequent interstitial radioelement application (at the time of or subsequent to the procedure)
31643	SourceAtomCluster	31643	False	False	CPT	8	0					NONE	NONE		NONE	C3520340;C5693551;C3520341;C3520339;C3520338;C0695022		Bronchoscopy, rigid or flexible, including fluoroscopic guidance, when performed; with placement of catheter(s) for intracavitary radioelement application
32553	SourceAtomCluster	32553	False	False	CPT	6	0					NONE	NONE		NONE	C2724263;C5693598;C5406390;C5406389		Placement of interstitial device(s) for radiation therapy guidance (eg, fiducial markers, dosimeter), percutaneous, intra-thoracic, single or multiple
32701	SourceAtomCluster	32701	False	False	CPT	6	0					NONE	NONE		NONE	C5406403;C3511512;C5406404;C5693626		Thoracic target(s) delineation for stereotactic body radiation therapy (SRS/SBRT), (photon or particle beam), entire course of treatment
36415	SourceAtomCluster	36415	False	False	CPT	5	0					NONE	NONE		NONE	C1548758		Collection of venous blood by venipuncture
41019	SourceAtomCluster	41019	False	False	CPT	22	0					NONE	NONE		NONE	C1964203;C5694315;C5407940;C5407943;C3521364;C5407941;C3521352;C3521354;C3521366;C3521351;C3521357;C3521358;C3521363;C3521367;C3521355;C3521360;C3521361;C5407938;C5407939;C5407942		Placement of needles, catheters, or other device(s) into the head and/or neck region (percutaneous, transoral, or transnasal) for subsequent interstitial radioelement application
49327	SourceAtomCluster	49327	False	False	CPT	16	0					NONE	NONE		NONE	C2939250;C5408704;C3522347;C3522339;C3522342;C3522348;C5694827;C3522341;C3522340;C5408700;C5408699;C5408703;C5408701;C5408702		Laparoscopy, surgical; with placement of interstitial device(s) for radiation therapy guidance (eg, fiducial markers, dosimeter), intra-abdominal, intrapelvic, and/or retroperitoneum, including imaging guidance, if performed, single or multiple (List separately in addition to code for primary procedure)
49411	SourceAtomCluster	49411	False	False	CPT	12	0					NONE	NONE		NONE	C2724291;C5408709;C5694834;C5408711;C5408712;C5408713;C5408714;C5408715;C5408708;C5408710		Placement of interstitial device(s) for radiation therapy guidance (eg, fiducial markers, dosimeter), percutaneous, intra-abdominal, intra-pelvic (except prostate), and/or retroperitoneum, single or multiple
49412	SourceAtomCluster	49412	False	False	CPT	16	0					NONE	NONE		NONE	C2939251;C3522363;C3522358;C3522359;C3522362;C3522364;C5694835;C3522356;C3522355;C3522360;C3522354;C3522357;C3522361;C3522365		Placement of interstitial device(s) for radiation therapy guidance (eg, fiducial markers, dosimeter), open, intra-abdominal, intrapelvic, and/or retroperitoneum, including image guidance, if performed, single or multiple (List separately in addition to code for primary procedure)
51020	SourceAtomCluster	51020	False	False	CPT	10	0					NONE	NONE		NONE	C3522787;C2066271;C3514575;C3522789;C2066273;C3522788;C3522790;C0372359		Cystotomy or cystostomy, with fulguration and/or insertion of radioactive material
51798	SourceAtomCluster	51798	False	False	CPT	6	0					NONE	NONE		NONE	C5408997;C1144666;C3514616;C5408996		Measurement of post-voiding residual urine and/or bladder capacity by ultrasound, non-imaging
55875	SourceAtomCluster	55875	False	False	CPT	8	0					NONE	NONE		NONE	C3867541;C0372514;C3523188;C3867540;C5695224;C3523189		Transperineal placement of needles or catheters into prostate for interstitial radioelement application, with or without cystoscopy
55876	SourceAtomCluster	55876	False	False	CPT	10	0					NONE	NONE		NONE	C5695225;C3867538;C3867535;C3867537;C3867539;C3523190;C1737192;C4052186		Placement of interstitial device(s) for radiation therapy guidance (eg, fiducial markers, dosimeter), prostate (via needle, any approach), single or multiple
55920	SourceAtomCluster	55920	False	False	CPT	10	0					NONE	NONE		NONE	C1964220;C5409239;C5409235;C3523193;C5697563;C5409237;C5409238;C5409236		Placement of needles or catheters into pelvic organs and/or genitalia (except prostate) for subsequent interstitial radioelement application
57155	SourceAtomCluster	57155	False	False	CPT	7	0					NONE	NONE		NONE	C0973318;C5697565;C3523208;C3523209;C3523210		Insertion of uterine tandem and/or vaginal ovoids for clinical brachytherapy
57156	SourceAtomCluster	57156	False	False	CPT	5	0					NONE	NONE		NONE	C2939256;C5695257		Insertion of a vaginal radiation afterloading apparatus for clinical brachytherapy
58346	SourceAtomCluster	58346	False	False	CPT	5	0					NONE	NONE		NONE	C5695321;C0973319		Insertion of Heyman capsules for clinical brachytherapy
61715	SourceAtomCluster	61715	False	False	CPT	6	0					NONE	NONE		NONE	C5944453;C5944455;C5944452;C5944454		Magnetic resonance image guided high intensity focused ultrasound (MRgFUS), stereotactic ablation of target, intracranial, including stereotactic navigation and frame placement, when performed
61770	SourceAtomCluster	61770	False	False	CPT	8	0					NONE	NONE		NONE	C5695555;C3524183;C3524181;C0196063;C3524180;C3524182		Stereotactic localization, including burr hole(s), with insertion of catheter(s) or probe(s) for placement of radiation source
61796	SourceAtomCluster	61796	False	False	CPT	5	0					NONE	NONE		NONE	C2366674;C5695559;C5409641		Stereotactic radiosurgery (particle beam, gamma ray, or linear accelerator); 1 simple cranial lesion
61797	SourceAtomCluster	61797	False	False	CPT	5	0					NONE	NONE		NONE	C2366675;C5695560;C5409643		Stereotactic radiosurgery (particle beam, gamma ray, or linear accelerator); each additional cranial lesion, simple (List separately in addition to code for primary procedure)
61798	SourceAtomCluster	61798	False	False	CPT	5	0					NONE	NONE		NONE	C2366676;C5695561;C5409644		Stereotactic radiosurgery (particle beam, gamma ray, or linear accelerator); 1 complex cranial lesion
61799	SourceAtomCluster	61799	False	False	CPT	5	0					NONE	NONE		NONE	C5695562;C5409646;C2366677		Stereotactic radiosurgery (particle beam, gamma ray, or linear accelerator); each additional cranial lesion, complex (List separately in addition to code for primary procedure)
61800	SourceAtomCluster	61800	False	False	CPT	5	0					NONE	NONE		NONE	C2366678;C5695563;C3515200		Application of stereotactic headframe for stereotactic radiosurgery (List separately in addition to code for primary procedure)
63620	SourceAtomCluster	63620	False	False	CPT	7	0					NONE	NONE		NONE	C3866866;C3866865;C3866867;C2366680;C5695709		Stereotactic radiosurgery (particle beam, gamma ray, or linear accelerator); 1 spinal lesion
63621	SourceAtomCluster	63621	False	False	CPT	7	0					NONE	NONE		NONE	C5410310;C5410311;C2366681;C5695710;C5410309		Stereotactic radiosurgery (particle beam, gamma ray, or linear accelerator); each additional spinal lesion (List separately in addition to code for primary procedure)
70100	SourceAtomCluster	70100	False	False	CPT	9	0					NONE	NONE		NONE	C0202719;C3866675;C3866678;C3866676;C3866677;C5696049		Radiologic examination, mandible; partial, less than 4 views
70110	SourceAtomCluster	70110	False	False	CPT	6	0					NONE	NONE		NONE	C3866674;C0202720;C5696050		Radiologic examination, mandible; complete, minimum of 4 views
70120	SourceAtomCluster	70120	False	False	CPT	11	0					NONE	NONE		NONE	C3866668;C3866671;C0202728;C3866669;C3866672;C3866670;C3866673;C5696051		Radiologic examination, mastoids; less than 3 views per side
70130	SourceAtomCluster	70130	False	False	CPT	6	0					NONE	NONE		NONE	C3866667;C0202729;C5696052		Radiologic examination, mastoids; complete, minimum of 3 views per side
70134	SourceAtomCluster	70134	False	False	CPT	6	0					NONE	NONE		NONE	C3866666;C0202736;C5696053		Radiologic examination, internal auditory meati, complete
70140	SourceAtomCluster	70140	False	False	CPT	8	0					NONE	NONE		NONE	C0202710;C3866664;C3866665;C3866663;C5697548		Radiologic examination, facial bones; less than 3 views
70150	SourceAtomCluster	70150	False	False	CPT	6	0					NONE	NONE		NONE	C0202711;C3866661;C3527532		Radiologic examination, facial bones; complete, minimum of 3 views
70160	SourceAtomCluster	70160	False	False	CPT	6	0					NONE	NONE		NONE	C0202731;C3515732;C3866659		Radiologic examination, nasal bones, complete, minimum of 3 views
70190	SourceAtomCluster	70190	False	False	CPT	5	0					NONE	NONE		NONE	C0202748;C5696055		Radiologic examination; optic foramina
70200	SourceAtomCluster	70200	False	False	CPT	9	0					NONE	NONE		NONE	C0202747;C3866656;C3866654;C3866655;C3866657;C5696056;C2013765		Radiologic examination; orbits, complete, minimum of 4 views
70210	SourceAtomCluster	70210	False	False	CPT	6	0					NONE	NONE		NONE	C3866653;C0202733;C5697549		Radiologic examination, sinuses, paranasal, less than 3 views
70220	SourceAtomCluster	70220	False	False	CPT	7	0					NONE	NONE		NONE	C0202734;C3866650;C3866651;C5696057		Radiologic examination, sinuses, paranasal, complete, minimum of 3 views
70240	SourceAtomCluster	70240	False	False	CPT	5	0					NONE	NONE		NONE	C0202686;C3515735		Radiologic examination, sella turcica
70250	SourceAtomCluster	70250	False	False	CPT	7	0					NONE	NONE		NONE	C3866647;C3866649;C3866648;C5696058;C0373139		Radiologic examination, skull; less than 4 views
70260	SourceAtomCluster	70260	False	False	CPT	6	0					NONE	NONE		NONE	C3866646;C5696059;C0373140		Radiologic examination, skull; complete, minimum of 4 views
70300	SourceAtomCluster	70300	False	False	CPT	10	0					NONE	NONE		NONE	C3866644;C0202775;C2586170;C3866645;C3866642;C3866643;C5697550		Radiologic examination, teeth; single view
70310	SourceAtomCluster	70310	False	False	CPT	5	0					NONE	NONE		NONE	C5410809;C0202776		Radiologic examination, teeth; partial examination, less than full mouth
70320	SourceAtomCluster	70320	False	False	CPT	5	0					NONE	NONE		NONE	C0202777;C5410810		Radiologic examination, teeth; complete, full mouth
70328	SourceAtomCluster	70328	False	False	CPT	5	0					NONE	NONE		NONE	C0202723;C5410811;C5696060		Radiologic examination, temporomandibular joint, open and closed mouth; unilateral
70330	SourceAtomCluster	70330	False	False	CPT	6	0					NONE	NONE		NONE	C5416789;C0202724;C5410812;C5696061		Radiologic examination, temporomandibular joint, open and closed mouth; bilateral
70336	SourceAtomCluster	70336	False	False	CPT	6	0					NONE	NONE		NONE	C5410814;C0202726		Magnetic resonance (eg, proton) imaging, temporomandibular joint(s)
70350	SourceAtomCluster	70350	False	False	CPT	5	0					NONE	NONE		NONE	C5696063;C0407698		Cephalogram, orthodontic
70355	SourceAtomCluster	70355	False	False	CPT	5	0					NONE	NONE		NONE	C0034579;C5696064		Orthopantogram (eg, panoramic x-ray)
70360	SourceAtomCluster	70360	False	False	CPT	5	0					NONE	NONE		NONE	C0373142		Radiologic examination; neck, soft tissue
70370	SourceAtomCluster	70370	False	False	CPT	10	0					NONE	NONE		NONE	C3866639;C0202769;C3525137;C3525140;C3527533;C3866638;C3525139;C3525136		Radiologic examination; pharynx or larynx, including fluoroscopy and/or magnification technique
70371	SourceAtomCluster	70371	False	False	CPT	6	0					NONE	NONE		NONE	C0202770;C3866636;C3866637;C3515739		Complex dynamic pharyngeal and speech evaluation by cine or video recording
70380	SourceAtomCluster	70380	False	False	CPT	6	0					NONE	NONE		NONE	C0202741;C1659593;C2121222;C5696065		Radiologic examination, salivary gland for calculus
70450	SourceAtomCluster	70450	False	False	CPT	6	0					NONE	NONE		NONE	C5410817;C0202692;C5696067;C5410816		Computed tomography, head or brain; without contrast material
70460	SourceAtomCluster	70460	False	False	CPT	6	0					NONE	NONE		NONE	C3515742;C5410818;C5410819;C1275583		Computed tomography, head or brain; with contrast material(s)
70470	SourceAtomCluster	70470	False	False	CPT	6	0					NONE	NONE		NONE	C0202694;C3515743;C5410821;C5410820		Computed tomography, head or brain; without contrast material, followed by contrast material(s) and further sections
70471																		
70472																		
70473																		
70480	SourceAtomCluster	70480	False	False	CPT	10	0					NONE	NONE		NONE	C5696068;C5410825;C5410822;C5410823;C5410826;C5410824;C5410827;C0373145		Computed tomography, orbit, sella, or posterior fossa or outer, middle, or inner ear; without contrast material
70481	SourceAtomCluster	70481	False	False	CPT	10	0					NONE	NONE		NONE	C5410829;C5410831;C3515745;C5410828;C5410830;C5410832;C5410833;C0373146		Computed tomography, orbit, sella, or posterior fossa or outer, middle, or inner ear; with contrast material(s)
70482	SourceAtomCluster	70482	False	False	CPT	10	0					NONE	NONE		NONE	C5410838;C5410834;C5410835;C3515746;C5410839;C5410836;C5410837;C0373147		Computed tomography, orbit, sella, or posterior fossa or outer, middle, or inner ear; without contrast material, followed by contrast material(s) and further sections
70486	SourceAtomCluster	70486	False	False	CPT	5	0					NONE	NONE		NONE	C0202715;C5696069;C5410840		Computed tomography, maxillofacial area; without contrast material
70487	SourceAtomCluster	70487	False	False	CPT	5	0					NONE	NONE		NONE	C5410841;C0202716;C3515748		Computed tomography, maxillofacial area; with contrast material(s)
70488	SourceAtomCluster	70488	False	False	CPT	5	0					NONE	NONE		NONE	C0202717;C3515749;C5410842		Computed tomography, maxillofacial area; without contrast material, followed by contrast material(s) and further sections
70490	SourceAtomCluster	70490	False	False	CPT	5	0					NONE	NONE		NONE	C0202758;C5410843		Computed tomography, soft tissue neck; without contrast material
70491	SourceAtomCluster	70491	False	False	CPT	5	0					NONE	NONE		NONE	C0202759;C5410844		Computed tomography, soft tissue neck; with contrast material(s)
70492	SourceAtomCluster	70492	False	False	CPT	5	0					NONE	NONE		NONE	C0202760;C5410845;C5696070		Computed tomography, soft tissue neck; without contrast material followed by contrast material(s) and further sections
70496	SourceAtomCluster	70496	False	False	CPT	6	0					NONE	NONE		NONE	C5410846;C3703790;C5410847;C0918137		Computed tomographic angiography, head, with contrast material(s), including noncontrast images, if performed, and image postprocessing
70498	SourceAtomCluster	70498	False	False	CPT	6	0					NONE	NONE		NONE	C5410849;C3703791;C5410848;C0918138		Computed tomographic angiography, neck, with contrast material(s), including noncontrast images, if performed, and image postprocessing
70540	SourceAtomCluster	70540	False	False	CPT	11	0					NONE	NONE		NONE	C3495410;C5696071;C5410853;C5410854;C5410855;C5410856;C5410850;C5410851;C5410852		Magnetic resonance (eg, proton) imaging, orbit, face, and/or neck; without contrast material(s)
70542	SourceAtomCluster	70542	False	False	CPT	11	0					NONE	NONE		NONE	C5410858;C5410863;C5410857;C5410860;C5410862;C5696072;C5410861;C5410859;C0918139		Magnetic resonance (eg, proton) imaging, orbit, face, and/or neck; with contrast material(s)
70543	SourceAtomCluster	70543	False	False	CPT	11	0					NONE	NONE		NONE	C5410867;C5410870;C5410865;C5410868;C5696073;C5410866;C5410864;C5410869;C0918140		Magnetic resonance (eg, proton) imaging, orbit, face, and/or neck; without contrast material(s), followed by contrast material(s) and further sequences
70544	SourceAtomCluster	70544	False	False	CPT	5	0					NONE	NONE		NONE	C4305213;C5696074;C5410871		Magnetic resonance angiography, head; without contrast material(s)
70545	SourceAtomCluster	70545	False	False	CPT	5	0					NONE	NONE		NONE	C3839357;C5696075;C5410872		Magnetic resonance angiography, head; with contrast material(s)
70546	SourceAtomCluster	70546	False	False	CPT	5	0					NONE	NONE		NONE	C5410873;C5696076;C0918143		Magnetic resonance angiography, head; without contrast material(s), followed by contrast material(s) and further sequences
70547	SourceAtomCluster	70547	False	False	CPT	5	0					NONE	NONE		NONE	C5410874;C4305212;C5696077		Magnetic resonance angiography, neck; without contrast material(s)
70548	SourceAtomCluster	70548	False	False	CPT	5	0					NONE	NONE		NONE	C5696078;C5410875;C0918145		Magnetic resonance angiography, neck; with contrast material(s)
70549	SourceAtomCluster	70549	False	False	CPT	5	0					NONE	NONE		NONE	C5410876;C5696079;C0918146		Magnetic resonance angiography, neck; without contrast material(s), followed by contrast material(s) and further sequences
70551	SourceAtomCluster	70551	False	False	CPT	6	0					NONE	NONE		NONE	C0202699;C5410878;C5696080;C5410877		Magnetic resonance (eg, proton) imaging, brain (including brain stem); without contrast material
70552	SourceAtomCluster	70552	False	False	CPT	6	0					NONE	NONE		NONE	C3515757;C0202700;C5410880;C5410879		Magnetic resonance (eg, proton) imaging, brain (including brain stem); with contrast material(s)
70553	SourceAtomCluster	70553	False	False	CPT	6	0					NONE	NONE		NONE	C5410881;C3515758;C5410882;C0373149		Magnetic resonance (eg, proton) imaging, brain (including brain stem); without contrast material, followed by contrast material(s) and further sequences
70554	SourceAtomCluster	70554	False	False	CPT	7	0					NONE	NONE		NONE	C5410884;C1740478;C5410885;C3515759;C5410883		Magnetic resonance imaging, brain, functional MRI; including test selection and administration of repetitive body part movement and/or visual stimulation, not requiring physician or psychologist administration
70555	SourceAtomCluster	70555	False	False	CPT	6	0					NONE	NONE		NONE	C1738519;C5696081;C5410886;C5410887		Magnetic resonance imaging, brain, functional MRI; requiring physician or psychologist administration of entire neurofunctional testing
71045	SourceAtomCluster	71045	False	False	CPT	5	0					NONE	NONE		NONE	C4523436		Radiologic examination, chest; single view
71046	SourceAtomCluster	71046	False	False	CPT	5	0					NONE	NONE		NONE	C4523437		Radiologic examination, chest; 2 views
71047	SourceAtomCluster	71047	False	False	CPT	5	0					NONE	NONE		NONE	C4523438		Radiologic examination, chest; 3 views
71048	SourceAtomCluster	71048	False	False	CPT	5	0					NONE	NONE		NONE	C3515762;C4523439		Radiologic examination, chest; 4 or more views
71100	SourceAtomCluster	71100	False	False	CPT	7	0					NONE	NONE		NONE	C0202814;C3866577;C3866578;C5696085		Radiologic examination, ribs, unilateral; 2 views
71101	SourceAtomCluster	71101	False	False	CPT	7	0					NONE	NONE		NONE	C0202815;C3866576;C3866575;C5696086		Radiologic examination, ribs, unilateral; including posteroanterior chest, minimum of 3 views
71110	SourceAtomCluster	71110	False	False	CPT	7	0					NONE	NONE		NONE	C3866573;C3866574;C0202817;C5696087		Radiologic examination, ribs, bilateral; 3 views
71111	SourceAtomCluster	71111	False	False	CPT	7	0					NONE	NONE		NONE	C3866571;C0202818;C3866572;C5696088		Radiologic examination, ribs, bilateral; including posteroanterior chest, minimum of 4 views
71120	SourceAtomCluster	71120	False	False	CPT	6	0					NONE	NONE		NONE	C0202821;C3866570;C5696089		Radiologic examination; sternum, minimum of 2 views
71130	SourceAtomCluster	71130	False	False	CPT	6	0					NONE	NONE		NONE	C0202822;C3866569;C5696090		Radiologic examination; sternoclavicular joint or joints, minimum of 3 views
71250	SourceAtomCluster	71250	False	False	CPT	5	0					NONE	NONE		NONE	C1961126;C5410899;C2041475		Computed tomography, thorax, diagnostic; without contrast material
71260	SourceAtomCluster	71260	False	False	CPT	5	0					NONE	NONE		NONE	C0202824;C3515769;C5410901		Computed tomography, thorax, diagnostic; with contrast material(s)
71270	SourceAtomCluster	71270	False	False	CPT	5	0					NONE	NONE		NONE	C5696091;C0202825;C5410902		Computed tomography, thorax, diagnostic; without contrast material, followed by contrast material(s) and further sections
71271	SourceAtomCluster	71271	False	False	CPT	5	0					NONE	NONE		NONE	C5410903;C5410904;C5410905		Computed tomography, thorax, low dose for lung cancer screening, without contrast material(s)
71275	SourceAtomCluster	71275	False	False	CPT	6	0					NONE	NONE		NONE	C5410907;C3703801;C5410906;C0918147		Computed tomographic angiography, chest (noncoronary), with contrast material(s), including noncontrast images, if performed, and image postprocessing
71550	SourceAtomCluster	71550	False	False	CPT	6	0					NONE	NONE		NONE	C5696092;C5410908;C0202826;C5410909		Magnetic resonance (eg, proton) imaging, chest (eg, for evaluation of hilar and mediastinal lymphadenopathy); without contrast material(s)
71551	SourceAtomCluster	71551	False	False	CPT	6	0					NONE	NONE		NONE	C5410910;C5410911;C2316260;C0918148		Magnetic resonance (eg, proton) imaging, chest (eg, for evaluation of hilar and mediastinal lymphadenopathy); with contrast material(s)
71552	SourceAtomCluster	71552	False	False	CPT	6	0					NONE	NONE		NONE	C5410913;C3515771;C5410912;C0918149		Magnetic resonance (eg, proton) imaging, chest (eg, for evaluation of hilar and mediastinal lymphadenopathy); without contrast material(s), followed by contrast material(s) and further sequences
71555	SourceAtomCluster	71555	False	False	CPT	6	0					NONE	NONE		NONE	C5410914;C5410915;C3515772;C0373154		Magnetic resonance angiography, chest (excluding myocardium), with or without contrast material(s)
72020	SourceAtomCluster	72020	False	False	CPT	12	0					NONE	NONE		NONE	C3866556;C3866559;C3866557;C3866561;C0373156;C3515774;C3866554;C3866555;C3866560;C3866558		Radiologic examination, spine, single view, specify level
72040	SourceAtomCluster	72040	False	False	CPT	10	0					NONE	NONE		NONE	C3866548;C3866549;C3866551;C3866552;C3866553;C3866550;C3701998;C5696093		Radiologic examination, spine, cervical; 2 or 3 views
72050	SourceAtomCluster	72050	False	False	CPT	8	0					NONE	NONE		NONE	C5696094;C3866544;C3511537;C3866545;C3866546;C3866547		Radiologic examination, spine, cervical; 4 or 5 views
72052	SourceAtomCluster	72052	False	False	CPT	7	0					NONE	NONE		NONE	C5410918;C3515777;C5410916;C5410917;C0373157		Radiologic examination, spine, cervical; 6 or more views
72070	SourceAtomCluster	72070	False	False	CPT	6	0					NONE	NONE		NONE	C3853585;C2061525;C5410919		Radiologic examination, spine; thoracic, 2 views
72072	SourceAtomCluster	72072	False	False	CPT	6	0					NONE	NONE		NONE	C0203159;C3866540;C3515779		Radiologic examination, spine; thoracic, 3 views
72074	SourceAtomCluster	72074	False	False	CPT	7	0					NONE	NONE		NONE	C3866539;C0203160;C3866537;C3866538;C3515780		Radiologic examination, spine; thoracic, minimum of 4 views
72080	SourceAtomCluster	72080	False	False	CPT	6	0					NONE	NONE		NONE	C3853576;C2061523;C3515781;C5410920		Radiologic examination, spine; thoracolumbar junction, minimum of 2 views
72081	SourceAtomCluster	72081	False	False	CPT	6	0					NONE	NONE		NONE	C4051877;C5696095;C5410922;C5410923		Radiologic examination, spine, entire thoracic and lumbar, including skull, cervical and sacral spine if performed (eg, scoliosis evaluation); one view
72082	SourceAtomCluster	72082	False	False	CPT	8	0					NONE	NONE		NONE	C5410925;C4051876;C5696096;C5410927;C5410926;C5410928		Radiologic examination, spine, entire thoracic and lumbar, including skull, cervical and sacral spine if performed (eg, scoliosis evaluation); 2 or 3 views
72083	SourceAtomCluster	72083	False	False	CPT	8	0					NONE	NONE		NONE	C5410930;C5410931;C4051875;C5696097;C5410933;C5410932		Radiologic examination, spine, entire thoracic and lumbar, including skull, cervical and sacral spine if performed (eg, scoliosis evaluation); 4 or 5 views
72084	SourceAtomCluster	72084	False	False	CPT	6	0					NONE	NONE		NONE	C5410935;C5410934;C5696098;C4051874		Radiologic examination, spine, entire thoracic and lumbar, including skull, cervical and sacral spine if performed (eg, scoliosis evaluation); minimum of 6 views
72100	SourceAtomCluster	72100	False	False	CPT	8	0					NONE	NONE		NONE	C5696099;C3866532;C3515783;C3866534;C3866533;C2061524		Radiologic examination, spine, lumbosacral; 2 or 3 views
72110	SourceAtomCluster	72110	False	False	CPT	6	0					NONE	NONE		NONE	C3866531;C3866530;C3515784		Radiologic examination, spine, lumbosacral; minimum of 4 views
72114	SourceAtomCluster	72114	False	False	CPT	6	0					NONE	NONE		NONE	C5696100;C3866528;C3866529;C3853587		Radiologic examination, spine, lumbosacral; complete, including bending views, minimum of 6 views
72120	SourceAtomCluster	72120	False	False	CPT	8	0					NONE	NONE		NONE	C3866524;C3853588;C3866525;C5696101;C5410937;C5410936		Radiologic examination, spine, lumbosacral; bending views only, 2 or 3 views
72125	SourceAtomCluster	72125	False	False	CPT	5	0					NONE	NONE		NONE	C0203150;C5697551;C5410938		Computed tomography, cervical spine; without contrast material
72126	SourceAtomCluster	72126	False	False	CPT	5	0					NONE	NONE		NONE	C0203151;C3515788;C5410939		Computed tomography, cervical spine; with contrast material
72127	SourceAtomCluster	72127	False	False	CPT	5	0					NONE	NONE		NONE	C0203152;C3515789;C5410940		Computed tomography, cervical spine; without contrast material, followed by contrast material(s) and further sections
72128	SourceAtomCluster	72128	False	False	CPT	5	0					NONE	NONE		NONE	C5696102;C0203164;C5410941		Computed tomography, thoracic spine; without contrast material
72129	SourceAtomCluster	72129	False	False	CPT	5	0					NONE	NONE		NONE	C0203165;C3515791;C5410942		Computed tomography, thoracic spine; with contrast material
72130	SourceAtomCluster	72130	False	False	CPT	5	0					NONE	NONE		NONE	C5410943;C0203166;C3515792		Computed tomography, thoracic spine; without contrast material, followed by contrast material(s) and further sections
72131	SourceAtomCluster	72131	False	False	CPT	5	0					NONE	NONE		NONE	C5416811;C0203173;C5696103		Computed tomography, lumbar spine; without contrast material
72132	SourceAtomCluster	72132	False	False	CPT	5	0					NONE	NONE		NONE	C0203174;C5410944;C3515794		Computed tomography, lumbar spine; with contrast material
72133	SourceAtomCluster	72133	False	False	CPT	5	0					NONE	NONE		NONE	C0203175;C3515795;C5410945		Computed tomography, lumbar spine; without contrast material, followed by contrast material(s) and further sections
72141	SourceAtomCluster	72141	False	False	CPT	5	0					NONE	NONE		NONE	C0373158;C5696104;C5410946		Magnetic resonance (eg, proton) imaging, spinal canal and contents, cervical; without contrast material
72142	SourceAtomCluster	72142	False	False	CPT	5	0					NONE	NONE		NONE	C5410947;C3515797;C0373159		Magnetic resonance (eg, proton) imaging, spinal canal and contents, cervical; with contrast material(s)
72146	SourceAtomCluster	72146	False	False	CPT	5	0					NONE	NONE		NONE	C5696105;C5410948;C0373160		Magnetic resonance (eg, proton) imaging, spinal canal and contents, thoracic; without contrast material
72147	SourceAtomCluster	72147	False	False	CPT	5	0					NONE	NONE		NONE	C3515799;C5410949;C0373161		Magnetic resonance (eg, proton) imaging, spinal canal and contents, thoracic; with contrast material(s)
72148	SourceAtomCluster	72148	False	False	CPT	5	0					NONE	NONE		NONE	C5696106;C5410950;C0373162		Magnetic resonance (eg, proton) imaging, spinal canal and contents, lumbar; without contrast material
72149	SourceAtomCluster	72149	False	False	CPT	5	0					NONE	NONE		NONE	C0373163;C5410951;C3515801		Magnetic resonance (eg, proton) imaging, spinal canal and contents, lumbar; with contrast material(s)
72156	SourceAtomCluster	72156	False	False	CPT	5	0					NONE	NONE		NONE	C3515802;C5410952;C0373164		Magnetic resonance (eg, proton) imaging, spinal canal and contents, without contrast material, followed by contrast material(s) and further sequences; cervical
72157	SourceAtomCluster	72157	False	False	CPT	5	0					NONE	NONE		NONE	C3515803;C5410953;C0373165		Magnetic resonance (eg, proton) imaging, spinal canal and contents, without contrast material, followed by contrast material(s) and further sequences; thoracic
72158	SourceAtomCluster	72158	False	False	CPT	5	0					NONE	NONE		NONE	C0373166;C5410954;C3515804		Magnetic resonance (eg, proton) imaging, spinal canal and contents, without contrast material, followed by contrast material(s) and further sequences; lumbar
72159	SourceAtomCluster	72159	False	False	CPT	6	0					NONE	NONE		NONE	C5410955;C5696107;C5410956;C0373167		Magnetic resonance angiography, spinal canal and contents, with or without contrast material(s)
72170	SourceAtomCluster	72170	False	False	CPT	11	0					NONE	NONE		NONE	C5696108;C5410957;C0203194;C3860868;C3860862;C3866518;C3866519;C4052149;C4052150		Radiologic examination, pelvis; 1 or 2 views
72190	SourceAtomCluster	72190	False	False	CPT	6	0					NONE	NONE		NONE	C0203195;C3866516;C3515806;C4052148		Radiologic examination, pelvis; complete, minimum of 3 views
72191	SourceAtomCluster	72191	False	False	CPT	6	0					NONE	NONE		NONE	C5410959;C5696109;C5410958;C0918150		Computed tomographic angiography, pelvis, with contrast material(s), including noncontrast images, if performed, and image postprocessing
72192	SourceAtomCluster	72192	False	False	CPT	5	0					NONE	NONE		NONE	C0203198;C5410960		Computed tomography, pelvis; without contrast material
72193	SourceAtomCluster	72193	False	False	CPT	5	0					NONE	NONE		NONE	C0203199;C5410961		Computed tomography, pelvis; with contrast material(s)
72194	SourceAtomCluster	72194	False	False	CPT	5	0					NONE	NONE		NONE	C0203200;C3515808;C5410962		Computed tomography, pelvis; without contrast material, followed by contrast material(s) and further sections
72195	SourceAtomCluster	72195	False	False	CPT	5	0					NONE	NONE		NONE	C5410963;C5696110;C0918151		Magnetic resonance (eg, proton) imaging, pelvis; without contrast material(s)
72196	SourceAtomCluster	72196	False	False	CPT	5	0					NONE	NONE		NONE	C0203201;C2315896;C5410964		Magnetic resonance (eg, proton) imaging, pelvis; with contrast material(s)
72197	SourceAtomCluster	72197	False	False	CPT	5	0					NONE	NONE		NONE	C3515810;C5410965;C0918152		Magnetic resonance (eg, proton) imaging, pelvis; without contrast material(s), followed by contrast material(s) and further sequences
72198	SourceAtomCluster	72198	False	False	CPT	6	0					NONE	NONE		NONE	C5696111;C0373168;C5410967;C5410966		Magnetic resonance angiography, pelvis, with or without contrast material(s)
72200	SourceAtomCluster	72200	False	False	CPT	7	0					NONE	NONE		NONE	C3866511;C0373169;C3866512;C5696112		Radiologic examination, sacroiliac joints; less than 3 views
72202	SourceAtomCluster	72202	False	False	CPT	6	0					NONE	NONE		NONE	C5696113;C0203187;C3866510		Radiologic examination, sacroiliac joints; 3 or more views
72220	SourceAtomCluster	72220	False	False	CPT	7	0					NONE	NONE		NONE	C0203189;C3866509;C3866508;C5696114		Radiologic examination, sacrum and coccyx, minimum of 2 views
73000	SourceAtomCluster	73000	False	False	CPT	8	0					NONE	NONE		NONE	C0203226;C3866501;C3515824;C3866502;C3866503;C2075294		Radiologic examination; clavicle, complete
73010	SourceAtomCluster	73010	False	False	CPT	7	0					NONE	NONE		NONE	C2121206;C3866500;C3866499;C3515825;C0373176		Radiologic examination; scapula, complete
73020	SourceAtomCluster	73020	False	False	CPT	9	0					NONE	NONE		NONE	C0203222;C3860528;C3866498;C2061623;C3866497;C3866496		Radiologic examination, shoulder; 1 view
73030	SourceAtomCluster	73030	False	False	CPT	7	0					NONE	NONE		NONE	C0373177;C3866494;C3866495;C3515826		Radiologic examination, shoulder; complete, minimum of 2 views
73050	SourceAtomCluster	73050	False	False	CPT	10	0					NONE	NONE		NONE	C3866493;C3525206;C3866492;C5696122;C3525207;C5410979;C5410980;C0373179		Radiologic examination; acromioclavicular joints, bilateral, with or without weighted distraction
73060	SourceAtomCluster	73060	False	False	CPT	7	0					NONE	NONE		NONE	C0203216;C3866488;C3866489;C3515828		Radiologic examination; humerus, minimum of 2 views
73070	SourceAtomCluster	73070	False	False	CPT	7	0					NONE	NONE		NONE	C0203231;C3853590;C3866487		Radiologic examination, elbow; 2 views
73080	SourceAtomCluster	73080	False	False	CPT	8	0					NONE	NONE		NONE	C3866485;C0203232;C3866484;C3866486;C3515829		Radiologic examination, elbow; complete, minimum of 3 views
73090	SourceAtomCluster	73090	False	False	CPT	6	0					NONE	NONE		NONE	C0203237;C3515830		Radiologic examination; forearm, 2 views
73092	SourceAtomCluster	73092	False	False	CPT	6	0					NONE	NONE		NONE	C0203217;C3866483		Radiologic examination; upper extremity, infant, minimum of 2 views
73100	SourceAtomCluster	73100	False	False	CPT	7	0					NONE	NONE		NONE	C3853591;C3866482;C3865637		Radiologic examination, wrist; 2 views
73110	SourceAtomCluster	73110	False	False	CPT	8	0					NONE	NONE		NONE	C0203242;C3866479;C3866481;C3866480;C3515831		Radiologic examination, wrist; complete, minimum of 3 views
73120	SourceAtomCluster	73120	False	False	CPT	7	0					NONE	NONE		NONE	C2028623;C0203246;C3866478;C3866477		Radiologic examination, hand; 2 views
73130	SourceAtomCluster	73130	False	False	CPT	8	0					NONE	NONE		NONE	C3866475;C0203247;C3866476;C3866474		Radiologic examination, hand; minimum of 3 views
73140	SourceAtomCluster	73140	False	False	CPT	12	0					NONE	NONE		NONE	C3866471;C0203250;C3866472;C3866470;C3866473		Radiologic examination, finger(s), minimum of 2 views
73200	SourceAtomCluster	73200	False	False	CPT	5	0					NONE	NONE		NONE	C5410983;C0203252;C5696125		Computed tomography, upper extremity; without contrast material
73201	SourceAtomCluster	73201	False	False	CPT	5	0					NONE	NONE		NONE	C0203253;C5410984		Computed tomography, upper extremity; with contrast material(s)
73202	SourceAtomCluster	73202	False	False	CPT	5	0					NONE	NONE		NONE	C5410985;C0203254;C3515832		Computed tomography, upper extremity; without contrast material, followed by contrast material(s) and further sections
73206	SourceAtomCluster	73206	False	False	CPT	6	0					NONE	NONE		NONE	C5410987;C3703808;C5410986;C0918153		Computed tomographic angiography, upper extremity, with contrast material(s), including noncontrast images, if performed, and image postprocessing
73218	SourceAtomCluster	73218	False	False	CPT	5	0					NONE	NONE		NONE	C5696126;C5410988;C0918154		Magnetic resonance (eg, proton) imaging, upper extremity, other than joint; without contrast material(s)
73219	SourceAtomCluster	73219	False	False	CPT	7	0					NONE	NONE		NONE	C5410991;C3515835;C5410989;C5410990;C0918155		Magnetic resonance (eg, proton) imaging, upper extremity, other than joint; with contrast material(s)
73220	SourceAtomCluster	73220	False	False	CPT	7	0					NONE	NONE		NONE	C0203255;C3515836;C5410994;C5410992;C5410993		Magnetic resonance (eg, proton) imaging, upper extremity, other than joint; without contrast material(s), followed by contrast material(s) and further sequences
73221	SourceAtomCluster	73221	False	False	CPT	8	0					NONE	NONE		NONE	C5410996;C5696127;C5410995;C5410997;C5410998;C3853592		Magnetic resonance (eg, proton) imaging, any joint of upper extremity; without contrast material(s)
73222	SourceAtomCluster	73222	False	False	CPT	8	0					NONE	NONE		NONE	C5411000;C5411002;C5411001;C5410999;C0918156		Magnetic resonance (eg, proton) imaging, any joint of upper extremity; with contrast material(s)
73223	SourceAtomCluster	73223	False	False	CPT	8	0					NONE	NONE		NONE	C5411004;C5411003;C3515837;C5411005;C5411006;C0918157		Magnetic resonance (eg, proton) imaging, any joint of upper extremity; without contrast material(s), followed by contrast material(s) and further sequences
73225	SourceAtomCluster	73225	False	False	CPT	6	0					NONE	NONE		NONE	C5696128;C5411008;C5411007;C0373182		Magnetic resonance angiography, upper extremity, with or without contrast material(s)
73501	SourceAtomCluster	73501	False	False	CPT	6	0					NONE	NONE		NONE	C4052147;C5696129;C4051873;C4052146		Radiologic examination, hip, unilateral, with pelvis when performed; 1 view
73502	SourceAtomCluster	73502	False	False	CPT	6	0					NONE	NONE		NONE	C5411009;C5411010;C5696130;C4051872		Radiologic examination, hip, unilateral, with pelvis when performed; 2-3 views
73503	SourceAtomCluster	73503	False	False	CPT	6	0					NONE	NONE		NONE	C5696131;C5411011;C4051871;C4052142		Radiologic examination, hip, unilateral, with pelvis when performed; minimum of 4 views
73521	SourceAtomCluster	73521	False	False	CPT	6	0					NONE	NONE		NONE	C5696132;C4052141;C4051870		Radiologic examination, hips, bilateral, with pelvis when performed; 2 views
73522	SourceAtomCluster	73522	False	False	CPT	8	0					NONE	NONE		NONE	C4052140;C5696133;C4052137;C4051869;C4052026;C4052138		Radiologic examination, hips, bilateral, with pelvis when performed; 3-4 views
73523	SourceAtomCluster	73523	False	False	CPT	6	0					NONE	NONE		NONE	C4052135;C5696134;C4051868;C4052136		Radiologic examination, hips, bilateral, with pelvis when performed; minimum of 5 views
73551	SourceAtomCluster	73551	False	False	CPT	5	0					NONE	NONE		NONE	C3861760;C5696136;C4051867		Radiologic examination, femur; 1 view
73552	SourceAtomCluster	73552	False	False	CPT	5	0					NONE	NONE		NONE	C4051866;C5696137;C4051980		Radiologic examination, femur; minimum 2 views
73560	SourceAtomCluster	73560	False	False	CPT	16	0					NONE	NONE		NONE	C3866437;C3866439;C5411013;C3866435;C3866438;C3866440;C3853674;C2061628;C3861157;C3861242;C3861291;C3865625;C3866436;C5696138		Radiologic examination, knee; 1 or 2 views
73562	SourceAtomCluster	73562	False	False	CPT	8	0					NONE	NONE		NONE	C0203275;C3866434;C3866432;C3866433		Radiologic examination, knee; 3 views
73564	SourceAtomCluster	73564	False	False	CPT	6	0					NONE	NONE		NONE	C0373185;C3866431;C3515844		Radiologic examination, knee; complete, 4 or more views
73565	SourceAtomCluster	73565	False	False	CPT	5	0					NONE	NONE		NONE	C0373186;C5696139;C5411014		Radiologic examination, knee; both knees, standing, anteroposterior
73590	SourceAtomCluster	73590	False	False	CPT	6	0					NONE	NONE		NONE	C0203278;C2061914;C3515847		Radiologic examination; tibia and fibula, 2 views
73592	SourceAtomCluster	73592	False	False	CPT	6	0					NONE	NONE		NONE	C0203270;C3515848;C5411015		Radiologic examination; lower extremity, infant, minimum of 2 views
73600	SourceAtomCluster	73600	False	False	CPT	11	0					NONE	NONE		NONE	C3866425;C3866427;C3866429;C3515849;C2061515;C3866426;C3866428		Radiologic examination, ankle; 2 views
73610	SourceAtomCluster	73610	False	False	CPT	9	0					NONE	NONE		NONE	C3866421;C0373188;C3866422;C3866424;C3866423;C3515850		Radiologic examination, ankle; complete, minimum of 3 views
73620	SourceAtomCluster	73620	False	False	CPT	8	0					NONE	NONE		NONE	C3866419;C3866420;C0203289;C3853595		Radiologic examination, foot; 2 views
73630	SourceAtomCluster	73630	False	False	CPT	6	0					NONE	NONE		NONE	C0203290;C3866418;C3515852		Radiologic examination, foot; complete, minimum of 3 views
73650	SourceAtomCluster	73650	False	False	CPT	6	0					NONE	NONE		NONE	C0203292;C2322419;C3515853		Radiologic examination; calcaneus, minimum of 2 views
73660	SourceAtomCluster	73660	False	False	CPT	13	0					NONE	NONE		NONE	C3866414;C3866417;C0203294;C3866416;C3866415		Radiologic examination; toe(s), minimum of 2 views
73700	SourceAtomCluster	73700	False	False	CPT	5	0					NONE	NONE		NONE	C0203295;C5696142;C5411017		Computed tomography, lower extremity; without contrast material
73701	SourceAtomCluster	73701	False	False	CPT	5	0					NONE	NONE		NONE	C5696143;C5411018;C3840192		Computed tomography, lower extremity; with contrast material(s)
73702	SourceAtomCluster	73702	False	False	CPT	5	0					NONE	NONE		NONE	C5696144;C0203297;C5411019		Computed tomography, lower extremity; without contrast material, followed by contrast material(s) and further sections
73706	SourceAtomCluster	73706	False	False	CPT	6	0					NONE	NONE		NONE	C5411021;C3703815;C5411020;C0918158		Computed tomographic angiography, lower extremity, with contrast material(s), including noncontrast images, if performed, and image postprocessing
73718	SourceAtomCluster	73718	False	False	CPT	7	0					NONE	NONE		NONE	C5696145;C5411023;C5411024;C5411022;C0918159		Magnetic resonance (eg, proton) imaging, lower extremity other than joint; without contrast material(s)
73719	SourceAtomCluster	73719	False	False	CPT	7	0					NONE	NONE		NONE	C3515858;C5411026;C5411027;C5411025;C0918160		Magnetic resonance (eg, proton) imaging, lower extremity other than joint; with contrast material(s)
73720	SourceAtomCluster	73720	False	False	CPT	7	0					NONE	NONE		NONE	C0203299;C3515859;C5411028;C5411029;C5411030		Magnetic resonance (eg, proton) imaging, lower extremity other than joint; without contrast material(s), followed by contrast material(s) and further sequences
73721	SourceAtomCluster	73721	False	False	CPT	9	0					NONE	NONE		NONE	C5411035;C5696146;C5411032;C5411031;C5411033;C5411034;C0373190		Magnetic resonance (eg, proton) imaging, any joint of lower extremity; without contrast material
73722	SourceAtomCluster	73722	False	False	CPT	9	0					NONE	NONE		NONE	C5411039;C5411040;C5411036;C5411037;C3515861;C5411038;C0918161		Magnetic resonance (eg, proton) imaging, any joint of lower extremity; with contrast material(s)
73723	SourceAtomCluster	73723	False	False	CPT	9	0					NONE	NONE		NONE	C5411041;C3527539;C5411042;C5411045;C5411043;C5411044;C0918162		Magnetic resonance (eg, proton) imaging, any joint of lower extremity; without contrast material(s), followed by contrast material(s) and further sequences
73725	SourceAtomCluster	73725	False	False	CPT	6	0					NONE	NONE		NONE	C5696147;C5411046;C5411047;C0373191		Magnetic resonance angiography, lower extremity, with or without contrast material(s)
74018	SourceAtomCluster	74018	False	False	CPT	5	0					NONE	NONE		NONE	C3853584		Radiologic examination, abdomen; 1 view
74019	SourceAtomCluster	74019	False	False	CPT	5	0					NONE	NONE		NONE	C4523441		Radiologic examination, abdomen; 2 views
74021	SourceAtomCluster	74021	False	False	CPT	5	0					NONE	NONE		NONE	C4523442		Radiologic examination, abdomen; 3 or more views
74022	SourceAtomCluster	74022	False	False	CPT	12	0					NONE	NONE		NONE	C5696148;C3866381;C0373193;C3866382;C5201618;C5201619;C5201620;C5201621;C5201622;C5201623		Radiologic examination, complete acute abdomen series, including 2 or more views of the abdomen (eg, supine, erect, decubitus), and a single view chest
74150	SourceAtomCluster	74150	False	False	CPT	5	0					NONE	NONE		NONE	C0202838;C2041478;C5411048		Computed tomography, abdomen; without contrast material
74160	SourceAtomCluster	74160	False	False	CPT	5	0					NONE	NONE		NONE	C0202840;C5411049		Computed tomography, abdomen; with contrast material(s)
74170	SourceAtomCluster	74170	False	False	CPT	5	0					NONE	NONE		NONE	C0202841;C3515864;C5411050		Computed tomography, abdomen; without contrast material, followed by contrast material(s) and further sections
74174	SourceAtomCluster	74174	False	False	CPT	6	0					NONE	NONE		NONE	C3248117;C5696149;C5411052;C5411051		Computed tomographic angiography, abdomen and pelvis, with contrast material(s), including noncontrast images, if performed, and image postprocessing
74175	SourceAtomCluster	74175	False	False	CPT	6	0					NONE	NONE		NONE	C5411054;C5696150;C5411053;C0918163		Computed tomographic angiography, abdomen, with contrast material(s), including noncontrast images, if performed, and image postprocessing
74176	SourceAtomCluster	74176	False	False	CPT	5	0					NONE	NONE		NONE	C2939268;C2957164;C5411055		Computed tomography, abdomen and pelvis; without contrast material
74177	SourceAtomCluster	74177	False	False	CPT	5	0					NONE	NONE		NONE	C5411056;C2315935;C3703818		Computed tomography, abdomen and pelvis; with contrast material(s)
74178	SourceAtomCluster	74178	False	False	CPT	7	0					NONE	NONE		NONE	C3703819;C5411058;C2939270;C5411057;C5411059		Computed tomography, abdomen and pelvis; without contrast material in one or both body regions, followed by contrast material(s) and further sections in one or both body regions
74181	SourceAtomCluster	74181	False	False	CPT	5	0					NONE	NONE		NONE	C5411060;C5696151;C0412693		Magnetic resonance (eg, proton) imaging, abdomen; without contrast material(s)
74182	SourceAtomCluster	74182	False	False	CPT	5	0					NONE	NONE		NONE	C2314953;C5411061		Magnetic resonance (eg, proton) imaging, abdomen; with contrast material(s)
74183	SourceAtomCluster	74183	False	False	CPT	5	0					NONE	NONE		NONE	C3515867;C5411062;C0918165		Magnetic resonance (eg, proton) imaging, abdomen; without contrast material(s), followed by with contrast material(s) and further sequences
74185	SourceAtomCluster	74185	False	False	CPT	6	0					NONE	NONE		NONE	C3515868;C5411064;C5411063;C0373196		Magnetic resonance angiography, abdomen, with or without contrast material(s)
74210	SourceAtomCluster	74210	False	False	CPT	13	0					NONE	NONE		NONE	C0373198;C5411070;C5411072;C5696153;C5411068;C5411071;C5411067;C5411069		Radiologic examination, pharynx and/or cervical esophagus, including scout neck radiograph(s) and delayed image(s), when performed, contrast (eg, barium) study
74220	SourceAtomCluster	74220	False	False	CPT	10	0					NONE	NONE		NONE	C5411074;C5201632;C5201635;C5201634;C5201633;C5411073		Radiologic examination, esophagus, including scout chest radiograph(s) and delayed image(s), when performed; single-contrast (eg, barium) study
74221	SourceAtomCluster	74221	False	False	CPT	10	0					NONE	NONE		NONE	C5201638;C5201639;C5201641;C5201642;C5201643;C5201640		Radiologic examination, esophagus, including scout chest radiograph(s) and delayed image(s), when performed; double-contrast (eg, high-density barium and effervescent agent) study
74230	SourceAtomCluster	74230	False	False	CPT	10	0					NONE	NONE		NONE	C5411077;C5411075;C3515871;C5201644;C5201645;C5411076		Radiologic examination, swallowing function, with cineradiography/videoradiography, including scout neck radiograph(s) and delayed image(s), when performed, contrast (eg, barium) study
74240	SourceAtomCluster	74240	False	False	CPT	10	0					NONE	NONE		NONE	C5201650;C5201651;C5201652;C5201654;C5201653;C0373200		Radiologic examination, upper gastrointestinal tract, including scout abdominal radiograph(s) and delayed image(s), when performed; single-contrast (eg, barium) study
74246	SourceAtomCluster	74246	False	False	CPT	11	0					NONE	NONE		NONE	C5201659;C5201656;C5201657;C5201658;C5201660;C5201655;C0373202		Radiologic examination, upper gastrointestinal tract, including scout abdominal radiograph(s) and delayed image(s), when performed; double-contrast (eg, high-density barium and effervescent agent) study, including glucagon, when administered
74248	SourceAtomCluster	74248	False	False	CPT	5	0					NONE	NONE		NONE	C5696155;C5201661;C5201663		Radiologic small intestine follow-through study, including multiple serial images (List separately in addition to code for primary procedure for upper GI radiologic examination)
74250	SourceAtomCluster	74250	False	False	CPT	7	0					NONE	NONE		NONE	C5201669;C5696156;C5201665;C5201668		Radiologic examination, small intestine, including multiple serial images and scout abdominal radiograph(s), when performed; single-contrast (eg, barium) study
74251	SourceAtomCluster	74251	False	False	CPT	13	0					NONE	NONE		NONE	C0373205;C5201671;C5201675;C5696157;C5201673;C5201672;C5201676;C5201674		Radiologic examination, small intestine, including multiple serial images and scout abdominal radiograph(s), when performed; double-contrast (eg, high-density barium and air via enteroclysis tube) study, including glucagon, when administered
74261	SourceAtomCluster	74261	False	False	CPT	5	0					NONE	NONE		NONE	C2724309;C5696158;C5411079		Computed tomographic (CT) colonography, diagnostic, including image postprocessing; without contrast material
74262	SourceAtomCluster	74262	False	False	CPT	6	0					NONE	NONE		NONE	C5411080;C5411081;C2724310;C5696159		Computed tomographic (CT) colonography, diagnostic, including image postprocessing; with contrast material(s) including non-contrast images, if performed
74263	SourceAtomCluster	74263	False	False	CPT	5	0					NONE	NONE		NONE	C2724311;C5411082;C5696160		Computed tomographic (CT) colonography, screening, including image postprocessing
74270	SourceAtomCluster	74270	False	False	CPT	10	0					NONE	NONE		NONE	C5411083;C5411084;C5696161;C5201679;C5201680;C0373206		Radiologic examination, colon, including scout abdominal radiograph(s) and delayed image(s), when performed; single-contrast (eg, barium) study
74280	SourceAtomCluster	74280	False	False	CPT	11	0					NONE	NONE		NONE	C5696162;C5201684;C5201685;C5201686;C5201683;C5411085;C0373207		Radiologic examination, colon, including scout abdominal radiograph(s) and delayed image(s), when performed; double-contrast (eg, high density barium and air) study, including glucagon, when administered
74290	SourceAtomCluster	74290	False	False	CPT	5	0					NONE	NONE		NONE	C0203079;C3515886		Cholecystography, oral contrast
74712	SourceAtomCluster	74712	False	False	CPT	6	0					NONE	NONE		NONE	C5411120;C5696183;C4051818;C5411121		Magnetic resonance (eg, proton) imaging, fetal, including placental and maternal pelvic imaging when performed; single or first gestation
75557	SourceAtomCluster	75557	False	False	CPT	5	0					NONE	NONE		NONE	C4545711;C5696187;C5411125		Cardiac magnetic resonance imaging for morphology and function without contrast material
75559	SourceAtomCluster	75559	False	False	CPT	5	0					NONE	NONE		NONE	C1964046;C5411126;C5696188		Cardiac magnetic resonance imaging for morphology and function without contrast material; with stress imaging
75561	SourceAtomCluster	75561	False	False	CPT	5	0					NONE	NONE		NONE	C1964048;C5696189;C5411127		Cardiac magnetic resonance imaging for morphology and function without contrast material(s), followed by contrast material(s) and further sequences
75563	SourceAtomCluster	75563	False	False	CPT	5	0					NONE	NONE		NONE	C1964050;C5696190;C5411128		Cardiac magnetic resonance imaging for morphology and function without contrast material(s), followed by contrast material(s) and further sequences; with stress imaging
75565	SourceAtomCluster	75565	False	False	CPT	5	0					NONE	NONE		NONE	C5411129;C5696191;C2724312		Cardiac magnetic resonance imaging for velocity flow mapping (List separately in addition to code for primary procedure)
75571	SourceAtomCluster	75571	False	False	CPT	5	0					NONE	NONE		NONE	C2724313;C3515916;C5411130		Computed tomography, heart, without contrast material, with quantitative evaluation of coronary calcium
75572	SourceAtomCluster	75572	False	False	CPT	6	0					NONE	NONE		NONE	C5411132;C2724314;C3703843;C5411131		Computed tomography, heart, with contrast material, for evaluation of cardiac structure and morphology (including 3D image postprocessing, assessment of cardiac function, and evaluation of venous structures, if performed)
75573	SourceAtomCluster	75573	False	False	CPT	6	0					NONE	NONE		NONE	C5411133;C5411134;C2724315;C5696192		Computed tomography, heart, with contrast material, for evaluation of cardiac structure and morphology in the setting of congenital heart disease (including 3D image postprocessing, assessment of left ventricular [LV] cardiac function, right ventricular [RV] structure and function and evaluation of vascular structures, if performed)
75574	SourceAtomCluster	75574	False	False	CPT	8	0					NONE	NONE		NONE	C5411136;C2724316;C5411137;C5696193;C5411135;C5411138		Computed tomographic angiography, heart, coronary arteries and bypass grafts (when present), with contrast material, including 3D image postprocessing (including evaluation of cardiac structure and morphology, assessment of cardiac function, and evaluation of venous structures, if performed)
75577																		
75580	SourceAtomCluster	75580	False	False	CPT	5	0					NONE	NONE		NONE	C4523769;C5850683		Noninvasive estimate of coronary fractional flow reserve (FFR) derived from augmentative software analysis of the data set from a coronary computed tomography angiography, with interpretation and report by a physician or other qualified health care professional
75635	SourceAtomCluster	75635	False	False	CPT	6	0					NONE	NONE		NONE	C3703848;C5411144;C5411145;C0918166		Computed tomographic angiography, abdominal aorta and bilateral iliofemoral lower extremity runoff, with contrast material(s), including noncontrast images, if performed, and image postprocessing
76000	SourceAtomCluster	76000	False	False	CPT	5	0					NONE	NONE		NONE	C5411254;C5696243;C0373311		Fluoroscopy (separate procedure), up to 1 hour physician or other qualified health care professional time
76010	SourceAtomCluster	76010	False	False	CPT	6	0					NONE	NONE		NONE	C5696244;C0203055;C3866197		Radiologic examination from nose to rectum for foreign body, single view, child
76100	SourceAtomCluster	76100	False	False	CPT	5	0					NONE	NONE		NONE	C5411257;C5696246;C0373324		Radiologic examination, single plane body section (eg, tomography), other than with urography
76120	SourceAtomCluster	76120	False	False	CPT	6	0					NONE	NONE		NONE	C0373325;C3515978;C3525383;C0008797		Cineradiography/videoradiography, except where specifically included
76125	SourceAtomCluster	76125	False	False	CPT	6	0					NONE	NONE		NONE	C5411263;C0202611;C5411262		Cineradiography/videoradiography to complement routine examination (List separately in addition to code for primary procedure)
76376	SourceAtomCluster	76376	False	False	CPT	12	0					NONE	NONE		NONE	C5411267;C5411268;C1609547;C5411269;C5411274;C3515980;C5411273;C5411270;C5411271;C5411272		3D rendering with interpretation and reporting of computed tomography, magnetic resonance imaging, ultrasound, or other tomographic modality with image postprocessing under concurrent supervision; not requiring image postprocessing on an independent workstation
76377	SourceAtomCluster	76377	False	False	CPT	12	0					NONE	NONE		NONE	C1608996;C5411279;C5411280;C5411281;C5411278;C3515981;C5411275;C5411282;C5411277;C5411276		3D rendering with interpretation and reporting of computed tomography, magnetic resonance imaging, ultrasound, or other tomographic modality with image postprocessing under concurrent supervision; requiring image postprocessing on an independent workstation
76380	SourceAtomCluster	76380	False	False	CPT	6	0					NONE	NONE		NONE	C5411283;C0202657;C5696247;C5411284		Computed tomography, limited or localized follow-up study
76391	SourceAtomCluster	76391	False	False	CPT	5	0					NONE	NONE		NONE	C1518156;C5696249;C5411285		Magnetic resonance (eg, vibration) elastography
76499	SourceAtomCluster	76499	False	False	CPT	5	0					NONE	NONE		NONE	C5696251;C5411294;C0373327		Unlisted diagnostic radiographic procedure
76506	SourceAtomCluster	76506	False	False	CPT	6	0					NONE	NONE		NONE	C3866179;C0412508;C3866180;C0373328		Echoencephalography, real time with image documentation (gray scale) (for determination of ventricular size, delineation of cerebral contents, and detection of fluid masses or other intracranial abnormalities), including A-mode encephalography as secondary component where indicated
76510	SourceAtomCluster	76510	False	False	CPT	5	0					NONE	NONE		NONE	C5697537;C1504143;C5411295		Ophthalmic ultrasound, diagnostic; B-scan and quantitative A-scan performed during the same patient encounter
76511	SourceAtomCluster	76511	False	False	CPT	5	0					NONE	NONE		NONE	C5411296;C5696252;C0373329		Ophthalmic ultrasound, diagnostic; quantitative A-scan only
76512	SourceAtomCluster	76512	False	False	CPT	6	0					NONE	NONE		NONE	C5411297;C0203446;C5696253;C5411298		Ophthalmic ultrasound, diagnostic; B-scan (with or without superimposed non-quantitative A-scan)
76513	SourceAtomCluster	76513	False	False	CPT	9	0					NONE	NONE		NONE	C5696254;C5411300;C0373331;C5411299;C5411301;C5411303;C5411302		Ophthalmic ultrasound, diagnostic; anterior segment ultrasound, immersion (water bath) B-scan or high resolution biomicroscopy, unilateral or bilateral
76514	SourceAtomCluster	76514	False	False	CPT	6	0					NONE	NONE		NONE	C5696255;C1314092;C3866173;C3525396		Ophthalmic ultrasound, diagnostic; corneal pachymetry, unilateral or bilateral (determination of corneal thickness)
76516	SourceAtomCluster	76516	False	False	CPT	5	0					NONE	NONE		NONE	C0412515;C5696256		Ophthalmic biometry by ultrasound echography, A-scan
76519	SourceAtomCluster	76519	False	False	CPT	5	0					NONE	NONE		NONE	C5696257;C0203449		Ophthalmic biometry by ultrasound echography, A-scan; with intraocular lens power calculation
76536	SourceAtomCluster	76536	False	False	CPT	5	0					NONE	NONE		NONE	C0203453;C3866171;C4510089		Ultrasound, soft tissues of head and neck (eg, thyroid, parathyroid, parotid), real time with image documentation
76604	SourceAtomCluster	76604	False	False	CPT	6	0					NONE	NONE		NONE	C5411304;C5411305;C5696259;C0373332		Ultrasound, chest (includes mediastinum), real time with image documentation
76641	SourceAtomCluster	76641	False	False	CPT	6	0					NONE	NONE		NONE	C3862147;C5411306;C3865382;C5696260		Ultrasound, breast, unilateral, real time with image documentation, including axilla when performed; complete
76642	SourceAtomCluster	76642	False	False	CPT	6	0					NONE	NONE		NONE	C3865381;C5696261;C5411308;C5411309		Ultrasound, breast, unilateral, real time with image documentation, including axilla when performed; limited
76700	SourceAtomCluster	76700	False	False	CPT	5	0					NONE	NONE		NONE	C5696262;C5411311;C0373334		Ultrasound, abdominal, real time with image documentation; complete
76705	SourceAtomCluster	76705	False	False	CPT	12	0					NONE	NONE		NONE	C5411314;C5411317;C5411319;C5411320;C5696263;C5411313;C5411315;C5411316;C5411318;C0373335		Ultrasound, abdominal, real time with image documentation; limited (eg, single organ, quadrant, follow-up)
76706	SourceAtomCluster	76706	False	False	CPT	5	0					NONE	NONE		NONE	C0412525;C5411321;C4291772		Ultrasound, abdominal aorta, real time with image documentation, screening study for abdominal aortic aneurysm (AAA)
76770	SourceAtomCluster	76770	False	False	CPT	8	0					NONE	NONE		NONE	C5411322;C5411324;C5696264;C5411325;C5411323;C0373336		Ultrasound, retroperitoneal (eg, renal, aorta, nodes), real time with image documentation; complete
76775	SourceAtomCluster	76775	False	False	CPT	8	0					NONE	NONE		NONE	C5411328;C3866152;C5696265;C5411326;C5411327;C0373337		Ultrasound, retroperitoneal (eg, renal, aorta, nodes), real time with image documentation; limited
76776	SourceAtomCluster	76776	False	False	CPT	5	0					NONE	NONE		NONE	C1737169;C0412548		Ultrasound, transplanted kidney, real time and duplex Doppler with image documentation
76800	SourceAtomCluster	76800	False	False	CPT	5	0					NONE	NONE		NONE	C0203451;C5696266		Ultrasound, spinal canal and contents
76801	SourceAtomCluster	76801	False	False	CPT	6	0					NONE	NONE		NONE	C5411329;C1144704;C5696267;C5411330		Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, first trimester (< 14 weeks 0 days), transabdominal approach; single or first gestation
76802	SourceAtomCluster	76802	False	False	CPT	5	0					NONE	NONE		NONE	C1144705;C5696268;C5411331		Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, first trimester (< 14 weeks 0 days), transabdominal approach; each additional gestation (List separately in addition to code for primary procedure)
76805	SourceAtomCluster	76805	False	False	CPT	6	0					NONE	NONE		NONE	C0203421;C5696269;C5411333;C5411332		Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, after first trimester (> or = 14 weeks 0 days), transabdominal approach; single or first gestation
76810	SourceAtomCluster	76810	False	False	CPT	5	0					NONE	NONE		NONE	C5696270;C5411334;C0373339		Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, after first trimester (> or = 14 weeks 0 days), transabdominal approach; each additional gestation (List separately in addition to code for primary procedure)
76811	SourceAtomCluster	76811	False	False	CPT	6	0					NONE	NONE		NONE	C1144706;C5696271;C5411336;C5411335		Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation plus detailed fetal anatomic examination, transabdominal approach; single or first gestation
76812	SourceAtomCluster	76812	False	False	CPT	5	0					NONE	NONE		NONE	C5411337;C5696272;C1144707		Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation plus detailed fetal anatomic examination, transabdominal approach; each additional gestation (List separately in addition to code for primary procedure)
76815	SourceAtomCluster	76815	False	False	CPT	9	0					NONE	NONE		NONE	C0203420;C5411344;C5411348;C5696275;C5411345;C5411346;C5411347		Ultrasound, pregnant uterus, real time with image documentation, limited (eg, fetal heart beat, placental location, fetal position and/or qualitative amniotic fluid volume), 1 or more fetuses
76816	SourceAtomCluster	76816	False	False	CPT	8	0					NONE	NONE		NONE	C5411352;C5411351;C5696276;C5411349;C5411350;C0373340		Ultrasound, pregnant uterus, real time with image documentation, follow-up (eg, re-evaluation of fetal size by measuring standard growth parameters and amniotic fluid volume, re-evaluation of organ system(s) suspected or confirmed to be abnormal on a previous scan), transabdominal approach, per fetus
76818	SourceAtomCluster	76818	False	False	CPT	5	0					NONE	NONE		NONE	C2243062;C3516004;C5411353		Fetal biophysical profile; with non-stress testing
76819	SourceAtomCluster	76819	False	False	CPT	6	0					NONE	NONE		NONE	C5411354;C0203425;C0203428;C0918172		Fetal biophysical profile; without non-stress testing
76820	SourceAtomCluster	76820	False	False	CPT	5	0					NONE	NONE		NONE	C1504144;C5696277		Doppler velocimetry, fetal; umbilical artery
76821	SourceAtomCluster	76821	False	False	CPT	5	0					NONE	NONE		NONE	C1504145;C5696278		Doppler velocimetry, fetal; middle cerebral artery
76825	SourceAtomCluster	76825	False	False	CPT	6	0					NONE	NONE		NONE	C5411356;C5696279;C5411355;C0373341		Echocardiography, fetal, cardiovascular system, real time with image documentation (2D), with or without M-mode recording
76826	SourceAtomCluster	76826	False	False	CPT	8	0					NONE	NONE		NONE	C5411358;C5411357;C5696280;C5411359;C5411360;C0373342		Echocardiography, fetal, cardiovascular system, real time with image documentation (2D), with or without M-mode recording; follow-up or repeat study
76827	SourceAtomCluster	76827	False	False	CPT	7	0					NONE	NONE		NONE	C0373343;C5696281;C5411361;C5411362;C5411363		Doppler echocardiography, fetal, pulsed wave and/or continuous wave with spectral display; complete
76828	SourceAtomCluster	76828	False	False	CPT	10	0					NONE	NONE		NONE	C5411369;C5696282;C5411368;C5411365;C5411367;C5411364;C5411366;C0373344		Doppler echocardiography, fetal, pulsed wave and/or continuous wave with spectral display; follow-up or repeat study
76856	SourceAtomCluster	76856	False	False	CPT	6	0					NONE	NONE		NONE	C0203479;C3866110;C5696285;C5411373		Ultrasound, pelvic (nonobstetric), real time with image documentation; complete
76857	SourceAtomCluster	76857	False	False	CPT	6	0					NONE	NONE		NONE	C0203480;C5411375;C5696286;C5411376		Ultrasound, pelvic (nonobstetric), real time with image documentation; limited or follow-up (eg, for follicles)
76870	SourceAtomCluster	76870	False	False	CPT	5	0					NONE	NONE		NONE	C0412550;C0845888		Ultrasound, scrotum and contents
76881	SourceAtomCluster	76881	False	False	CPT	5	0					NONE	NONE		NONE	C2939271;C5696289;C5411380		Ultrasound, complete joint (ie, joint space and peri-articular soft-tissue structures), real-time with image documentation
76882	SourceAtomCluster	76882	False	False	CPT	16	0					NONE	NONE		NONE	C5702006;C5411382;C5411387;C2939272;C5411388;C5702004;C5702007;C5702003;C5702005;C5411381;C5411386		Ultrasound, limited, joint or focal evaluation of other nonvascular extremity structure(s) (eg, joint space, peri-articular tendon[s], muscle[s], nerve[s], other soft-tissue structure[s], or soft-tissue mass[es]), real-time with image documentation
76883	SourceAtomCluster	76883	False	False	CPT	6	0					NONE	NONE		NONE	C5702008;C5702010;C5702009		Ultrasound, nerve(s) and accompanying structures throughout their entire anatomic course in one extremity, comprehensive, including real-time cine imaging with image documentation, per extremity
76885	SourceAtomCluster	76885	False	False	CPT	6	0					NONE	NONE		NONE	C5411389;C5411390;C5696291;C0519821		Ultrasound, infant hips, real time with imaging documentation; dynamic (requiring physician or other qualified health care professional manipulation)
76886	SourceAtomCluster	76886	False	False	CPT	7	0					NONE	NONE		NONE	C2122220;C5411391;C3866104;C5411392;C0520378		Ultrasound, infant hips, real time with imaging documentation; limited, static (not requiring physician or other qualified health care professional manipulation)
76977	SourceAtomCluster	76977	False	False	CPT	6	0					NONE	NONE		NONE	C3525424;C5696300;C0695041		Ultrasound bone density measurement and interpretation, peripheral site(s), any method
76978	SourceAtomCluster	76978	False	False	CPT	5	0					NONE	NONE		NONE	C5696301;C4732077;C5411396		Ultrasound, targeted dynamic microbubble sonographic contrast characterization (non-cardiac); initial lesion
76979	SourceAtomCluster	76979	False	False	CPT	5	0					NONE	NONE		NONE	C4732080;C5696302;C5411397		Ultrasound, targeted dynamic microbubble sonographic contrast characterization (non-cardiac); each additional lesion with separate injection (List separately in addition to code for primary procedure)
76981	SourceAtomCluster	76981	False	False	CPT	5	0					NONE	NONE		NONE	C5696303;C4732083;C4732085		Ultrasound, elastography; parenchyma (eg, organ)
76982	SourceAtomCluster	76982	False	False	CPT	5	0					NONE	NONE		NONE	C4732086;C5696304		Ultrasound, elastography; first target lesion
76983	SourceAtomCluster	76983	False	False	CPT	5	0					NONE	NONE		NONE	C5696305;C4732090;C4732088		Ultrasound, elastography; each additional target lesion (List separately in addition to code for primary procedure)
76984	SourceAtomCluster	76984	False	False	CPT	6	0					NONE	NONE		NONE	C5850684;C5850685;C5850686		Ultrasound, intraoperative thoracic aorta (eg, epiaortic), diagnostic
76987	SourceAtomCluster	76987	False	False	CPT	6	0					NONE	NONE		NONE	C5850688;C5850689		Intraoperative epicardial cardiac ultrasound (ie, echocardiography) for congenital heart disease, diagnostic; including placement and manipulation of transducer, image acquisition, interpretation and report
76988	SourceAtomCluster	76988	False	False	CPT	6	0					NONE	NONE		NONE	C5850690;C5850691;C5850692		Intraoperative epicardial cardiac ultrasound (ie, echocardiography) for congenital heart disease, diagnostic; placement, manipulation of transducer, and image acquisition only
76989	SourceAtomCluster	76989	False	False	CPT	6	0					NONE	NONE		NONE	C5850693;C5850694		Intraoperative epicardial cardiac ultrasound (ie, echocardiography) for congenital heart disease, diagnostic; interpretation and report only
76999	SourceAtomCluster	76999	False	False	CPT	7	0					NONE	NONE		NONE	C5411398;C5411400;C5696306;C0041618;C5411399		Unlisted ultrasound procedure (eg, diagnostic, interventional)
77046	SourceAtomCluster	77046	False	False	CPT	5	0					NONE	NONE		NONE	C5696315;C4732092;C5411415		Magnetic resonance imaging, breast, without contrast material; unilateral
77047	SourceAtomCluster	77047	False	False	CPT	5	0					NONE	NONE		NONE	C5696316;C4732094;C5411416		Magnetic resonance imaging, breast, without contrast material; bilateral
77048	SourceAtomCluster	77048	False	False	CPT	6	0					NONE	NONE		NONE	C5411417;C5696317;C4732097;C5411418		Magnetic resonance imaging, breast, without and with contrast material(s), including computer-aided detection (CAD real-time lesion detection, characterization and pharmacokinetic analysis), when performed; unilateral
77049	SourceAtomCluster	77049	False	False	CPT	6	0					NONE	NONE		NONE	C4732101;C5411419;C5696318;C5411420		Magnetic resonance imaging, breast, without and with contrast material(s), including computer-aided detection (CAD real-time lesion detection, characterization and pharmacokinetic analysis), when performed; bilateral
77061	SourceAtomCluster	77061	False	False	CPT	5	0					NONE	NONE		NONE	C3863722;C5696321		Diagnostic digital breast tomosynthesis; unilateral
77062	SourceAtomCluster	77062	False	False	CPT	5	0					NONE	NONE		NONE	C5696322;C3863729		Diagnostic digital breast tomosynthesis; bilateral
77065	SourceAtomCluster	77065	False	False	CPT	6	0					NONE	NONE		NONE	C4292313;C5696324;C4292312;C0993890		Diagnostic mammography, including computer-aided detection (CAD) when performed; unilateral
77066	SourceAtomCluster	77066	False	False	CPT	6	0					NONE	NONE		NONE	C0993888;C5416729;C4292314;C5411426		Diagnostic mammography, including computer-aided detection (CAD) when performed; bilateral
77071	SourceAtomCluster	77071	False	False	CPT	6	0					NONE	NONE		NONE	C3866049;C3525438;C5696325;C0695040		Manual application of stress performed by physician or other qualified health care professional for joint radiography, including contralateral joint if indicated
77072	SourceAtomCluster	77072	False	False	CPT	7	0					NONE	NONE		NONE	C5696326;C3866047;C0411916;C3866048		Bone age studies
77073	SourceAtomCluster	77073	False	False	CPT	6	0					NONE	NONE		NONE	C5696327;C3866046;C0373314		Bone length studies (orthoroentgenogram, scanogram)
77074	SourceAtomCluster	77074	False	False	CPT	6	0					NONE	NONE		NONE	C5696328;C0202617;C3866045;C3866044		Radiologic examination, osseous survey; limited (eg, for metastases)
77075	SourceAtomCluster	77075	False	False	CPT	5	0					NONE	NONE		NONE	C5696329;C0202616;C3866043		Radiologic examination, osseous survey; complete (axial and appendicular skeleton)
77076	SourceAtomCluster	77076	False	False	CPT	5	0					NONE	NONE		NONE	C0202618;C5696330		Radiologic examination, osseous survey, infant
77077	SourceAtomCluster	77077	False	False	CPT	5	0					NONE	NONE		NONE	C1736630;C5696331;C5411428		Joint survey, single view, 2 or more joints (specify)
77078	SourceAtomCluster	77078	False	False	CPT	9	0					NONE	NONE		NONE	C5411429;C5411430;C1737711;C5696332;C5411431;C5411433;C5411432		Computed tomography, bone mineral density study, 1 or more sites, axial skeleton (eg, hips, pelvis, spine)
77080	SourceAtomCluster	77080	False	False	CPT	9	0					NONE	NONE		NONE	C5411434;C1740748;C5696333;C5411437;C5411435;C5411438;C5411436		Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)
77081	SourceAtomCluster	77081	False	False	CPT	10	0					NONE	NONE		NONE	C5696334;C5411444;C1740480;C5411442;C5411440;C5411441;C5411445;C5411443		Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; appendicular skeleton (peripheral) (eg, radius, wrist, heel)
77084	SourceAtomCluster	77084	False	False	CPT	5	0					NONE	NONE		NONE	C0202674;C5411452		Magnetic resonance (eg, proton) imaging, bone marrow blood supply
77085	SourceAtomCluster	77085	False	False	CPT	9	0					NONE	NONE		NONE	C3865380;C5411447;C5411448;C5411450;C5696335;C5411451;C5411449		Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine), including vertebral fracture assessment
77086	SourceAtomCluster	77086	False	False	CPT	5	0					NONE	NONE		NONE	C5411453;C3865379;C5696336		Vertebral fracture assessment via dual-energy X-ray absorptiometry (DXA)
77089	SourceAtomCluster	77089	False	False	CPT	6	0					NONE	NONE		NONE	C5697863;C5691479;C5696337;C5697862		Trabecular bone score (TBS), structural condition of the bone microarchitecture; using dual X-ray absorptiometry (DXA) or other imaging data on gray-scale variogram, calculation, with interpretation and report on fracture-risk
77261	SourceAtomCluster	77261	False	False	CPT	6	0					NONE	NONE		NONE	C0373358;C3866025;C5696341		Therapeutic radiology treatment planning; simple
77262	SourceAtomCluster	77262	False	False	CPT	6	0					NONE	NONE		NONE	C5411454;C5696342;C0373359		Therapeutic radiology treatment planning; intermediate
77263	SourceAtomCluster	77263	False	False	CPT	6	0					NONE	NONE		NONE	C0203502;C5411455;C5696343;C5411456		Therapeutic radiology treatment planning; complex
77280	SourceAtomCluster	77280	False	False	CPT	6	0					NONE	NONE		NONE	C3866022;C5696344;C0373360		Therapeutic radiology simulation-aided field setting; simple
77285	SourceAtomCluster	77285	False	False	CPT	6	0					NONE	NONE		NONE	C5411457;C5696345;C0373361		Therapeutic radiology simulation-aided field setting; intermediate
77290	SourceAtomCluster	77290	False	False	CPT	6	0					NONE	NONE		NONE	C0373362;C5696346;C5411458		Therapeutic radiology simulation-aided field setting; complex
77295	SourceAtomCluster	77295	False	False	CPT	6	0					NONE	NONE		NONE	C3702030;C5411460;C5696349;C5411461		3-dimensional radiotherapy plan, including dose-volume histograms
77299	SourceAtomCluster	77299	False	False	CPT	5	0					NONE	NONE		NONE	C0203527;C5696348		Unlisted procedure, therapeutic radiology clinical treatment planning
77300	SourceAtomCluster	77300	False	False	CPT	5	0					NONE	NONE		NONE	C3516053;C5411462;C0373364		Basic radiation dosimetry calculation, central axis depth dose calculation, TDF, NSD, gap calculation, off axis factor, tissue inhomogeneity factors, calculation of non-ionizing radiation surface and depth dose, as required during course of treatment, only when prescribed by the treating physician
77301	SourceAtomCluster	77301	False	False	CPT	6	0					NONE	NONE		NONE	C5411463;C0973330;C5696350;C3525445		Intensity modulated radiotherapy plan, including dose-volume histograms for target and critical structure partial tolerance specifications
77306	SourceAtomCluster	77306	False	False	CPT	5	0					NONE	NONE		NONE	C5696351;C3865378;C0203516		Teletherapy isodose plan; simple (1 or 2 unmodified ports directed to a single area of interest), includes basic dosimetry calculation(s)
77307	SourceAtomCluster	77307	False	False	CPT	5	0					NONE	NONE		NONE	C5696352;C3865377;C0203518		Teletherapy isodose plan; complex (multiple treatment areas, tangential ports, the use of wedges, blocking, rotational beam, or special beam considerations), includes basic dosimetry calculation(s)
77316	SourceAtomCluster	77316	False	False	CPT	6	0					NONE	NONE		NONE	C3865376;C5411468;C5696353;C5411467		Brachytherapy isodose plan; simple (calculation[s] made from 1 to 4 sources, or remote afterloading brachytherapy, 1 channel), includes basic dosimetry calculation(s)
77317	SourceAtomCluster	77317	False	False	CPT	6	0					NONE	NONE		NONE	C3865375;C5411471;C5411470;C5696354		Brachytherapy isodose plan; intermediate (calculation[s] made from 5 to 10 sources, or remote afterloading brachytherapy, 2-12 channels), includes basic dosimetry calculation(s)
77318	SourceAtomCluster	77318	False	False	CPT	6	0					NONE	NONE		NONE	C3865374;C5411474;C5696355;C5411473		Brachytherapy isodose plan; complex (calculation[s] made from over 10 sources, or remote afterloading brachytherapy, over 12 channels), includes basic dosimetry calculation(s)
77321	SourceAtomCluster	77321	False	False	CPT	6	0					NONE	NONE		NONE	C5696356;C0203524;C3866017;C3866016		Special teletherapy port plan, particles, hemibody, total body
77331	SourceAtomCluster	77331	False	False	CPT	7	0					NONE	NONE		NONE	C3866015;C0203512;C3516061;C0039814;C0373365		Special dosimetry (eg, TLD, microdosimetry) (specify), only when prescribed by the treating physician
77332	SourceAtomCluster	77332	False	False	CPT	7	0					NONE	NONE		NONE	C0203528;C5411477;C3516062;C5411475;C5411476		Treatment devices, design and construction; simple (simple block, simple bolus)
77333	SourceAtomCluster	77333	False	False	CPT	9	0					NONE	NONE		NONE	C5411478;C5411481;C0203529;C3866011;C3516063;C5411479;C5411480		Treatment devices, design and construction; intermediate (multiple blocks, stents, bite blocks, special bolus)
77334	SourceAtomCluster	77334	False	False	CPT	11	0					NONE	NONE		NONE	C3866005;C0203530;C3865999;C3866001;C3866002;C3866003;C3866004;C3866000;C2094482		Treatment devices, design and construction; complex (irregular blocks, special shields, compensators, wedges, molds or casts)
77336	SourceAtomCluster	77336	False	False	CPT	6	0					NONE	NONE		NONE	C5696357;C0373366;C5411482;C3525448		Continuing medical physics consultation, including assessment of treatment parameters, quality assurance of dose delivery, and review of patient treatment documentation in support of the radiation oncologist, reported per week of therapy
77338	SourceAtomCluster	77338	False	False	CPT	5	0					NONE	NONE		NONE	C5696358;C2724318;C5411483		Multi-leaf collimator (MLC) device(s) for intensity modulated radiation therapy (IMRT), design and construction per IMRT plan
77370	SourceAtomCluster	77370	False	False	CPT	5	0					NONE	NONE		NONE	C0203493;C5696359		Special medical radiation physics consultation
77371	SourceAtomCluster	77371	False	False	CPT	6	0					NONE	NONE		NONE	C1736900;C5696360;C5411484;C5411485		Radiation treatment delivery, stereotactic radiosurgery (SRS), complete course of treatment of cranial lesion(s) consisting of 1 session; multi-source Cobalt 60 based
77372	SourceAtomCluster	77372	False	False	CPT	6	0					NONE	NONE		NONE	C3865994;C1736631;C5696361		Radiation treatment delivery, stereotactic radiosurgery (SRS), complete course of treatment of cranial lesion(s) consisting of 1 session; linear accelerator based
77373	SourceAtomCluster	77373	False	False	CPT	5	0					NONE	NONE		NONE	C1737712;C5411487;C5944543		Stereotactic body radiation therapy, treatment delivery, per fraction to 1 or more lesions, including image guidance, entire course not to exceed 5 fractions
77387	SourceAtomCluster	77387	False	False	CPT	6	0					NONE	NONE		NONE	C3865371;C5696368;C5411493;C5411494		Guidance for localization of target volume for delivery of radiation treatment, includes intrafraction tracking, when performed
77399	SourceAtomCluster	77399	False	False	CPT	8	0					NONE	NONE		NONE	C0203495;C5411505;C5696363;C5411504;C5411502;C5411503		Unlisted procedure, medical radiation physics, dosimetry and treatment devices, and special services
77402	SourceAtomCluster	77402	False	False	CPT	5	0					NONE	NONE		NONE	C3853605;C5411497		Radiation treatment delivery, >=1 MeV; simple
77407	SourceAtomCluster	77407	False	False	CPT	5	0					NONE	NONE		NONE	C0373371;C5411498		Radiation treatment delivery, >=1 MeV; intermediate
77412	SourceAtomCluster	77412	False	False	CPT	5	0					NONE	NONE		NONE	C3853606;C5411499		Radiation treatment delivery, >=1 MeV; complex
77417	SourceAtomCluster	77417	False	False	CPT	6	0					NONE	NONE		NONE	C5696365;C4051864		Therapeutic radiology port image(s)
77423	SourceAtomCluster	77423	False	False	CPT	6	0					NONE	NONE		NONE	C3865982;C3865983;C1611757;C5696371		High energy neutron radiation treatment delivery, 1 or more isocenter(s) with coplanar or non-coplanar geometry with blocking and/or wedge, and/or compensator(s)
77427	SourceAtomCluster	77427	False	False	CPT	5	0					NONE	NONE		NONE	C3865981;C5696372;C0812547		Radiation treatment management, 5 treatments
77431	SourceAtomCluster	77431	False	False	CPT	6	0					NONE	NONE		NONE	C3865979;C3865980;C5696373;C0373384		Radiation therapy management with complete course of therapy consisting of 1 or 2 fractions only
77432	SourceAtomCluster	77432	False	False	CPT	6	0					NONE	NONE		NONE	C0373385;C3865978;C5696374		Stereotactic radiation treatment management of cranial lesion(s) (complete course of treatment consisting of 1 session)
77435	SourceAtomCluster	77435	False	False	CPT	8	0					NONE	NONE		NONE	C5411506;C1742711;C3865976;C5696375;C3525466;C5411507		Stereotactic body radiation therapy, treatment management, per treatment course, to 1 or more lesions, including image guidance, entire course not to exceed 5 fractions
77436																		
77437																		
77438																		
77439																		
77470	SourceAtomCluster	77470	False	False	CPT	9	0					NONE	NONE		NONE	C0206113;C1719237;C3865973;C3865974;C0043162		Special treatment procedure (eg, total body irradiation, hemibody radiation, per oral or endocavitary irradiation)
77499	SourceAtomCluster	77499	False	False	CPT	5	0					NONE	NONE		NONE	C5697538;C0373387		Unlisted procedure, therapeutic radiology treatment management
77520	SourceAtomCluster	77520	False	False	CPT	5	0					NONE	NONE		NONE	C5696376;C3516077;C0695042		Proton treatment delivery; simple, without compensation
77522	SourceAtomCluster	77522	False	False	CPT	5	0					NONE	NONE		NONE	C5696377;C0918173		Proton treatment delivery; simple, with compensation
77523	SourceAtomCluster	77523	False	False	CPT	5	0					NONE	NONE		NONE	C5696378;C0812548		Proton treatment delivery; intermediate
77525	SourceAtomCluster	77525	False	False	CPT	5	0					NONE	NONE		NONE	C5696379;C0918174		Proton treatment delivery; complex
77600	SourceAtomCluster	77600	False	False	CPT	5	0					NONE	NONE		NONE	C0373388;C5696380;C5411509		Hyperthermia, externally generated; superficial (ie, heating to a depth of 4 cm or less)
77605	SourceAtomCluster	77605	False	False	CPT	5	0					NONE	NONE		NONE	C0373389;C5696381;C5411510		Hyperthermia, externally generated; deep (ie, heating to depths greater than 4 cm)
77610	SourceAtomCluster	77610	False	False	CPT	5	0					NONE	NONE		NONE	C0203601;C5696382;C5411511		Hyperthermia generated by interstitial probe(s); 5 or fewer interstitial applicators
77615	SourceAtomCluster	77615	False	False	CPT	5	0					NONE	NONE		NONE	C5696383;C3865971;C0203602		Hyperthermia generated by interstitial probe(s); more than 5 interstitial applicators
77620	SourceAtomCluster	77620	False	False	CPT	6	0					NONE	NONE		NONE	C0203603;C5696384		Hyperthermia generated by intracavitary probe(s)
77750	SourceAtomCluster	77750	False	False	CPT	6	0					NONE	NONE		NONE	C3865969;C0203631;C3665453;C3865970		Infusion or instillation of radioelement solution (includes 3-month follow-up care)
77761	SourceAtomCluster	77761	False	False	CPT	6	0					NONE	NONE		NONE	C0203575;C5696385;C5411512;C5411513		Intracavitary radiation source application; simple
77762	SourceAtomCluster	77762	False	False	CPT	6	0					NONE	NONE		NONE	C5696386;C3865967;C5411514;C0203576		Intracavitary radiation source application; intermediate
77763	SourceAtomCluster	77763	False	False	CPT	6	0					NONE	NONE		NONE	C0203577;C3865966;C5411515;C5696387		Intracavitary radiation source application; complex
77767	SourceAtomCluster	77767	False	False	CPT	6	0					NONE	NONE		NONE	C4052120;C5411516;C4050034;C5696388		Remote afterloading high dose rate radionuclide skin surface brachytherapy, includes basic dosimetry, when performed; lesion diameter up to 2.0 cm or 1 channel
77768	SourceAtomCluster	77768	False	False	CPT	8	0					NONE	NONE		NONE	C5696389;C4050033;C5411518;C5411519;C5411517;C4052117		Remote afterloading high dose rate radionuclide skin surface brachytherapy, includes basic dosimetry, when performed; lesion diameter over 2.0 cm and 2 or more channels, or multiple lesions
77770	SourceAtomCluster	77770	False	False	CPT	8	0					NONE	NONE		NONE	C5411520;C4052114;C4050030;C5696390;C5411521;C4052113		Remote afterloading high dose rate radionuclide interstitial or intracavitary brachytherapy, includes basic dosimetry, when performed; 1 channel
77771	SourceAtomCluster	77771	False	False	CPT	8	0					NONE	NONE		NONE	C5411522;C5696391;C4050032;C5411523;C4052111;C4052112		Remote afterloading high dose rate radionuclide interstitial or intracavitary brachytherapy, includes basic dosimetry, when performed; 2-12 channels
77772	SourceAtomCluster	77772	False	False	CPT	8	0					NONE	NONE		NONE	C5411524;C4050031;C5696392;C5411525;C4052109;C4052110		Remote afterloading high dose rate radionuclide interstitial or intracavitary brachytherapy, includes basic dosimetry, when performed; over 12 channels
77778	SourceAtomCluster	77778	False	False	CPT	6	0					NONE	NONE		NONE	C0203583;C5411526;C3865963		Interstitial radiation source application, complex, includes supervision, handling, loading of radiation source, when performed
77789	SourceAtomCluster	77789	False	False	CPT	5	0					NONE	NONE		NONE	C5696393;C4051863		Surface application of low dose rate radionuclide source
77790	SourceAtomCluster	77790	False	False	CPT	5	0					NONE	NONE		NONE	C0203606		Supervision, handling, loading of radiation source
77799	SourceAtomCluster	77799	False	False	CPT	5	0					NONE	NONE		NONE	C0203596;C5696395		Unlisted procedure, clinical brachytherapy
78012	SourceAtomCluster	78012	False	False	CPT	6	0					NONE	NONE		NONE	C3865961;C3511538;C3865962;C5696396		Thyroid uptake, single or multiple quantitative measurement(s) (including stimulation, suppression, or discharge, when performed)
78013	SourceAtomCluster	78013	False	False	CPT	6	0					NONE	NONE		NONE	C0203779;C0203785;C3865960;C5696397		Thyroid imaging (including vascular flow, when performed)
78014	SourceAtomCluster	78014	False	False	CPT	8	0					NONE	NONE		NONE	C3865959;C3865958;C3865957;C3865956;C5696398;C3496323		Thyroid imaging (including vascular flow, when performed); with single or multiple uptake(s) quantitative measurement(s) (including stimulation, suppression, or discharge, when performed)
78015	SourceAtomCluster	78015	False	False	CPT	6	0					NONE	NONE		NONE	C3865955;C0203786;C5696399;C5411527		Thyroid carcinoma metastases imaging; limited area (eg, neck and chest only)
78016	SourceAtomCluster	78016	False	False	CPT	6	0					NONE	NONE		NONE	C5696400;C5411528;C0203791;C3865953		Thyroid carcinoma metastases imaging; with additional studies (eg, urinary recovery)
78018	SourceAtomCluster	78018	False	False	CPT	5	0					NONE	NONE		NONE	C0203790;C3865952;C3516087		Thyroid carcinoma metastases imaging; whole body
78020	SourceAtomCluster	78020	False	False	CPT	5	0					NONE	NONE		NONE	C3865951;C5696401;C0695044		Thyroid carcinoma metastases uptake (List separately in addition to code for primary procedure)
78070	SourceAtomCluster	78070	False	False	CPT	6	0					NONE	NONE		NONE	C3511539;C3865950;C5696402		Parathyroid planar imaging (including subtraction, when performed)
78071	SourceAtomCluster	78071	False	False	CPT	6	0					NONE	NONE		NONE	C5696403;C5411529;C3511540;C5411530		Parathyroid planar imaging (including subtraction, when performed); with tomographic (SPECT)
78072	SourceAtomCluster	78072	False	False	CPT	6	0					NONE	NONE		NONE	C5411531;C5696404;C3511541;C5411532		Parathyroid planar imaging (including subtraction, when performed); with tomographic (SPECT), and concurrently acquired computed tomography (CT) for anatomical localization
78075	SourceAtomCluster	78075	False	False	CPT	7	0					NONE	NONE		NONE	C0373398;C2094532;C3865947;C2094533;C5696405		Adrenal imaging, cortex and/or medulla
78099	SourceAtomCluster	78099	False	False	CPT	5	0					NONE	NONE		NONE	C5411533;C3516092;C0373399		Unlisted endocrine procedure, diagnostic nuclear medicine
78102	SourceAtomCluster	78102	False	False	CPT	5	0					NONE	NONE		NONE	C0203801;C3865946;C5696406		Bone marrow imaging; limited area
78103	SourceAtomCluster	78103	False	False	CPT	5	0					NONE	NONE		NONE	C5696407;C0203802;C3865944		Bone marrow imaging; multiple areas
78104	SourceAtomCluster	78104	False	False	CPT	5	0					NONE	NONE		NONE	C5411534;C0203803;C5696408		Bone marrow imaging; whole body
78110	SourceAtomCluster	78110	False	False	CPT	5	0					NONE	NONE		NONE	C3865942;C5696409;C0373400		Plasma volume, radiopharmaceutical volume-dilution technique (separate procedure); single sampling
78111	SourceAtomCluster	78111	False	False	CPT	5	0					NONE	NONE		NONE	C3865940;C0373401;C5696410		Plasma volume, radiopharmaceutical volume-dilution technique (separate procedure); multiple samplings
78120	SourceAtomCluster	78120	False	False	CPT	5	0					NONE	NONE		NONE	C3865939;C0203809;C5696411		Red cell volume determination (separate procedure); single sampling
78121	SourceAtomCluster	78121	False	False	CPT	5	0					NONE	NONE		NONE	C5696412;C3865937;C0203810		Red cell volume determination (separate procedure); multiple samplings
78122	SourceAtomCluster	78122	False	False	CPT	6	0					NONE	NONE		NONE	C5411538;C0203805;C3865936;C5696413		Whole blood volume determination, including separate measurement of plasma volume and red cell volume (radiopharmaceutical volume-dilution technique)
78130	SourceAtomCluster	78130	False	False	CPT	5	0					NONE	NONE		NONE	C0412489;C3865935;C5696414		Red cell survival study
78140	SourceAtomCluster	78140	False	False	CPT	5	0					NONE	NONE		NONE	C3865933;C0373403;C5696415		Labeled red cell sequestration, differential organ/tissue (eg, splenic and/or hepatic)
78185	SourceAtomCluster	78185	False	False	CPT	6	0					NONE	NONE		NONE	C3865932;C3865931;C5696416;C0373405		Spleen imaging only, with or without vascular flow
78191	SourceAtomCluster	78191	False	False	CPT	5	0					NONE	NONE		NONE	C3865926;C5696417;C0412490		Platelet survival study
78195	SourceAtomCluster	78195	False	False	CPT	5	0					NONE	NONE		NONE	C0203827;C5696418		Lymphatics and lymph nodes imaging
78199	SourceAtomCluster	78199	False	False	CPT	5	0					NONE	NONE		NONE	C5411542;C5411541;C0373407		Unlisted hematopoietic, reticuloendothelial and lymphatic procedure, diagnostic nuclear medicine
78201	SourceAtomCluster	78201	False	False	CPT	5	0					NONE	NONE		NONE	C0203759;C3865924;C3516100		Liver imaging; static only
78202	SourceAtomCluster	78202	False	False	CPT	5	0					NONE	NONE		NONE	C3865923;C0203761;C3516101		Liver imaging; with vascular flow
78215	SourceAtomCluster	78215	False	False	CPT	5	0					NONE	NONE		NONE	C3865920;C0203766;C5696419		Liver and spleen imaging; static only
78216	SourceAtomCluster	78216	False	False	CPT	5	0					NONE	NONE		NONE	C0203767;C3865919;C5696420		Liver and spleen imaging; with vascular flow
78226	SourceAtomCluster	78226	False	False	CPT	6	0					NONE	NONE		NONE	C3248121;C3865918;C5697539;C5411543		Hepatobiliary system imaging, including gallbladder when present
78227	SourceAtomCluster	78227	False	False	CPT	8	0					NONE	NONE		NONE	C3248122;C3865913;C5411544;C3865914;C5696421;C5411545		Hepatobiliary system imaging, including gallbladder when present; with pharmacologic intervention, including quantitative measurement(s) when performed
78230	SourceAtomCluster	78230	False	False	CPT	5	0					NONE	NONE		NONE	C3496536;C3865912;C3516105		Salivary gland imaging
78231	SourceAtomCluster	78231	False	False	CPT	5	0					NONE	NONE		NONE	C5696422;C3865911;C0373410		Salivary gland imaging; with serial images
78232	SourceAtomCluster	78232	False	False	CPT	5	0					NONE	NONE		NONE	C0203772;C3865910;C5696423		Salivary gland function study
78258	SourceAtomCluster	78258	False	False	CPT	5	0					NONE	NONE		NONE	C5696424;C0700223;C3865909		Esophageal motility
78261	SourceAtomCluster	78261	False	False	CPT	5	0					NONE	NONE		NONE	C0203748;C3865908;C5696425		Gastric mucosa imaging
78262	SourceAtomCluster	78262	False	False	CPT	5	0					NONE	NONE		NONE	C3865907;C0473905;C5696426		Gastroesophageal reflux study
78264	SourceAtomCluster	78264	False	False	CPT	5	0					NONE	NONE		NONE	C5696427;C0203071;C3865906		Gastric emptying imaging study (eg, solid, liquid, or both)
78265	SourceAtomCluster	78265	False	False	CPT	5	0					NONE	NONE		NONE	C5696428;C4050028;C4052108		Gastric emptying imaging study (eg, solid, liquid, or both); with small bowel transit
78266	SourceAtomCluster	78266	False	False	CPT	5	0					NONE	NONE		NONE	C4050029;C5696429;C5411548		Gastric emptying imaging study (eg, solid, liquid, or both); with small bowel and colon transit, multiple days
78267	SourceAtomCluster	78267	False	False	CPT	5	0					NONE	NONE		NONE	C5411550;C5696430;C0812549		Urea breath test, C-14 (isotopic); acquisition for analysis
78268	SourceAtomCluster	78268	False	False	CPT	5	0					NONE	NONE		NONE	C5696431;C0812550;C5411552		Urea breath test, C-14 (isotopic); analysis
78278	SourceAtomCluster	78278	False	False	CPT	5	0					NONE	NONE		NONE	C0203751;C3865899;C5696432		Acute gastrointestinal blood loss imaging
78282	SourceAtomCluster	78282	False	False	CPT	5	0					NONE	NONE		NONE	C3865898;C0473916;C5696433		Gastrointestinal protein loss
78290	SourceAtomCluster	78290	False	False	CPT	5	0					NONE	NONE		NONE	C5696434;C1278711;C3865897		Intestine imaging (eg, ectopic gastric mucosa, Meckel's localization, volvulus)
78291	SourceAtomCluster	78291	False	False	CPT	7	0					NONE	NONE		NONE	C5696435;C0203872;C3865896;C3865894;C3865895		Peritoneal-venous shunt patency test (eg, for LeVeen, Denver shunt)
78299	SourceAtomCluster	78299	False	False	CPT	5	0					NONE	NONE		NONE	C5411553;C3516109;C0373413		Unlisted gastrointestinal procedure, diagnostic nuclear medicine
78300	SourceAtomCluster	78300	False	False	CPT	7	0					NONE	NONE		NONE	C5696436;C3865891;C3865893;C3865892;C0373414		Bone and/or joint imaging; limited area
78305	SourceAtomCluster	78305	False	False	CPT	7	0					NONE	NONE		NONE	C3865888;C3865889;C3865890;C5696437;C0373415		Bone and/or joint imaging; multiple areas
78306	SourceAtomCluster	78306	False	False	CPT	7	0					NONE	NONE		NONE	C0373416;C5411554;C5696438;C5411555;C5411556		Bone and/or joint imaging; whole body
78315	SourceAtomCluster	78315	False	False	CPT	7	0					NONE	NONE		NONE	C3865882;C3865883;C3865884;C5696439;C0373417		Bone and/or joint imaging; 3 phase study
78399	SourceAtomCluster	78399	False	False	CPT	5	0					NONE	NONE		NONE	C5696442;C5411557;C0373419		Unlisted musculoskeletal procedure, diagnostic nuclear medicine
78428	SourceAtomCluster	78428	False	False	CPT	5	0					NONE	NONE		NONE	C0203739;C5696444		Cardiac shunt detection
78429	SourceAtomCluster	78429	False	False	CPT	8	0					NONE	NONE		NONE	C5696452;C5411564;C5411565;C5201688;C5411566;C5411567		Myocardial imaging, positron emission tomography (PET), metabolic evaluation study (including ventricular wall motion[s] and/or ejection fraction[s], when performed), single study; with concurrently acquired computed tomography transmission scan
78430	SourceAtomCluster	78430	False	False	CPT	16	0					NONE	NONE		NONE	C5411572;C5411574;C5411580;C5411582;C5411573;C5411577;C5696459;C5201700;C5411575;C5411576;C5411578;C5411583;C5411579;C5411581		Myocardial imaging, positron emission tomography (PET), perfusion study (including ventricular wall motion[s] and/or ejection fraction[s], when performed); single study, at rest or stress (exercise or pharmacologic), with concurrently acquired computed tomography transmission scan
78431	SourceAtomCluster	78431	False	False	CPT	16	0					NONE	NONE		NONE	C5411584;C5411590;C5411595;C5411587;C5411594;C5201714;C5696459;C5411586;C5411589;C5411591;C5411593;C5411585;C5411588;C5411592		Myocardial imaging, positron emission tomography (PET), perfusion study (including ventricular wall motion[s] and/or ejection fraction[s], when performed); multiple studies at rest and stress (exercise or pharmacologic), with concurrently acquired computed tomography transmission scan
78432	SourceAtomCluster	78432	False	False	CPT	8	0					NONE	NONE		NONE	C5411615;C5696460;C5201746;C5411614;C5411616;C5411617		Myocardial imaging, positron emission tomography (PET), combined perfusion with metabolic evaluation study (including ventricular wall motion[s] and/or ejection fraction[s], when performed), dual radiotracer (eg, myocardial viability)
78433	SourceAtomCluster	78433	False	False	CPT	8	0					NONE	NONE		NONE	C5411618;C5201751;C5696461;C5411619;C5411620;C5411621		Myocardial imaging, positron emission tomography (PET), combined perfusion with metabolic evaluation study (including ventricular wall motion[s] and/or ejection fraction[s], when performed), dual radiotracer (eg, myocardial viability); with concurrently acquired computed tomography transmission scan
78434	SourceAtomCluster	78434	False	False	CPT	5	0					NONE	NONE		NONE	C5696462;C5411622;C5201757		Absolute quantitation of myocardial blood flow (AQMBF), positron emission tomography (PET), rest and pharmacologic stress (List separately in addition to code for primary procedure)
78445	SourceAtomCluster	78445	False	False	CPT	7	0					NONE	NONE		NONE	C3865861;C3865859;C5696445;C0519146;C5411623		Non-cardiac vascular flow imaging (ie, angiography, venography)
78451	SourceAtomCluster	78451	False	False	CPT	8	0					NONE	NONE		NONE	C2724319;C5411625;C5696446;C5411626;C5411627;C5411624		Myocardial perfusion imaging, tomographic (SPECT) (including attenuation correction, qualitative or quantitative wall motion, ejection fraction by first pass or gated technique, additional quantification, when performed); single study, at rest or stress (exercise or pharmacologic)
78452	SourceAtomCluster	78452	False	False	CPT	8	0					NONE	NONE		NONE	C5411628;C2724320;C5696446;C5411630;C5411629;C5411631		Myocardial perfusion imaging, tomographic (SPECT) (including attenuation correction, qualitative or quantitative wall motion, ejection fraction by first pass or gated technique, additional quantification, when performed); multiple studies, at rest and/or stress (exercise or pharmacologic) and/or redistribution and/or rest reinjection
78453	SourceAtomCluster	78453	False	False	CPT	8	0					NONE	NONE		NONE	C2724321;C4052106;C5696447;C4052104;C4052105;C4052103		Myocardial perfusion imaging, planar (including qualitative or quantitative wall motion, ejection fraction by first pass or gated technique, additional quantification, when performed); single study, at rest or stress (exercise or pharmacologic)
78454	SourceAtomCluster	78454	False	False	CPT	8	0					NONE	NONE		NONE	C3865840;C3865842;C2724322;C3865839;C3865841;C5696447		Myocardial perfusion imaging, planar (including qualitative or quantitative wall motion, ejection fraction by first pass or gated technique, additional quantification, when performed); multiple studies, at rest and/or stress (exercise or pharmacologic) and/or redistribution and/or rest reinjection
78456	SourceAtomCluster	78456	False	False	CPT	5	0					NONE	NONE		NONE	C5696448;C0812551		Acute venous thrombosis imaging, peptide
78457	SourceAtomCluster	78457	False	False	CPT	5	0					NONE	NONE		NONE	C3865838;C0203737;C5696449		Venous thrombosis imaging, venogram; unilateral
78458	SourceAtomCluster	78458	False	False	CPT	6	0					NONE	NONE		NONE	C0203738;C5696450;C5411632;C5411633		Venous thrombosis imaging, venogram; bilateral
78459	SourceAtomCluster	78459	False	False	CPT	8	0					NONE	NONE		NONE	C5411569;C5411571;C5411568;C5696451;C5411570;C0373423		Myocardial imaging, positron emission tomography (PET), metabolic evaluation study (including ventricular wall motion[s] and/or ejection fraction[s], when performed), single study
78466	SourceAtomCluster	78466	False	False	CPT	6	0					NONE	NONE		NONE	C3865836;C3865837;C3516129;C0373427		Myocardial imaging, infarct avid, planar; qualitative or quantitative
78468	SourceAtomCluster	78468	False	False	CPT	5	0					NONE	NONE		NONE	C5696453;C0373428		Myocardial imaging, infarct avid, planar; with ejection fraction by first pass technique
78469	SourceAtomCluster	78469	False	False	CPT	8	0					NONE	NONE		NONE	C5696454;C5411635;C5411638;C5411637;C5411636;C0373429		Myocardial imaging, infarct avid, planar; tomographic SPECT with or without quantification
78472	SourceAtomCluster	78472	False	False	CPT	14	0					NONE	NONE		NONE	C5696455;C3865834;C3865828;C3865831;C3865833;C3865829;C3865827;C3865830;C3865832;C3525524;C3525527;C0373430		Cardiac blood pool imaging, gated equilibrium; planar, single study at rest or stress (exercise and/or pharmacologic), wall motion study plus ejection fraction, with or without additional quantitative processing
78473	SourceAtomCluster	78473	False	False	CPT	14	0					NONE	NONE		NONE	C3865822;C3865833;C3865834;C0373431;C3865823;C3865826;C3865832;C3865825;C3865824;C3525527;C5696455;C3525526		Cardiac blood pool imaging, gated equilibrium; multiple studies, wall motion study plus ejection fraction, at rest and stress (exercise and/or pharmacologic), with or without additional quantification
78481	SourceAtomCluster	78481	False	False	CPT	14	0					NONE	NONE		NONE	C5696456;C5411642;C5411644;C5411648;C5411640;C5411641;C5411643;C5411646;C5411647;C5411649;C0519149;C5411645		Cardiac blood pool imaging (planar), first pass technique; single study, at rest or with stress (exercise and/or pharmacologic), wall motion study plus ejection fraction, with or without quantification
78483	SourceAtomCluster	78483	False	False	CPT	14	0					NONE	NONE		NONE	C5411650;C5411652;C5411656;C5411658;C5696457;C5411654;C5411651;C5411653;C5411655;C5411659;C5411657;C0519150		Cardiac blood pool imaging (planar), first pass technique; multiple studies, at rest and with stress (exercise and/or pharmacologic), wall motion study plus ejection fraction, with or without quantification
78491	SourceAtomCluster	78491	False	False	CPT	16	0					NONE	NONE		NONE	C5411600;C5411601;C5411602;C5411604;C5411596;C5411607;C5696458;C5411605;C5411599;C5411606;C5411597;C5411598;C5411603;C0519151		Myocardial imaging, positron emission tomography (PET), perfusion study (including ventricular wall motion[s] and/or ejection fraction[s], when performed); single study, at rest or stress (exercise or pharmacologic)
78492	SourceAtomCluster	78492	False	False	CPT	10	0					NONE	NONE		NONE	C5411608;C5411610;C5696458;C5411611;C5411613;C5411609;C5411612;C0519152		Myocardial imaging, positron emission tomography (PET), perfusion study (including ventricular wall motion[s] and/or ejection fraction[s], when performed); multiple studies at rest and stress (exercise or pharmacologic)
78494	SourceAtomCluster	78494	False	False	CPT	6	0					NONE	NONE		NONE	C5696463;C0695046;C5411661;C5411660		Cardiac blood pool imaging, gated equilibrium, SPECT, at rest, wall motion study plus ejection fraction, with or without quantitative processing
78496	SourceAtomCluster	78496	False	False	CPT	5	0					NONE	NONE		NONE	C3865803;C5696464;C0695047		Cardiac blood pool imaging, gated equilibrium, single study, at rest, with right ventricular ejection fraction by first pass technique (List separately in addition to code for primary procedure)
78499	SourceAtomCluster	78499	False	False	CPT	5	0					NONE	NONE		NONE	C5411662;C0373434;C5696465		Unlisted cardiovascular procedure, diagnostic nuclear medicine
78579	SourceAtomCluster	78579	False	False	CPT	7	0					NONE	NONE		NONE	C3248123;C3865801;C3865802;C3516138		Pulmonary ventilation imaging (eg, aerosol or gas)
78580	SourceAtomCluster	78580	False	False	CPT	6	0					NONE	NONE		NONE	C0203685;C3865800;C3525539;C5696466		Pulmonary perfusion imaging (eg, particulate)
78582	SourceAtomCluster	78582	False	False	CPT	7	0					NONE	NONE		NONE	C3248124;C5696467;C3865798;C3865799		Pulmonary ventilation (eg, aerosol or gas) and perfusion imaging
78597	SourceAtomCluster	78597	False	False	CPT	6	0					NONE	NONE		NONE	C3248125;C5696468;C3525540;C5411663		Quantitative differential pulmonary perfusion, including imaging when performed
78598	SourceAtomCluster	78598	False	False	CPT	10	0					NONE	NONE		NONE	C5696469;C3865794;C3248126;C3865796;C3525541;C5411666;C5411664;C5411665		Quantitative differential pulmonary perfusion and ventilation (eg, aerosol or gas), including imaging when performed
78599	SourceAtomCluster	78599	False	False	CPT	5	0					NONE	NONE		NONE	C5696470;C5411667;C0373436		Unlisted respiratory procedure, diagnostic nuclear medicine
78600	SourceAtomCluster	78600	False	False	CPT	5	0					NONE	NONE		NONE	C0203861;C5696471		Brain imaging, less than 4 static views
78601	SourceAtomCluster	78601	False	False	CPT	5	0					NONE	NONE		NONE	C0203864;C5696472		Brain imaging, less than 4 static views; with vascular flow
78605	SourceAtomCluster	78605	False	False	CPT	5	0					NONE	NONE		NONE	C5696473;C0203862		Brain imaging, minimum 4 static views
78606	SourceAtomCluster	78606	False	False	CPT	5	0					NONE	NONE		NONE	C0203865;C5411669;C5696474		Brain imaging, minimum 4 static views; with vascular flow
78608	SourceAtomCluster	78608	False	False	CPT	5	0					NONE	NONE		NONE	C3516146;C5411670;C0373437		Brain imaging, positron emission tomography (PET); metabolic evaluation
78610	SourceAtomCluster	78610	False	False	CPT	5	0					NONE	NONE		NONE	C0203863;C5696472;C0373439		Brain imaging, vascular flow only
78630	SourceAtomCluster	78630	False	False	CPT	5	0					NONE	NONE		NONE	C5696476;C0412343;C0373441		Cerebrospinal fluid flow, imaging (not including introduction of material); cisternography
78635	SourceAtomCluster	78635	False	False	CPT	5	0					NONE	NONE		NONE	C0203870;C0373442;C5696477		Cerebrospinal fluid flow, imaging (not including introduction of material); ventriculography
78645	SourceAtomCluster	78645	False	False	CPT	5	0					NONE	NONE		NONE	C0412344;C5696478;C0373443		Cerebrospinal fluid flow, imaging (not including introduction of material); shunt evaluation
78650	SourceAtomCluster	78650	False	False	CPT	5	0					NONE	NONE		NONE	C3865791;C5696479;C0203874		Cerebrospinal fluid leakage detection and localization
78660	SourceAtomCluster	78660	False	False	CPT	5	0					NONE	NONE		NONE	C0412346;C5696480		Radiopharmaceutical dacryocystography
78699	SourceAtomCluster	78699	False	False	CPT	5	0					NONE	NONE		NONE	C0373445;C5696481;C5411672		Unlisted nervous system procedure, diagnostic nuclear medicine
78700	SourceAtomCluster	78700	False	False	CPT	5	0					NONE	NONE		NONE	C3865790;C3665455;C3516158		Kidney imaging morphology
78701	SourceAtomCluster	78701	False	False	CPT	5	0					NONE	NONE		NONE	C0203845;C3865789;C5696482		Kidney imaging morphology; with vascular flow
78707	SourceAtomCluster	78707	False	False	CPT	5	0					NONE	NONE		NONE	C5696483;C0519153;C5411674		Kidney imaging morphology; with vascular flow and function, single study without pharmacological intervention
78708	SourceAtomCluster	78708	False	False	CPT	8	0					NONE	NONE		NONE	C5411678;C5696484;C0520383;C5411676;C5411677;C5411679		Kidney imaging morphology; with vascular flow and function, single study, with pharmacological intervention (eg, angiotensin converting enzyme inhibitor and/or diuretic)
78709	SourceAtomCluster	78709	False	False	CPT	8	0					NONE	NONE		NONE	C5696483;C5411680;C5411681;C5411682;C5411683;C0520384		Kidney imaging morphology; with vascular flow and function, multiple studies, with and without pharmacological intervention (eg, angiotensin converting enzyme inhibitor and/or diuretic)
78725	SourceAtomCluster	78725	False	False	CPT	5	0					NONE	NONE		NONE	C0373448;C3516159;C5411684		Kidney function study, non-imaging radioisotopic study
78730	SourceAtomCluster	78730	False	False	CPT	5	0					NONE	NONE		NONE	C0203852;C3865780;C3516160		Urinary bladder residual study (List separately in addition to code for primary procedure)
78740	SourceAtomCluster	78740	False	False	CPT	5	0					NONE	NONE		NONE	C0203853;C5696485;C3525551		Ureteral reflux study (radiopharmaceutical voiding cystogram)
78761	SourceAtomCluster	78761	False	False	CPT	5	0					NONE	NONE		NONE	C5696486;C0203855;C3865779		Testicular imaging with vascular flow
78799	SourceAtomCluster	78799	False	False	CPT	5	0					NONE	NONE		NONE	C5696487;C5411685;C0373449		Unlisted genitourinary procedure, diagnostic nuclear medicine
78800	SourceAtomCluster	78800	False	False	CPT	44	0					NONE	NONE		NONE	C5696488;C5411696;C5411695;C5201768;C5201771;C5201776;C5201780;C5201782;C5201788;C5201765;C5201769;C5201767;C5201770;C5201778;C5201779;C5201785;C5201789;C5201766;C5201772;C5201784;C5201786;C5201787;C5201790;C5201762;C5201764		Radiopharmaceutical localization of tumor, inflammatory process or distribution of radiopharmaceutical agent(s) (includes vascular flow and blood pool imaging, when performed); planar, single area (eg, head, neck, chest, pelvis), single day imaging
78801	SourceAtomCluster	78801	False	False	CPT	7	0					NONE	NONE		NONE	C3865776;C2094655;C5696489;C5201801		Radiopharmaceutical localization of tumor, inflammatory process or distribution of radiopharmaceutical agent(s) (includes vascular flow and blood pool imaging, when performed); planar, 2 or more areas (eg, abdomen and pelvis, head and chest), 1 or more days imaging or single area imaging over 2 or more days
78802	SourceAtomCluster	78802	False	False	CPT	12	0					NONE	NONE		NONE	C5411697;C5411698;C5696490;C5201806;C5201809;C5201810;C5201803;C5201807;C5201808;C5201805		Radiopharmaceutical localization of tumor, inflammatory process or distribution of radiopharmaceutical agent(s) (includes vascular flow and blood pool imaging, when performed); planar, whole body, single day imaging
78803	SourceAtomCluster	78803	False	False	CPT	50	0					NONE	NONE		NONE	C5702011;C5702012;C5702013;C5411699;C5411701;C5411703;C5411704;C5411705;C5411714;C5411719;C5411721;C5411724;C5411700;C5411702;C5411708;C5411716;C5411717;C5411718;C5411722;C5702014;C5702016;C5702015;C5702017;C5411706;C5411707		Radiopharmaceutical localization of tumor, inflammatory process or distribution of radiopharmaceutical agent(s) (includes vascular flow and blood pool imaging, when performed); tomographic (SPECT), single area (eg, head, neck, chest, pelvis) or acquisition, single day imaging
78804	SourceAtomCluster	78804	False	False	CPT	12	0					NONE	NONE		NONE	C1314095;C5696491;C5201854;C5201852;C5201856;C5201851;C5201855;C5411729;C5411730		Radiopharmaceutical localization of tumor, inflammatory process or distribution of radiopharmaceutical agent(s) (includes vascular flow and blood pool imaging, when performed); planar, whole body, requiring 2 or more days imaging
78811	SourceAtomCluster	78811	False	False	CPT	9	0					NONE	NONE		NONE	C1504146;C3516172;C5411810;C5411808;C5411809;C5411811;C5411812		Positron emission tomography (PET) imaging; limited area (eg, chest, head/neck)
78812	SourceAtomCluster	78812	False	False	CPT	5	0					NONE	NONE		NONE	C1504147;C5696498;C5411813		Positron emission tomography (PET) imaging; skull base to mid-thigh
78813	SourceAtomCluster	78813	False	False	CPT	5	0					NONE	NONE		NONE	C1504148;C5696490;C5411814		Positron emission tomography (PET) imaging; whole body
78814	SourceAtomCluster	78814	False	False	CPT	13	0					NONE	NONE		NONE	C5411815;C5411819;C5411820;C1504149;C5411816;C5411823;C5696499;C5411822;C5411821;C5411817;C5411818		Positron emission tomography (PET) with concurrently acquired computed tomography (CT) for attenuation correction and anatomical localization imaging; limited area (eg, chest, head/neck)
78815	SourceAtomCluster	78815	False	False	CPT	5	0					NONE	NONE		NONE	C1504150;C5411824;C5696500		Positron emission tomography (PET) with concurrently acquired computed tomography (CT) for attenuation correction and anatomical localization imaging; skull base to mid-thigh
78816	SourceAtomCluster	78816	False	False	CPT	6	0					NONE	NONE		NONE	C1504151;C5696501;C5411826;C5411825		Positron emission tomography (PET) with concurrently acquired computed tomography (CT) for attenuation correction and anatomical localization imaging; whole body
78830	SourceAtomCluster	78830	False	False	CPT	47	0					NONE	NONE		NONE	C5702019;C5702020;C5411731;C5411732;C5411733;C5411735;C5411737;C5411738;C5411741;C5411746;C5411754;C5411744;C5411747;C5411748;C5411752;C5411753;C5411758;C5411759;C5201859;C5702021;C5702022;C5702018;C5411736;C5411740;C5411757		Radiopharmaceutical localization of tumor, inflammatory process or distribution of radiopharmaceutical agent(s) (includes vascular flow and blood pool imaging, when performed); tomographic (SPECT) with concurrently acquired computed tomography (CT) transmission scan for anatomical review, localization and determination/detection of pathology, single area (eg, head, neck, chest, pelvis) or acquisition, single day imaging
78831	SourceAtomCluster	78831	False	False	CPT	43	0					NONE	NONE		NONE	C5702023;C5702033;C5702035;C5702036;C5702038;C5702039;C5411769;C5411772;C5411774;C5411776;C5411777;C5411767;C5411768;C5411773;C5411775;C5411781;C5411782;C5411783;C5411785;C5702025;C5702027;C5201895;C5702024;C5702026;C5702028		Radiopharmaceutical localization of tumor, inflammatory process or distribution of radiopharmaceutical agent(s) (includes vascular flow and blood pool imaging, when performed); tomographic (SPECT), minimum 2 areas (eg, pelvis and knees, chest and abdomen) or separate acquisitions (eg, lung ventilation and perfusion), single day imaging, or single area or acquisition over 2 or more days
78832	SourceAtomCluster	78832	False	False	CPT	32	0					NONE	NONE		NONE	C5702041;C5702045;C5702046;C5411788;C5411791;C5411798;C5411802;C5411804;C5411790;C5411797;C5411799;C5702042;C5702043;C5201927;C5702040;C5702044;C5411789;C5411794;C5411795;C5411792;C5411796;C5411793;C5411803;C5411805;C5411806		Radiopharmaceutical localization of tumor, inflammatory process or distribution of radiopharmaceutical agent(s) (includes vascular flow and blood pool imaging, when performed); tomographic (SPECT) with concurrently acquired computed tomography (CT) transmission scan for anatomical review, localization and determination/detection of pathology, minimum 2 areas (eg, pelvis and knees, chest and abdomen) or separate acquisitions (eg, lung ventilation and perfusion), single day imaging, or single area or acquisition over 2 or more days
78835	SourceAtomCluster	78835	False	False	CPT	6	0					NONE	NONE		NONE	C5696496;C5201958;C5201956		Radiopharmaceutical quantification measurement(s) single area (List separately in addition to code for primary procedure)
78999	SourceAtomCluster	78999	False	False	CPT	5	0					NONE	NONE		NONE	C0373458;C5696502;C5411827		Unlisted miscellaneous procedure, diagnostic nuclear medicine
79005	SourceAtomCluster	79005	False	False	CPT	5	0					NONE	NONE		NONE	C2169312;C5696503;C1504152		Radiopharmaceutical therapy, by oral administration
79101	SourceAtomCluster	79101	False	False	CPT	5	0					NONE	NONE		NONE	C2169305;C1504153;C5696504		Radiopharmaceutical therapy, by intravenous administration
79200	SourceAtomCluster	79200	False	False	CPT	5	0					NONE	NONE		NONE	C0203614;C5696505;C3525561		Radiopharmaceutical therapy, by intracavitary administration
79300	SourceAtomCluster	79300	False	False	CPT	5	0					NONE	NONE		NONE	C5696506;C0203615;C3525562		Radiopharmaceutical therapy, by interstitial radioactive colloid administration
79403	SourceAtomCluster	79403	False	False	CPT	5	0					NONE	NONE		NONE	C5696507;C1314096		Radiopharmaceutical therapy, radiolabeled monoclonal antibody by intravenous infusion
79440	SourceAtomCluster	79440	False	False	CPT	5	0					NONE	NONE		NONE	C2094671;C5696508;C0373463		Radiopharmaceutical therapy, by intra-articular administration
79445	SourceAtomCluster	79445	False	False	CPT	5	0					NONE	NONE		NONE	C1504154;C3865755;C5696509		Radiopharmaceutical therapy, by intra-arterial particulate administration
79999	SourceAtomCluster	79999	False	False	CPT	5	0					NONE	NONE		NONE	C0203608;C5411829;C0373465		Radiopharmaceutical therapy, unlisted procedure
80061	SourceAtomCluster	80061	False	False	CPT	8	0					NONE	NONE		NONE	C5411876;C0200382;C5574763;C5411875;C5411874		Lipid panel This panel must include the following: Cholesterol, serum, total (82465) Lipoprotein, direct measurement, high density cholesterol (HDL cholesterol) (83718) Triglycerides (84478)
81528	SourceAtomCluster	81528	False	False	CPT	5	0					NONE	NONE		NONE	C5413264;C4051849;C4051914		Oncology (colorectal) screening, quantitative real-time target and signal amplification of 10 DNA markers (KRAS mutations, promoter methylation of NDRG4 and BMP3) and fecal hemoglobin, utilizing stool, algorithm reported as a positive or negative result
82270	SourceAtomCluster	82270	False	False	CPT	5	0					NONE	NONE		NONE	C5413325;C0519828;C3516305		Blood, occult, by peroxidase activity (eg, guaiac), qualitative; feces, consecutive collected specimens with single determination, for colorectal neoplasm screening (ie, patient was provided 3 cards or single triple card for consecutive collection)
82465	SourceAtomCluster	82465	False	False	CPT	6	0					NONE	NONE		NONE	C0201950;C0373576;C1445957;C3525706		Cholesterol, serum or whole blood, total
82947	SourceAtomCluster	82947	False	False	CPT	5	0					NONE	NONE		NONE	C5413394;C0392201;C0523658		Glucose; quantitative, blood (except reagent strip)
82950	SourceAtomCluster	82950	False	False	CPT	5	0					NONE	NONE		NONE	C0373621		Glucose; post glucose dose (includes glucose)
82951	SourceAtomCluster	82951	False	False	CPT	5	0					NONE	NONE		NONE	C5413396;C5413395;C0373622		Glucose; tolerance test (GTT), 3 specimens (includes glucose)
83718	SourceAtomCluster	83718	False	False	CPT	5	0					NONE	NONE		NONE	C0392885		Lipoprotein, direct measurement; high density cholesterol (HDL cholesterol)
84478	SourceAtomCluster	84478	False	False	CPT	5	0					NONE	NONE		NONE	C0202236		Triglycerides
86890	SourceAtomCluster	86890	False	False	CPT	6	0					NONE	NONE		NONE	C5413704;C3525871;C0398307;C0373961		Autologous blood or component, collection processing and storage; predeposited
86891	SourceAtomCluster	86891	False	False	CPT	8	0					NONE	NONE		NONE	C5413705;C5413706;C5413707;C5413708;C3516487;C0373962		Autologous blood or component, collection processing and storage; intra- or postoperative salvage
86927	SourceAtomCluster	86927	False	False	CPT	5	0					NONE	NONE		NONE	C3516492;C5413723;C0373972		Fresh frozen plasma, thawing, each unit
86930	SourceAtomCluster	86930	False	False	CPT	5	0					NONE	NONE		NONE	C3516493;C5413724;C0373973		Frozen blood, each unit; freezing (includes preparation)
86931	SourceAtomCluster	86931	False	False	CPT	5	0					NONE	NONE		NONE	C5413725;C3516494;C0373974		Frozen blood, each unit; thawing
86932	SourceAtomCluster	86932	False	False	CPT	5	0					NONE	NONE		NONE	C3516495;C5413726;C0373975		Frozen blood, each unit; freezing (includes preparation) and thawing
86945	SourceAtomCluster	86945	False	False	CPT	5	0					NONE	NONE		NONE	C0200620		Irradiation of blood product, each unit
86950	SourceAtomCluster	86950	False	False	CPT	5	0					NONE	NONE		NONE	C0086548		Leukocyte transfusion
86960	SourceAtomCluster	86960	False	False	CPT	6	0					NONE	NONE		NONE	C1609549;C3516497;C5413729;C5413728		Volume reduction of blood or blood product (eg, red blood cells or platelets), each unit
86965	SourceAtomCluster	86965	False	False	CPT	6	0					NONE	NONE		NONE	C0373978;C3525890;C2097072		Pooling of platelets or other blood products
86985	SourceAtomCluster	86985	False	False	CPT	6	0					NONE	NONE		NONE	C5413762;C0373984;C3516500;C5413763		Splitting of blood or blood products, each unit
90612																		
90613																		
90635																		
90637	SourceAtomCluster	90637	False	False	CPT	5	0					NONE	NONE		NONE	C5944836		Influenza virus vaccine, quadrivalent (qIRV), mRNA; 30 mcg/0.5 mL dosage, for intramuscular use
90638	SourceAtomCluster	90638	False	False	CPT	5	0					NONE	NONE		NONE	C5944837		Influenza virus vaccine, quadrivalent (qIRV), mRNA; 60 mcg/0.5 mL dosage, for intramuscular use
90653	SourceAtomCluster	90653	False	False	CPT	5	0					NONE	NONE		NONE	C3511580;C5696648;C5414799		Influenza vaccine, inactivated (IIV), subunit, adjuvanted, for intramuscular use
90655	SourceAtomCluster	90655	False	False	CPT	5	0					NONE	NONE		NONE	C4291797;C5696650		Influenza virus vaccine, trivalent (IIV3), split virus, preservative free, 0.25 mL dosage, for intramuscular use
90656	SourceAtomCluster	90656	False	False	CPT	5	0					NONE	NONE		NONE	C4291798;C5696651		Influenza virus vaccine, trivalent (IIV3), split virus, preservative free, 0.5 mL dosage, for intramuscular use
90657	SourceAtomCluster	90657	False	False	CPT	5	0					NONE	NONE		NONE	C4291799;C5696652		Influenza virus vaccine, trivalent (IIV3), split virus, 0.25 mL dosage, for intramuscular use
90658	SourceAtomCluster	90658	False	False	CPT	5	0					NONE	NONE		NONE	C5696653;C4291800		Influenza virus vaccine, trivalent (IIV3), split virus, 0.5 mL dosage, for intramuscular use
90660	SourceAtomCluster	90660	False	False	CPT	5	0					NONE	NONE		NONE	C4051836;C5696654		Influenza virus vaccine, trivalent, live (LAIV3), for intranasal use
90661	SourceAtomCluster	90661	False	False	CPT	5	0					NONE	NONE		NONE	C1964063;C5944832		Influenza virus vaccine, trivalent (ccIIV3), derived from cell cultures, subunit, antibiotic free, 0.5 mL dosage, for intramuscular use
90662	SourceAtomCluster	90662	False	False	CPT	5	0					NONE	NONE		NONE	C1964064;C5696659		Influenza virus vaccine (IIV), split virus, preservative free, enhanced immunogenicity via increased antigen content, for intramuscular use
90670	SourceAtomCluster	90670	False	False	CPT	5	0					NONE	NONE		NONE	C2724349;C5700427		Pneumococcal conjugate vaccine, 13 valent (PCV13), for intramuscular use
90671	SourceAtomCluster	90671	False	False	CPT	5	0					NONE	NONE		NONE	C5691554		Pneumococcal conjugate vaccine, 15 valent (PCV15), for intramuscular use
90672	SourceAtomCluster	90672	False	False	CPT	5	0					NONE	NONE		NONE	C4051835;C5414818		Influenza virus vaccine, quadrivalent, live (LAIV4), for intranasal use
90673	SourceAtomCluster	90673	False	False	CPT	5	0					NONE	NONE		NONE	C3702513;C5414820;C5696658		Influenza virus vaccine, trivalent (RIV3), derived from recombinant DNA, hemagglutinin (HA) protein only, preservative and antibiotic free, for intramuscular use
90674	SourceAtomCluster	90674	False	False	CPT	5	0					NONE	NONE		NONE	C4291801;C5696656		Influenza virus vaccine, quadrivalent (ccIIV4), derived from cell cultures, subunit, preservative and antibiotic free, 0.5 mL dosage, for intramuscular use
90677	SourceAtomCluster	90677	False	False	CPT	5	0					NONE	NONE		NONE	C5691555		Pneumococcal conjugate vaccine, 20 valent (PCV20), for intramuscular use
90682	SourceAtomCluster	90682	False	False	CPT	5	0					NONE	NONE		NONE	C4301942;C5696666		Influenza virus vaccine, quadrivalent (RIV4), derived from recombinant DNA, hemagglutinin (HA) protein only, preservative and antibiotic free, for intramuscular use
90684	SourceAtomCluster	90684	False	False	CPT	5	0					NONE	NONE		NONE	C5944834		Pneumococcal conjugate vaccine, 21 valent (PCV21), for intramuscular use
90685	SourceAtomCluster	90685	False	False	CPT	5	0					NONE	NONE		NONE	C4291802;C5696667		Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.25 mL dosage, for intramuscular use
90686	SourceAtomCluster	90686	False	False	CPT	5	0					NONE	NONE		NONE	C4291803;C5696668		Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use
90687	SourceAtomCluster	90687	False	False	CPT	5	0					NONE	NONE		NONE	C4291804;C5696669		Influenza virus vaccine, quadrivalent (IIV4), split virus, 0.25 mL dosage, for intramuscular use
90688	SourceAtomCluster	90688	False	False	CPT	5	0					NONE	NONE		NONE	C4291805;C5696670		Influenza virus vaccine, quadrivalent (IIV4), split virus, 0.5 mL dosage, for intramuscular use
90689	SourceAtomCluster	90689	False	False	CPT	5	0					NONE	NONE		NONE	C5696671;C4732390		Influenza virus vaccine, quadrivalent (IIV4), inactivated, adjuvanted, preservative free, 0.25 mL dosage, for intramuscular use
90694	SourceAtomCluster	90694	False	False	CPT	5	0					NONE	NONE		NONE	C5202239;C5696672		Influenza virus vaccine, quadrivalent (aIIV4), inactivated, adjuvanted, preservative free, 0.5 mL dosage, for intramuscular use
90695	SourceAtomCluster	90695	False	False	CPT	5	0					NONE	NONE		NONE	C5944833		Influenza virus vaccine, H5N8, derived from cell cultures, adjuvanted, for intramuscular use
90732	SourceAtomCluster	90732	False	False	CPT	6	0					NONE	NONE		NONE	C5696683;C5414851;C5414850;C0374122		Pneumococcal polysaccharide vaccine, 23-valent (PPSV23), adult or immunosuppressed patient dosage, when administered to individuals 2 years or older, for subcutaneous or intramuscular use
90739	SourceAtomCluster	90739	False	False	CPT	6	0					NONE	NONE		NONE	C5702325;C3511582;C5702326		Hepatitis B vaccine (HepB), CpG-adjuvanted, adult dosage, 2 dose or 4 dose schedule, for intramuscular use
90740	SourceAtomCluster	90740	False	False	CPT	6	0					NONE	NONE		NONE	C5696691;C5414858;C5414857;C0918229		Hepatitis B vaccine (HepB), dialysis or immunosuppressed patient dosage, 3 dose schedule, for intramuscular use
90743	SourceAtomCluster	90743	False	False	CPT	5	0					NONE	NONE		NONE	C5696692;C0918230		Hepatitis B vaccine (HepB), adolescent, 2 dose schedule, for intramuscular use
90744	SourceAtomCluster	90744	False	False	CPT	6	0					NONE	NONE		NONE	C5696693;C0374127;C5414860;C5414861		Hepatitis B vaccine (HepB), pediatric/adolescent dosage, 3 dose schedule, for intramuscular use
90746	SourceAtomCluster	90746	False	False	CPT	5	0					NONE	NONE		NONE	C5696694;C0374129		Hepatitis B vaccine (HepB), adult dosage, 3 dose schedule, for intramuscular use
90747	SourceAtomCluster	90747	False	False	CPT	6	0					NONE	NONE		NONE	C5696696;C5414864;C5414863;C0374130		Hepatitis B vaccine (HepB), dialysis or immunosuppressed patient dosage, 4 dose schedule, for intramuscular use
90749	SourceAtomCluster	90749	False	False	CPT	6	0					NONE	NONE		NONE	C5696699;C5414866;C5414867;C0374131		Unlisted vaccine/toxoid
90756	SourceAtomCluster	90756	False	False	CPT	5	0					NONE	NONE		NONE	C4523607;C5696657		Influenza virus vaccine, quadrivalent (ccIIV4), derived from cell cultures, subunit, antibiotic free, 0.5 mL dosage, for intramuscular use
90759	SourceAtomCluster	90759	False	False	CPT	5	0					NONE	NONE		NONE	C5696695;C5691558		Hepatitis B vaccine (HepB), 3-antigen (S, Pre-S1, Pre-S2), 10 mcg dosage, 3 dose schedule, for intramuscular use
90901	SourceAtomCluster	90901	False	False	CPT	5	0					NONE	NONE		NONE	C0204634;C0871664		Biofeedback training by any modality
90912	SourceAtomCluster	90912	False	False	CPT	28	0					NONE	NONE		NONE	C5414898;C5414901;C5414903;C5414889;C5414902;C5202244;C5202243;C5414883;C5414884;C5414886;C5414893;C5414896;C5414906;C5414885;C5414888;C5414891;C5414894;C5414895;C5414897;C5414899;C5414904;C5414905;C5414887;C5414890;C5414892		Biofeedback training, perineal muscles, anorectal or urethral sphincter, including EMG and/or manometry, when performed; initial 15 minutes of one-on-one physician or other qualified health care professional contact with the patient
90913	SourceAtomCluster	90913	False	False	CPT	16	0					NONE	NONE		NONE	C5414908;C5414909;C5414911;C5414917;C5414912;C5414915;C5414918;C5696716;C5202257;C5414910;C5414913;C5414907;C5414914;C5414916		Biofeedback training, perineal muscles, anorectal or urethral sphincter, including EMG and/or manometry, when performed; each additional 15 minutes of one-on-one physician or other qualified health care professional contact with the patient (List separately in addition to code for primary procedure)
91110	SourceAtomCluster	91110	False	False	CPT	5	0					NONE	NONE		NONE	C1314125;C3704003;C5414957		Gastrointestinal tract imaging, intraluminal (eg, capsule endoscopy), esophagus through ileum, with interpretation and report
91111	SourceAtomCluster	91111	False	False	CPT	5	0					NONE	NONE		NONE	C5414958;C3704004;C1740482		Gastrointestinal tract imaging, intraluminal (eg, capsule endoscopy), esophagus with interpretation and report
91304	SourceAtomCluster	91304	False	False	CPT	5	0					NONE	NONE		NONE	C5691553;C5696640		Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, recombinant spike protein nanoparticle, saponin-based adjuvant, 5 mcg/0.5 mL dosage, for intramuscular use
91318	SourceAtomCluster	91318	False	False	CPT	5	0					NONE	NONE		NONE	C5852108		Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, 3 mcg/0.3 mL dosage, tris-sucrose formulation, for intramuscular use
91319	SourceAtomCluster	91319	False	False	CPT	5	0					NONE	NONE		NONE	C5852109		Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, 10 mcg/0.3 mL dosage, tris-sucrose formulation, for intramuscular use
91320	SourceAtomCluster	91320	False	False	CPT	5	0					NONE	NONE		NONE	C5852110		Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, 30 mcg/0.3 mL dosage, tris-sucrose formulation, for intramuscular use
91321	SourceAtomCluster	91321	False	False	CPT	5	0					NONE	NONE		NONE	C5852111		Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, 25 mcg/0.25 mL dosage, for intramuscular use
91322	SourceAtomCluster	91322	False	False	CPT	5	0					NONE	NONE		NONE	C5852112		Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, 50 mcg/0.5 mL dosage, for intramuscular use
91323																		
92132	SourceAtomCluster	92132	False	False	CPT	8	0					NONE	NONE		NONE	C2939303;C5696778;C5944842;C5944839;C5944840;C5944841		Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), anterior segment, with interpretation and report, unilateral or bilateral
92133	SourceAtomCluster	92133	False	False	CPT	8	0					NONE	NONE		NONE	C2939304;C5696779;C5944844;C5944847;C5944846;C5944845		Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; optic nerve
92134	SourceAtomCluster	92134	False	False	CPT	8	0					NONE	NONE		NONE	C5696780;C2939305;C5944851;C5944848;C5944849;C5944850		Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; retina
92137	SourceAtomCluster	92137	False	False	CPT	8	0					NONE	NONE		NONE	C5944854;C5944856;C5944852;C5944857;C5944853;C5944855		Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; retina, including OCT angiography
92227	SourceAtomCluster	92227	False	False	CPT	8	0					NONE	NONE		NONE	C5414991;C2939306;C5414989;C5696784;C5414990;C5414988		Imaging of retina for detection or monitoring of disease; with remote clinical staff review and report, unilateral or bilateral
92228	SourceAtomCluster	92228	False	False	CPT	8	0					NONE	NONE		NONE	C2939307;C5414993;C5414994;C5414995;C5696785;C5414996		Imaging of retina for detection or monitoring of disease; with remote physician or other qualified health care professional interpretation and report, unilateral or bilateral
92229	SourceAtomCluster	92229	False	False	CPT	8	0					NONE	NONE		NONE	C5702333;C5702334;C5702336;C5702335;C5414997;C5414998		Imaging of retina for detection or monitoring of disease; point-of-care autonomous analysis and report, unilateral or bilateral
92507	SourceAtomCluster	92507	False	False	CPT	7	0					NONE	NONE		NONE	C5415038;C0374250;C3516880;C5415040;C5415039		Treatment of speech, language, voice, communication, and/or auditory processing disorder; individual
92508	SourceAtomCluster	92508	False	False	CPT	7	0					NONE	NONE		NONE	C5696813;C5415041;C5415042;C5415043;C0374251		Treatment of speech, language, voice, communication, and/or auditory processing disorder; group, 2 or more individuals
92520	SourceAtomCluster	92520	False	False	CPT	5	0					NONE	NONE		NONE	C5696815;C0199432		Laryngeal function studies (ie, aerodynamic testing and acoustic testing)
92521	SourceAtomCluster	92521	False	False	CPT	5	0					NONE	NONE		NONE	C5696816;C3702514		Evaluation of speech fluency (eg, stuttering, cluttering)
92522	SourceAtomCluster	92522	False	False	CPT	5	0					NONE	NONE		NONE	C3702515		Evaluation of speech sound production (eg, articulation, phonological process, apraxia, dysarthria)
92523	SourceAtomCluster	92523	False	False	CPT	5	0					NONE	NONE		NONE	C3702516;C3709158		Evaluation of speech sound production (eg, articulation, phonological process, apraxia, dysarthria); with evaluation of language comprehension and expression (eg, receptive and expressive language)
92524	SourceAtomCluster	92524	False	False	CPT	5	0					NONE	NONE		NONE	C5696817;C3702517		Behavioral and qualitative analysis of voice and resonance
92526	SourceAtomCluster	92526	False	False	CPT	7	0					NONE	NONE		NONE	C5696818;C3526665;C2121152;C3526664;C0374254		Treatment of swallowing dysfunction and/or oral function for feeding
92597	SourceAtomCluster	92597	False	False	CPT	7	0					NONE	NONE		NONE	C5696867;C3526674;C3526676;C3526675;C0374267		Evaluation for use and/or fitting of voice prosthetic device to supplement oral speech
92607	SourceAtomCluster	92607	False	False	CPT	5	0					NONE	NONE		NONE	C1144725;C5696871;C5415092		Evaluation for prescription for speech-generating augmentative and alternative communication device, face-to-face with the patient; first hour
92608	SourceAtomCluster	92608	False	False	CPT	5	0					NONE	NONE		NONE	C1144726;C5696872;C5415093		Evaluation for prescription for speech-generating augmentative and alternative communication device, face-to-face with the patient; each additional 30 minutes (List separately in addition to code for primary procedure)
92609	SourceAtomCluster	92609	False	False	CPT	5	0					NONE	NONE		NONE	C1144727;C5696873;C5415094		Therapeutic services for the use of speech-generating device, including programming and modification
92610	SourceAtomCluster	92610	False	False	CPT	5	0					NONE	NONE		NONE	C1144728;C3516936		Evaluation of oral and pharyngeal swallowing function
92611	SourceAtomCluster	92611	False	False	CPT	6	0					NONE	NONE		NONE	C1144729;C3526680;C5696874;C3516937		Motion fluoroscopic evaluation of swallowing function by cine or video recording
92612	SourceAtomCluster	92612	False	False	CPT	6	0					NONE	NONE		NONE	C5415095;C1144730;C3704010;C5415096		Flexible endoscopic evaluation of swallowing by cine or video recording
92614	SourceAtomCluster	92614	False	False	CPT	6	0					NONE	NONE		NONE	C5415099;C1144780;C3516940;C5415100		Flexible endoscopic evaluation, laryngeal sensory testing by cine or video recording
92616	SourceAtomCluster	92616	False	False	CPT	6	0					NONE	NONE		NONE	C3516942;C1144732;C5415104;C5415103		Flexible endoscopic evaluation of swallowing and laryngeal sensory testing by cine or video recording
92974	SourceAtomCluster	92974	False	False	CPT	5	0					NONE	NONE		NONE	C5696904;C0973347;C3526708		Transcatheter placement of radiation delivery device for subsequent coronary intravascular brachytherapy (List separately in addition to code for primary procedure)
93303	SourceAtomCluster	93303	False	False	CPT	5	0					NONE	NONE		NONE	C5696954;C0519171		Transthoracic echocardiography for congenital cardiac anomalies; complete
93304	SourceAtomCluster	93304	False	False	CPT	6	0					NONE	NONE		NONE	C5696955;C5415324;C5415325;C0519172		Transthoracic echocardiography for congenital cardiac anomalies; follow-up or limited study
93306	SourceAtomCluster	93306	False	False	CPT	6	0					NONE	NONE		NONE	C5415326;C5415327;C2366742;C5696956		Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography
93307	SourceAtomCluster	93307	False	False	CPT	6	0					NONE	NONE		NONE	C0519173;C5415329;C5415328;C0013516		Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, without spectral or color Doppler echocardiography
93308	SourceAtomCluster	93308	False	False	CPT	8	0					NONE	NONE		NONE	C5696957;C0519174;C5415330;C5415332;C5415331;C5415333		Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, follow-up or limited study
93320	SourceAtomCluster	93320	False	False	CPT	7	0					NONE	NONE		NONE	C5415345;C5696966;C0520400;C5415343;C5415344		Doppler echocardiography, pulsed wave and/or continuous wave with spectral display (List separately in addition to codes for echocardiographic imaging); complete
93321	SourceAtomCluster	93321	False	False	CPT	10	0					NONE	NONE		NONE	C5415348;C5415351;C5696967;C5415347;C5415349;C5415350;C5415346;C0520401		Doppler echocardiography, pulsed wave and/or continuous wave with spectral display (List separately in addition to codes for echocardiographic imaging); follow-up or limited study (List separately in addition to codes for echocardiographic imaging)
93325	SourceAtomCluster	93325	False	False	CPT	5	0					NONE	NONE		NONE	C2022193;C0474781;C5696968		Doppler echocardiography color flow velocity mapping (List separately in addition to codes for echocardiography)
93356	SourceAtomCluster	93356	False	False	CPT	5	0					NONE	NONE		NONE	C5202292;C5202294;C5202293		Myocardial strain imaging using speckle tracking-derived assessment of myocardial mechanics (List separately in addition to codes for echocardiography imaging)
93797	SourceAtomCluster	93797	False	False	CPT	6	0					NONE	NONE		NONE	C5697041;C3526866;C5415490;C0199540		Physician or other qualified health care professional services for outpatient cardiac rehabilitation; without continuous ECG monitoring (per session)
93798	SourceAtomCluster	93798	False	False	CPT	6	0					NONE	NONE		NONE	C5415492;C5697042;C5415491;C0199541		Physician or other qualified health care professional services for outpatient cardiac rehabilitation; with continuous ECG monitoring (per session)
93880	SourceAtomCluster	93880	False	False	CPT	5	0					NONE	NONE		NONE	C5415495;C5697044;C0374346		Duplex scan of extracranial arteries; complete bilateral study
93882	SourceAtomCluster	93882	False	False	CPT	6	0					NONE	NONE		NONE	C3526869;C3526868;C5697045;C0374347		Duplex scan of extracranial arteries; unilateral or limited study
93886	SourceAtomCluster	93886	False	False	CPT	5	0					NONE	NONE		NONE	C0203387;C5697046;C5415496		Transcranial Doppler study of the intracranial arteries; complete study
93888	SourceAtomCluster	93888	False	False	CPT	5	0					NONE	NONE		NONE	C0203388;C2061932;C5697047		Transcranial Doppler study of the intracranial arteries; limited study
93892	SourceAtomCluster	93892	False	False	CPT	5	0					NONE	NONE		NONE	C5697049;C1504189;C2145231		Transcranial Doppler study of the intracranial arteries; emboli detection without intravenous microbubble injection
93893	SourceAtomCluster	93893	False	False	CPT	5	0					NONE	NONE		NONE	C1504190;C5944859		Transcranial Doppler study of the intracranial arteries; venous-arterial shunt detection with intravenous microbubble injection
93896	SourceAtomCluster	93896	False	False	CPT	5	0					NONE	NONE		NONE	C5944860;C5944861		Vasoreactivity study performed with transcranial Doppler study of intracranial arteries, complete (List separately in addition to code for primary procedure)
93897	SourceAtomCluster	93897	False	False	CPT	5	0					NONE	NONE		NONE	C5944862;C5944863		Emboli detection without intravenous microbubble injection performed with transcranial Doppler study of intracranial arteries, complete (List separately in addition to code for primary procedure)
93898	SourceAtomCluster	93898	False	False	CPT	5	0					NONE	NONE		NONE	C5944864;C5944865		Venous-arterial shunt detection with intravenous microbubble injection performed with transcranial Doppler study of intracranial arteries, complete (List separately in addition to code for primary procedure)
93922	SourceAtomCluster	93922	False	False	CPT	6	0					NONE	NONE		NONE	C2939333;C3526871;C5697052;C3526872		Limited bilateral noninvasive physiologic studies of upper or lower extremity arteries, (eg, for lower extremity: ankle/brachial indices at distal posterior tibial and anterior tibial/dorsalis pedis arteries plus bidirectional, Doppler waveform recording and analysis at 1-2 levels, or ankle/brachial indices at distal posterior tibial and anterior tibial/dorsalis pedis arteries plus volume plethysmography at 1-2 levels, or ankle/brachial indices at distal posterior tibial and anterior tibial/dorsalis pedis arteries with, transcutaneous oxygen tension measurement at 1-2 levels)
93923	SourceAtomCluster	93923	False	False	CPT	6	0					NONE	NONE		NONE	C2939334;C5415500;C5697053;C5415499		Complete bilateral noninvasive physiologic studies of upper or lower extremity arteries, 3 or more levels (eg, for lower extremity: ankle/brachial indices at distal posterior tibial and anterior tibial/dorsalis pedis arteries plus segmental blood pressure measurements with bidirectional Doppler waveform recording and analysis, at 3 or more levels, or ankle/brachial indices at distal posterior tibial and anterior tibial/dorsalis pedis arteries plus segmental volume plethysmography at 3 or more levels, or ankle/brachial indices at distal posterior tibial and anterior tibial/dorsalis pedis arteries plus segmental transcutaneous oxygen tension measurements at 3 or more levels), or single level study with provocative functional maneuvers (eg, measurements with postural provocative tests, or measurements with reactive hyperemia)
93924	SourceAtomCluster	93924	False	False	CPT	5	0					NONE	NONE		NONE	C5415501;C2939335;C5697054		Noninvasive physiologic studies of lower extremity arteries, at rest and following treadmill stress testing, (ie, bidirectional Doppler waveform or volume plethysmography recording and analysis at rest with ankle/brachial indices immediately after and at timed intervals following performance of a standardized protocol on a motorized treadmill plus recording of time of onset of claudication or other symptoms, maximal walking time, and time to recovery) complete bilateral study
93925	SourceAtomCluster	93925	False	False	CPT	6	0					NONE	NONE		NONE	C0374351;C5697055;C5415503;C5415502		Duplex scan of lower extremity arteries or arterial bypass grafts; complete bilateral study
93926	SourceAtomCluster	93926	False	False	CPT	8	0					NONE	NONE		NONE	C5697056;C3526879;C3526878;C5415505;C5415504;C0374352		Duplex scan of lower extremity arteries or arterial bypass grafts; unilateral or limited study
93930	SourceAtomCluster	93930	False	False	CPT	6	0					NONE	NONE		NONE	C0374353;C5415507;C5697057;C5415506		Duplex scan of upper extremity arteries or arterial bypass grafts; complete bilateral study
93931	SourceAtomCluster	93931	False	False	CPT	8	0					NONE	NONE		NONE	C0374354;C3526883;C5697058;C3526882;C5415508;C5415509		Duplex scan of upper extremity arteries or arterial bypass grafts; unilateral or limited study
93970	SourceAtomCluster	93970	False	False	CPT	5	0					NONE	NONE		NONE	C0374356;C5415510;C5697059		Duplex scan of extremity veins including responses to compression and other maneuvers; complete bilateral study
93971	SourceAtomCluster	93971	False	False	CPT	6	0					NONE	NONE		NONE	C5697060;C0374357;C5415512;C5415511		Duplex scan of extremity veins including responses to compression and other maneuvers; unilateral or limited study
93975	SourceAtomCluster	93975	False	False	CPT	9	0					NONE	NONE		NONE	C5415514;C5415513;C5697061;C5415515;C5415516;C5415517;C0519183		Duplex scan of arterial inflow and venous outflow of abdominal, pelvic, scrotal contents and/or retroperitoneal organs; complete study
93976	SourceAtomCluster	93976	False	False	CPT	9	0					NONE	NONE		NONE	C5415519;C5415521;C5697062;C5415520;C5415518;C5415522;C0519184		Duplex scan of arterial inflow and venous outflow of abdominal, pelvic, scrotal contents and/or retroperitoneal organs; limited study
93978	SourceAtomCluster	93978	False	False	CPT	8	0					NONE	NONE		NONE	C5415525;C5697063;C5415526;C5415523;C5415524;C0374360		Duplex scan of aorta, inferior vena cava, iliac vasculature, or bypass grafts; complete study
93979	SourceAtomCluster	93979	False	False	CPT	12	0					NONE	NONE		NONE	C5697064;C5415528;C5415529;C3526898;C5415530;C3526896;C3526899;C3526897;C5415527;C0374361		Duplex scan of aorta, inferior vena cava, iliac vasculature, or bypass grafts; unilateral or limited study
93980	SourceAtomCluster	93980	False	False	CPT	5	0					NONE	NONE		NONE	C5697065;C5415531;C0374362		Duplex scan of arterial inflow and venous outflow of penile vessels; complete study
93981	SourceAtomCluster	93981	False	False	CPT	6	0					NONE	NONE		NONE	C0374363;C5697066;C5415532;C5415533		Duplex scan of arterial inflow and venous outflow of penile vessels; follow-up or limited study
93990	SourceAtomCluster	93990	False	False	CPT	5	0					NONE	NONE		NONE	C0374364;C5697069;C5415536		Duplex scan of hemodialysis access (including arterial inflow, body of access and venous outflow)
93998	SourceAtomCluster	93998	False	False	CPT	5	0					NONE	NONE		NONE	C3248239;C3248364		Unlisted noninvasive vascular diagnostic study
95851	SourceAtomCluster	95851	False	False	CPT	6	0					NONE	NONE		NONE	C3526977;C5697175;C3526978;C0374431		Range of motion measurements and report (separate procedure); each extremity (excluding hand) or each trunk section (spine)
95852	SourceAtomCluster	95852	False	False	CPT	6	0					NONE	NONE		NONE	C5415715;C0204063;C5415714;C5697176		Range of motion measurements and report (separate procedure); hand, with or without comparison with normal side
95992	SourceAtomCluster	95992	False	False	CPT	5	0					NONE	NONE		NONE	C5697251;C1096698;C5415840		Canalith repositioning procedure(s) (eg, Epley maneuver, Semont maneuver), per day
96000	SourceAtomCluster	96000	False	False	CPT	5	0					NONE	NONE		NONE	C0973355;C5697253;C5415843		Comprehensive computer-based motion analysis by video-taping and 3D kinematics
96001	SourceAtomCluster	96001	False	False	CPT	5	0					NONE	NONE		NONE	C0973356;C5697254;C5415844		Comprehensive computer-based motion analysis by video-taping and 3D kinematics; with dynamic plantar pressure measurements during walking
96002	SourceAtomCluster	96002	False	False	CPT	6	0					NONE	NONE		NONE	C5415845;C0973357;C5697255;C5415846		Dynamic surface electromyography, during walking or other functional activities, 1-12 muscles
96105	SourceAtomCluster	96105	False	False	CPT	5	0					NONE	NONE		NONE	C5415852;C5697267;C0374463		Assessment of aphasia (includes assessment of expressive and receptive speech and language function, language comprehension, speech production ability, reading, spelling, writing, eg, by Boston Diagnostic Aphasia Examination) with interpretation and report, per hour
96125	SourceAtomCluster	96125	False	False	CPT	5	0					NONE	NONE		NONE	C1964073;C5697268;C5415853		Standardized cognitive performance testing (eg, Ross Information Processing Assessment) per hour of a qualified health care professional's time, both face-to-face time administering tests to the patient and time interpreting these test results and preparing the report
97010	SourceAtomCluster	97010	False	False	CPT	8	0					NONE	NONE		NONE	C5415987;C0374482;C5697342;C5415985;C5415988;C5415986		Application of a modality to 1 or more areas; hot or cold packs
97012	SourceAtomCluster	97012	False	False	CPT	6	0					NONE	NONE		NONE	C5415990;C0553622;C5415989;C0374483		Application of a modality to 1 or more areas; traction, mechanical
97016	SourceAtomCluster	97016	False	False	CPT	6	0					NONE	NONE		NONE	C5697344;C5415993;C0374485;C5415994		Application of a modality to 1 or more areas; vasopneumatic devices
97018	SourceAtomCluster	97018	False	False	CPT	6	0					NONE	NONE		NONE	C5415995;C5415996;C5697345;C0374486		Application of a modality to 1 or more areas; paraffin bath
97022	SourceAtomCluster	97022	False	False	CPT	6	0					NONE	NONE		NONE	C5697346;C5416764;C5415997;C0374488		Application of a modality to 1 or more areas; whirlpool
97024	SourceAtomCluster	97024	False	False	CPT	6	0					NONE	NONE		NONE	C5697347;C5415998;C5415999;C0374489		Application of a modality to 1 or more areas; diathermy (eg, microwave)
97026	SourceAtomCluster	97026	False	False	CPT	6	0					NONE	NONE		NONE	C5697348;C0374490;C5416001;C5416000		Application of a modality to 1 or more areas; infrared
97028	SourceAtomCluster	97028	False	False	CPT	6	0					NONE	NONE		NONE	C5416003;C5697349;C5416002;C0374491		Application of a modality to 1 or more areas; ultraviolet
97032	SourceAtomCluster	97032	False	False	CPT	6	0					NONE	NONE		NONE	C0374492;C5416004;C5697350;C5416005		Application of a modality to 1 or more areas; electrical stimulation (manual), each 15 minutes
97033	SourceAtomCluster	97033	False	False	CPT	6	0					NONE	NONE		NONE	C5697351;C5416006;C5416007;C0374493		Application of a modality to 1 or more areas; iontophoresis, each 15 minutes
97034	SourceAtomCluster	97034	False	False	CPT	6	0					NONE	NONE		NONE	C5697352;C0374494;C5416008;C5416009		Application of a modality to 1 or more areas; contrast baths, each 15 minutes
97035	SourceAtomCluster	97035	False	False	CPT	6	0					NONE	NONE		NONE	C5416011;C5697353;C5416010;C0374495		Application of a modality to 1 or more areas; ultrasound, each 15 minutes
97036	SourceAtomCluster	97036	False	False	CPT	6	0					NONE	NONE		NONE	C5697354;C0374496;C5416013;C5416012		Application of a modality to 1 or more areas; Hubbard tank, each 15 minutes
97039	SourceAtomCluster	97039	False	False	CPT	5	0					NONE	NONE		NONE	C5697355;C5416014;C0374497		Unlisted modality (specify type and time if constant attendance)
97110	SourceAtomCluster	97110	False	False	CPT	5	0					NONE	NONE		NONE	C0374498;C3517306;C5697356		Therapeutic procedure, 1 or more areas, each 15 minutes; therapeutic exercises to develop strength and endurance, range of motion and flexibility
97112	SourceAtomCluster	97112	False	False	CPT	6	0					NONE	NONE		NONE	C0374499;C5697357;C5416015;C5416016		Therapeutic procedure, 1 or more areas, each 15 minutes; neuromuscular reeducation of movement, balance, coordination, kinesthetic sense, posture, and/or proprioception for sitting and/or standing activities
97113	SourceAtomCluster	97113	False	False	CPT	6	0					NONE	NONE		NONE	C0374500;C5697358;C5416017;C5416018		Therapeutic procedure, 1 or more areas, each 15 minutes; aquatic therapy with therapeutic exercises
97116	SourceAtomCluster	97116	False	False	CPT	6	0					NONE	NONE		NONE	C5697359;C5416019;C5416020;C0374501		Therapeutic procedure, 1 or more areas, each 15 minutes; gait training (includes stair climbing)
97124	SourceAtomCluster	97124	False	False	CPT	12	0					NONE	NONE		NONE	C5697360;C5416023;C5416024;C5416028;C5416022;C5416021;C5416026;C5416025;C5416027;C0374503		Therapeutic procedure, 1 or more areas, each 15 minutes; massage, including effleurage, petrissage and/or tapotement (stroking, compression, percussion)
97129	SourceAtomCluster	97129	False	False	CPT	5	0					NONE	NONE		NONE	C5697361;C5202410;C5202411		Therapeutic interventions that focus on cognitive function (eg, attention, memory, reasoning, executive function, problem solving, and/or pragmatic functioning) and compensatory strategies to manage the performance of an activity (eg, managing time or schedules, initiating, organizing, and sequencing tasks), direct (one-on-one) patient contact; initial 15 minutes
97130	SourceAtomCluster	97130	False	False	CPT	5	0					NONE	NONE		NONE	C5697362;C5202412;C5202414		Therapeutic interventions that focus on cognitive function (eg, attention, memory, reasoning, executive function, problem solving, and/or pragmatic functioning) and compensatory strategies to manage the performance of an activity (eg, managing time or schedules, initiating, organizing, and sequencing tasks), direct (one-on-one) patient contact; each additional 15 minutes (List separately in addition to code for primary procedure)
97139	SourceAtomCluster	97139	False	False	CPT	5	0					NONE	NONE		NONE	C0393107;C5416029;C0374504		Unlisted therapeutic procedure (specify)
97140	SourceAtomCluster	97140	False	False	CPT	6	0					NONE	NONE		NONE	C5416030;C5697363;C0695171;C5416031		Manual therapy techniques (eg, mobilization/ manipulation, manual lymphatic drainage, manual traction), 1 or more regions, each 15 minutes
97150	SourceAtomCluster	97150	False	False	CPT	5	0					NONE	NONE		NONE	C0374505;C5697364		Therapeutic procedure(s), group (2 or more individuals)
97161	SourceAtomCluster	97161	False	False	CPT	5	0					NONE	NONE		NONE	C4292027;C4291816;C5416042		Physical therapy evaluation: low complexity, requiring these components: A history with no personal factors and/or comorbidities that impact the plan of care; An examination of body system(s) using standardized tests and measures addressing 1-2 elements from any of the following: body structures and functions, activity limitations, and/or participation restrictions; A clinical presentation with stable and/or uncomplicated characteristics; and Clinical decision making of low complexity using standardized patient assessment instrument and/or measurable assessment of functional outcome. Typically, 20 minutes are spent face-to-face with the patient and/or family.
97162	SourceAtomCluster	97162	False	False	CPT	7	0					NONE	NONE		NONE	C5416044;C5416043;C4291817;C4292028;C5416045		Physical therapy evaluation: moderate complexity, requiring these components: A history of present problem with 1-2 personal factors and/or comorbidities that impact the plan of care; An examination of body systems using standardized tests and measures in addressing a total of 3 or more elements from any of the following: body structures and functions, activity limitations, and/or participation restrictions; An evolving clinical presentation with changing characteristics; and Clinical decision making of moderate complexity using standardized patient assessment instrument and/or measurable assessment of functional outcome. Typically, 30 minutes are spent face-to-face with the patient and/or family.
97163	SourceAtomCluster	97163	False	False	CPT	7	0					NONE	NONE		NONE	C5416048;C5416047;C4292029;C4291818;C5416046		Physical therapy evaluation: high complexity, requiring these components: A history of present problem with 3 or more personal factors and/or comorbidities that impact the plan of care; An examination of body systems using standardized tests and measures addressing a total of 4 or more elements from any of the following: body structures and functions, activity limitations, and/or participation restrictions; A clinical presentation with unstable and unpredictable characteristics; and Clinical decision making of high complexity using standardized patient assessment instrument and/or measurable assessment of functional outcome. Typically, 45 minutes are spent face-to-face with the patient and/or family.
97164	SourceAtomCluster	97164	False	False	CPT	7	0					NONE	NONE		NONE	C4292030;C5416050;C4291819;C5416049;C5416051		Re-evaluation of physical therapy established plan of care, requiring these components: An examination including a review of history and use of standardized tests and measures is required; and Revised plan of care using a standardized patient assessment instrument and/or measurable assessment of functional outcome Typically, 20 minutes are spent face-to-face with the patient and/or family.
97165	SourceAtomCluster	97165	False	False	CPT	7	0					NONE	NONE		NONE	C4291820;C4292031;C5416053;C5416054;C5416052		Occupational therapy evaluation, low complexity, requiring these components: An occupational profile and medical and therapy history, which includes a brief history including review of medical and/or therapy records relating to the presenting problem; An assessment(s) that identifies 1-3 performance deficits (ie, relating to physical, cognitive, or psychosocial skills) that result in activity limitations and/or participation restrictions; and Clinical decision making of low complexity, which includes an analysis of the occupational profile, analysis of data from problem-focused assessment(s), and consideration of a limited number of treatment options. Patient presents with no comorbidities that affect occupational performance. Modification of tasks or assistance (eg, physical or verbal) with assessment(s) is not necessary to enable completion of evaluation component. Typically, 30 minutes are spent face-to-face with the patient and/or family.
97166	SourceAtomCluster	97166	False	False	CPT	7	0					NONE	NONE		NONE	C4291821;C4292032;C5416056;C5416055;C5416057		Occupational therapy evaluation, moderate complexity, requiring these components: An occupational profile and medical and therapy history, which includes an expanded review of medical and/or therapy records and additional review of physical, cognitive, or psychosocial history related to current functional performance; An assessment(s) that identifies 3-5 performance deficits (ie, relating to physical, cognitive, or psychosocial skills) that result in activity limitations and/or participation restrictions; and Clinical decision making of moderate analytic complexity, which includes an analysis of the occupational profile, analysis of data from detailed assessment(s), and consideration of several treatment options. Patient may present with comorbidities that affect occupational performance. Minimal to moderate modification of tasks or assistance (eg, physical or verbal) with assessment(s) is necessary to enable patient to complete evaluation component. Typically, 45 minutes are spent face-to-face with the patient and/or family.
97167	SourceAtomCluster	97167	False	False	CPT	7	0					NONE	NONE		NONE	C4291822;C5416059;C5697340;C5416058;C5416060		Occupational therapy evaluation, high complexity, requiring these components: An occupational profile and medical and therapy history, which includes review of medical and/or therapy records and extensive additional review of physical, cognitive, or psychosocial history related to current functional performance; An assessment(s) that identifies 5 or more performance deficits (ie, relating to physical, cognitive, or psychosocial skills) that result in activity limitations and/or participation restrictions; and Clinical decision making of high analytic complexity, which includes an analysis of the patient profile, analysis of data from comprehensive assessment(s), and consideration of multiple treatment options. Patient presents with comorbidities that affect occupational performance. Significant modification of tasks or assistance (eg, physical or verbal) with assessment(s) is necessary to enable patient to complete evaluation component. Typically, 60 minutes are spent face-to-face with the patient and/or family.
97168	SourceAtomCluster	97168	False	False	CPT	7	0					NONE	NONE		NONE	C4291823;C5416061;C5416063;C5697341;C5416062		Re-evaluation of occupational therapy established plan of care, requiring these components: An assessment of changes in patient functional or medical status with revised plan of care; An update to the initial occupational profile to reflect changes in condition or environment that affect future interventions and/or goals; and A revised plan of care. A formal reevaluation is performed when there is a documented change in functional status or a significant change to the plan of care is required. Typically, 30 minutes are spent face-to-face with the patient and/or family.
97530	SourceAtomCluster	97530	False	False	CPT	5	0					NONE	NONE		NONE	C5416032;C0374514;C5697365		Therapeutic activities, direct (one-on-one) patient contact (use of dynamic activities to improve functional performance), each 15 minutes
97533	SourceAtomCluster	97533	False	False	CPT	5	0					NONE	NONE		NONE	C5697366;C5416033;C0918239		Sensory integrative techniques to enhance sensory processing and promote adaptive responses to environmental demands, direct (one-on-one) patient contact, each 15 minutes
97535	SourceAtomCluster	97535	False	False	CPT	6	0					NONE	NONE		NONE	C5416035;C0374515;C3517314;C5416034		Self-care/home management training (eg, activities of daily living (ADL) and compensatory training, meal preparation, safety procedures, and instructions in use of assistive technology devices/adaptive equipment) direct one-on-one contact, each 15 minutes
97537	SourceAtomCluster	97537	False	False	CPT	6	0					NONE	NONE		NONE	C3517315;C5416036;C5416037;C0374516		Community/work reintegration training (eg, shopping, transportation, money management, avocational activities and/or work environment/modification analysis, work task analysis, use of assistive technology device/adaptive equipment), direct one-on-one contact, each 15 minutes
97542	SourceAtomCluster	97542	False	False	CPT	5	0					NONE	NONE		NONE	C5697367;C0374517		Wheelchair management (eg, assessment, fitting, training), each 15 minutes
97545	SourceAtomCluster	97545	False	False	CPT	6	0					NONE	NONE		NONE	C5697368;C5416039;C5416038;C0374518		Work hardening/conditioning; initial 2 hours
97546	SourceAtomCluster	97546	False	False	CPT	6	0					NONE	NONE		NONE	C5697369;C5416041;C5416040;C0374519		Work hardening/conditioning; each additional hour (List separately in addition to code for primary procedure)
97550	SourceAtomCluster	97550	False	False	CPT	13	0					NONE	NONE		NONE	C5852161;C5852160;C5852165;C5852163;C5852166;C5852167;C5852164;C5852168;C5852169;C5852162;C5852170		Caregiver training in strategies and techniques to facilitate the patient's functional performance in the home or community (eg, activities of daily living [ADLs], instrumental ADLs [iADLs], transfers, mobility, communication, swallowing, feeding, problem solving, safety practices) (without the patient present), face to face; initial 30 minutes
97551	SourceAtomCluster	97551	False	False	CPT	13	0					NONE	NONE		NONE	C5852171;C5852172;C5852179;C5852175;C5852176;C5852177;C5852181;C5852173;C5852174;C5852180;C5852178		Caregiver training in strategies and techniques to facilitate the patient's functional performance in the home or community (eg, activities of daily living [ADLs], instrumental ADLs [iADLs], transfers, mobility, communication, swallowing, feeding, problem solving, safety practices) (without the patient present), face to face; each additional 15 minutes (List separately in addition to code for primary service)
97552	SourceAtomCluster	97552	False	False	CPT	13	0					NONE	NONE		NONE	C5852190;C5852191;C5852192;C5852182;C5852184;C5852185;C5852186;C5852189;C5852183;C5852187;C5852188		Group caregiver training in strategies and techniques to facilitate the patient's functional performance in the home or community (eg, activities of daily living [ADLs], instrumental ADLs [iADLs], transfers, mobility, communication, swallowing, feeding, problem solving, safety practices) (without the patient present), face to face with multiple sets of caregivers
97597	SourceAtomCluster	97597	False	False	CPT	6	0					NONE	NONE		NONE	C2939339;C5416078;C5697370;C5416077		Debridement (eg, high pressure waterjet with/without suction, sharp selective debridement with scissors, scalpel and forceps), open wound, (eg, fibrin, devitalized epidermis and/or dermis, exudate, debris, biofilm), including topical application(s), wound assessment, use of a whirlpool, when performed and instruction(s) for ongoing care, per session, total wound(s) surface area; first 20 sq cm or less
97598	SourceAtomCluster	97598	False	False	CPT	6	0					NONE	NONE		NONE	C5416081;C2939340;C5697371;C5416080		Debridement (eg, high pressure waterjet with/without suction, sharp selective debridement with scissors, scalpel and forceps), open wound, (eg, fibrin, devitalized epidermis and/or dermis, exudate, debris, biofilm), including topical application(s), wound assessment, use of a whirlpool, when performed and instruction(s) for ongoing care, per session, total wound(s) surface area; each additional 20 sq cm, or part thereof (List separately in addition to code for primary procedure)
97602	SourceAtomCluster	97602	False	False	CPT	5	0					NONE	NONE		NONE	C5697372;C5416082;C0918241		Removal of devitalized tissue from wound(s), non-selective debridement, without anesthesia (eg, wet-to-moist dressings, enzymatic, abrasion, larval therapy), including topical application(s), wound assessment, and instruction(s) for ongoing care, per session
97605	SourceAtomCluster	97605	False	False	CPT	5	0					NONE	NONE		NONE	C1504199;C5697373;C5416083		Negative pressure wound therapy (eg, vacuum assisted drainage collection), utilizing durable medical equipment (DME), including topical application(s), wound assessment, and instruction(s) for ongoing care, per session; total wound(s) surface area less than or equal to 50 square centimeters
97606	SourceAtomCluster	97606	False	False	CPT	5	0					NONE	NONE		NONE	C5416084;C1504200;C5697374		Negative pressure wound therapy (eg, vacuum assisted drainage collection), utilizing durable medical equipment (DME), including topical application(s), wound assessment, and instruction(s) for ongoing care, per session; total wound(s) surface area greater than 50 square centimeters
97607	SourceAtomCluster	97607	False	False	CPT	5	0					NONE	NONE		NONE	C5416085;C3865293;C5697375		Negative pressure wound therapy, (eg, vacuum assisted drainage collection), utilizing disposable, non-durable medical equipment including provision of exudate management collection system, topical application(s), wound assessment, and instructions for ongoing care, per session; total wound(s) surface area less than or equal to 50 square centimeters
97608	SourceAtomCluster	97608	False	False	CPT	5	0					NONE	NONE		NONE	C5697376;C5416086;C3854210		Negative pressure wound therapy, (eg, vacuum assisted drainage collection), utilizing disposable, non-durable medical equipment including provision of exudate management collection system, topical application(s), wound assessment, and instructions for ongoing care, per session; total wound(s) surface area greater than 50 square centimeters
97610	SourceAtomCluster	97610	False	False	CPT	6	0					NONE	NONE		NONE	C1964170;C5416087;C5697377;C5416088		Low frequency, non-contact, non-thermal ultrasound, including topical application(s), when performed, wound assessment, and instruction(s) for ongoing care, per day
97750	SourceAtomCluster	97750	False	False	CPT	6	0					NONE	NONE		NONE	C5416089;C0374521;C5697378;C5416090		Physical performance test or measurement (eg, musculoskeletal, functional capacity), with written report, each 15 minutes
97755	SourceAtomCluster	97755	False	False	CPT	5	0					NONE	NONE		NONE	C5697379;C1314127;C5416091		Assistive technology assessment (eg, to restore, augment or compensate for existing function, optimize functional tasks and/or maximize environmental accessibility), direct one-on-one contact, with written report, each 15 minutes
97760	SourceAtomCluster	97760	False	False	CPT	14	0					NONE	NONE		NONE	C5416092;C5416094;C5416098;C1609004;C5416093;C5697380;C5416095;C5416096;C5416097;C5416099		Orthotic(s) management and training (including assessment and fitting when not otherwise reported), upper extremity(ies), lower extremity(ies) and/or trunk, initial orthotic(s) encounter, each 15 minutes
97761	SourceAtomCluster	97761	False	False	CPT	9	0					NONE	NONE		NONE	C5697381;C4523647;C4523648;C4523649;C0519195		Prosthetic(s) training, upper and/or lower extremity(ies), initial prosthetic(s) encounter, each 15 minutes
97763	SourceAtomCluster	97763	False	False	CPT	58	0					NONE	NONE		NONE	C4523650;C4523655;C4523660;C4523668;C4523671;C4523674;C4523677;C4523665;C4523667;C4523669;C4523670;C4523679;C5697382;C4523652;C4523656;C4523657;C4523658;C4523661;C4523662;C4523664;C4523678;C4523653;C4523659;C4523666;C4523672		Orthotic(s)/prosthetic(s) management and/or training, upper extremity(ies), lower extremity(ies), and/or trunk, subsequent orthotic(s)/prosthetic(s) encounter, each 15 minutes
97799	SourceAtomCluster	97799	False	False	CPT	8	0					NONE	NONE		NONE	C5697383;C5416102;C5416104;C5416105;C5416103;C0374523		Unlisted physical medicine/rehabilitation service or procedure
98966	SourceAtomCluster	98966	False	False	CPT	5	0					NONE	NONE		NONE	C1964074;C5944874;C5944873		Telephone assessment and management service provided by a nonphysician qualified health care professional to an established patient, parent, or guardian not originating from a related assessment and management service provided within the previous 7 days nor leading to an assessment and management service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion
98967	SourceAtomCluster	98967	False	False	CPT	5	0					NONE	NONE		NONE	C1964075;C5944876;C5944875		Telephone assessment and management service provided by a nonphysician qualified health care professional to an established patient, parent, or guardian not originating from a related assessment and management service provided within the previous 7 days nor leading to an assessment and management service or procedure within the next 24 hours or soonest available appointment; 11-20 minutes of medical discussion
98968	SourceAtomCluster	98968	False	False	CPT	5	0					NONE	NONE		NONE	C1964076;C5944878;C5944877		Telephone assessment and management service provided by a nonphysician qualified health care professional to an established patient, parent, or guardian not originating from a related assessment and management service provided within the previous 7 days nor leading to an assessment and management service or procedure within the next 24 hours or soonest available appointment; 21-30 minutes of medical discussion
98970	SourceAtomCluster	98970	False	False	CPT	5	0					NONE	NONE		NONE	C5416150;C5416151;C5944879		Nonphysician qualified health care professional online digital assessment and management, for an established patient, for up to 7 days, cumulative time during the 7 days; 5-10 minutes
98971	SourceAtomCluster	98971	False	False	CPT	5	0					NONE	NONE		NONE	C5944880;C5202419;C5416152		Nonphysician qualified health care professional online digital assessment and management, for an established patient, for up to 7 days, cumulative time during the 7 days; 11-20 minutes
98972	SourceAtomCluster	98972	False	False	CPT	5	0					NONE	NONE		NONE	C5416153;C5416154		Nonphysician qualified health care professional online digital assessment and management, for an established patient, for up to 7 days, cumulative time during the 7 days; 21 or more minutes
98975	SourceAtomCluster	98975	False	False	CPT	7	0					NONE	NONE		NONE	C5691569;C5944882;C5944883;C5944884;C5944885		Remote therapeutic monitoring (eg, therapy adherence, therapy response, digital therapeutic intervention); initial set-up and patient education on use of equipment
98976	SourceAtomCluster	98976	False	False	CPT	13	0					NONE	NONE		NONE	C5944892;C5691570;C5944886;C5944887;C5944891;C5944894;C5944895;C5944888;C5944890;C5944893;C5944889		Remote therapeutic monitoring (eg, therapy adherence, therapy response, digital therapeutic intervention); device(s) supply for data access or data transmissions to support monitoring of respiratory system, each 30 days
98977	SourceAtomCluster	98977	False	False	CPT	13	0					NONE	NONE		NONE	C5944896;C5944899;C5944901;C5944902;C5691571;C5944897;C5944898;C5944903;C5944905;C5944900;C5944904		Remote therapeutic monitoring (eg, therapy adherence, therapy response, digital therapeutic intervention); device(s) supply for data access or data transmissions to support monitoring of musculoskeletal system, each 30 days
98979																		
98980	SourceAtomCluster	98980	False	False	CPT	5	0					NONE	NONE		NONE	C5691572;C5697399;C5698309		Remote therapeutic monitoring treatment management services, physician or other qualified health care professional time in a calendar month requiring at least one interactive communication with the patient or caregiver during the calendar month; first 20 minutes
98981	SourceAtomCluster	98981	False	False	CPT	5	0					NONE	NONE		NONE	C5697400;C5698310;C5691573		Remote therapeutic monitoring treatment management services, physician or other qualified health care professional time in a calendar month requiring at least one interactive communication with the patient or caregiver during the calendar month; each additional 20 minutes (List separately in addition to code for primary procedure)
98984																		
98985																		
A4641																		
A4642																		
A4650																		
A9500																		
A9501																		
A9502																		
A9503																		
A9504																		
A9505																		
A9506																		
A9507																		
A9508																		
A9509																		
A9510																		
A9512																		
A9513																		
A9515																		
A9516																		
A9517																		
A9520																		
A9521																		
A9524																		
A9526																		
A9527																		
A9528																		
A9529																		
A9530																		
A9531																		
A9532																		
A9536																		
A9537																		
A9538																		
A9539																		
A9540																		
A9541																		
A9542																		
A9543																		
A9546																		
A9547																		
A9548																		
A9550																		
A9551																		
A9552																		
A9553																		
A9554																		
A9555																		
A9556																		
A9557																		
A9558																		
A9559																		
A9560																		
A9561																		
A9562																		
A9563																		
A9564																		
A9566																		
A9567																		
A9568																		
A9569																		
A9570																		
A9571																		
A9572																		
A9573																		
A9576																		
A9577																		
A9578																		
A9579																		
A9580																		
A9584																		
A9586																		
A9587																		
A9588																		
A9590																		
A9591																		
A9592																		
A9593																		
A9594																		
A9595																		
A9596																		
A9597																		
A9598																		
A9600																		
A9601																		
A9602																		
A9604																		
A9606																		
A9607																		
A9608																		
A9609																		
A9610																		
A9611																		
A9612																		
A9616																		
A9697																		
A9699																		
A9700																		
A9800																		
C1716																		
C1717																		
C1719																		
C2616																		
C2634																		
C2635																		
C2636																		
C2638																		
C2639																		
C2640																		
C2641																		
C2642																		
C2643																		
C2644																		
C2645																		
C2698																		
C2699																		
C8001																		
C8004																		
C8937																		
C9067																		
C9176																		
C9762																		
C9763																		
C9791																		
C9793																		
G0027																		
G0103																		
G0118																		
G0123																		
G0124																		
G0130																		
G0141																		
G0143																		
G0144																		
G0145																		
G0147																		
G0148																		
G0183																		
G0279																		
G0281																		
G0283																		
G0288																		
G0306																		
G0307																		
G0327																		
G0328																		
G0329																		
G0339																		
G0340																		
G0416																		
G0432																		
G0433																		
G0435																		
G0451																		
G0471																		
G0472																		
G0475																		
G0476																		
G0480																		
G0481																		
G0482																		
G0483																		
G0499																		
G0541																		
G0542																		
G0543																		
G0562																		
G0563																		
G0566																		
G0567																		
G0659																		
G2250																		
G2251																		
G9143																		
P2028																		
P2029																		
P2031																		
P2033																		
P2038																		
P3000																		
P3001																		
P9612																		
P9615																		
Q0092																		
Q0111																		
Q0112																		
Q0113																		
Q0114																		
Q0115																		
Q0224																		
Q0235																		
Q0237																		
Q0249																		
Q2034																		
Q2035																		
Q2036																		
Q2037																		
Q2038																		
Q2039																		
Q3001																		
Q9950																		
Q9951																		
Q9953																		
Q9954																		
Q9955																		
Q9956																		
Q9957																		
Q9958																		
Q9959																		
Q9960																		
Q9961																		
Q9962																		
Q9963																		
Q9964																		
Q9965																		
Q9966																		
Q9967																		
Q9982																		
Q9983																		
R0070																		
R0075																		
U0001																		
U0002																		
